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FSP Section 20,000
Checklists and Illustrative Financial
Statements for Life and Health
Insurance Entities
.01 The checklists and illustrative financial statements in this section have been developed by the AICPA
Accounting and Auditing Publications Team to serve as nonauthoritative practice aids for use by preparers
and auditors of financial statements. They have not been reviewed, approved, disapproved, or otherwise
acted on by any senior technical committee of the AICPA and do not represent official positions or pro
nouncements of the AICPA. Readers should be aware of the following:
•

The checklists and illustrative financial statements do not include all disclosures and presentation
items promulgated; as a result, pronouncements deemed unlikely to be encountered in financial
statements of life and health insurance companies are not included.

•

The checklists and illustrative financial statements are tools and in no way represent official posi
tions or pronouncements of the AICPA.

The checklists have been updated to include relevant reporting and disclosure guidance issued
through September 30, 2008, including the following:
•

Financial Accounting Standards Board (FASB) Statement of Financial Accounting Stan
dards (SFAS) No. 163, Accounting for Financial Guarantee Insurance Contracts— an inter
pretation of FASB Statement No. 60

•

Revised SFAFs issued through September 30, 2008, including SFAS 141(R), Business
Combinations

•

FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes—an interpretation
of FASB Statement No. 109

•

FASB Technical Bulletin No. 01-1, Effective Date for Certain Financial Institutions of Certain
Provisions of Statement 140 Related to the Isolation of Transferred Financial Assets

•

FASB Emerging Issues Task Force consensuses adopted through the September 2008
meeting

•

FASB Staff Positions issued through September 30, 2008

•

AICPA Statement on Auditing Standards No. 114, The Auditor's Communication With
Those Charged With Governance (AICPA, Professional Standards, vol. 1, AU sec. 380)

•

AICPA Statement of Position (SOP) 07-1, Clarification of the Scope of the Audit and Ac
counting Guide Investment Companies and Accounting by Parent Companies and Equity
Method Investors for Investments in Investment Companies (AICPA, Technical Practice Aids,
ACC sec. 10,930)

•

AICPA SOP 07-2, Attestation Engagements That Address Specified Compliance Control Objec
tives and Related Controls at Entities That Provide Services to Investment Companies, Invest
ment Advisers, or Other Service Providers (AICPA, Technical Practice Aids, AUD sec. 14,430)
(continued)
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•

AICPA Practice Bulletin No. 15, Accounting by the Issuer of Surplus Notes (AICPA, Tech
nical Practice Aids, PB sec. 12,150)

•

Interpretation No. 3, "Financial Statements Audited in Accordance With International
Standards on Auditing" of AU section 534, Reporting on Financial Statements Prepared for
Use in Other Countries (AICPA, Professional Standards, vol. 1, AU sec. 9534 par. .09-.11)

•

AICPA Statement on Standards for Accounting and Review Services (SSARS) No. 17,
Omnibus Statement on Standards for Accounting and Review Services-2008 (AICPA, Profes
sional Standards, vol. 2)

•

Interpretation No. 30, "Considerations Related to Financial Statements Prepared in Ac
cordance With International Financial Reporting Standards and Compilations and Re
views Performed in Accordance With International Standards" of AR section 100, Com
pilation and Review of Financial Statements (AICPA, Professional Standards, vol. 2, AR sec.
9100 par. .130-.135)

•

AICPA Statement on Standards for Attestation Engagements No. 14, SSAE Hierarchy
(AICPA, Professional Standards, vol. 1, AT sec. 50)

•

Interpretation No. 6, "Reporting on Attestation Engagements Performed in Accordance
With Government Auditing Standards" of AT section 101, Attest Engagements (AICPA,
Professional Standards, vol. 1, AT sec. 9101 par. .56-.58)

•

Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 6, Eval
uating Consistency of Financial Statements (AICPA, PCAOB Standards and Related Rules,
Rules of the Board, "Standards")

•

AICPA Audit and Accounting Guide Life and Health Insurance Entities (with conforming
changes through March 1, 2008)

The checklists and illustrative financial statements should be modified, as appropriate, for sub
sequent pronouncements. In determining the applicability of a pronouncement, its effective
date should also be considered.

.02 A description of the insurance industry and a description of common accounting and reporting fea
tures of stock life insurance companies are presented in the AICPA Audit and Accounting Guide Life and
Health Insurance Entities (2008) (product no. 012638kk).
.03 The checklists and illustrative financial statements should be used by, or under the supervision of,
persons having adequate technical training and proficiency in the application of generally accepted account
ing principles, generally accepted auditing standards, PCAOB Auditing Standards, SSARs.

.04 Users of the checklists and illustrative financial statements are urged to refer directly to applicable
authoritative pronouncements when appropriate. If you have further questions, call the AICPA Technical
Hotline at 1-877-242-7212.

Note: This publication was extracted from sections 20,000 through 20,600 of the AICPA Financial Statement
Preparation Manual (FSP).

FSP §20,000.02
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FSP Section 20,100
Introduction
.01 The function of insurance is to pool the risks of many persons who are exposed to similar risks. For
a payment known as a premium, insurance companies undertake to relieve the policyholder of all or part of
a risk and to spread the total cost of similar risks among large groups of policyholders. One of the primary
purposes of life insurance is to provide financial assistance to named beneficiaries at the time of the death
of the insured. The long-term nature of the coverage involving the risk of death—a risk that increases with
age—is the distinguishing characteristic that sets life insurance apart from other forms of insurance. Tradi
tionally, life insurance entities provided life and health products to protect against the loss of financial sta
bility resulting from premature death or illness, and provided annuity products to protect against the risk
of outliving one's financial resources. The primary emphasis was on meeting the customer's insurance
needs. The provisions of AICPA Audit and Accounting Guide Life and Health Insurance Entities (2008) (prod
uct no. 012638kk) apply to all life and health insurance entities including stock, mutual, fraternal, and as
sessment entities.

.02 The National Association of Insurance Commissioners (NAIC) codified statutory accounting prac
tices for certain insurance enterprises, resulting in a revised Accounting Practices and Procedures Manual. The
insurance laws and regulations of the states require insurance companies domiciled in the states to comply
with the guidance provided in the NAIC Accounting Practices and Procedures Manual except as prescribed or
permitted by state law.
.03 In December 2001, the AICPA issued Statement of Position (SOP) 01-5, Amendments to Specific AICPA
Pronouncements for Changes Related to the NAIC Codification (AICPA, Technical Practice Aids, ACC sec. 10,840),
which amends SOP 94-5, Disclosures of Certain Matters in the Financial Statements of Insurance Enterprises
(AICPA, Technical Practice Aids, ACC sec. 10,630), as a result of the completion of the NAIC codification of
statutory accounting practices for certain insurance enterprises.

.04 The amendments to SOP 94-5 included in SOP 01-5 require insurance enterprises to disclose, at the
date each balance sheet is presented, a description of the prescribed or permitted statutory accounting prac
tice and the related monetary effect on statutory surplus of using an accounting practice that differs from
either state prescribed statutory accounting practices or NAIC statutory accounting practices.
.05 Those disclosures should be made if (a) state prescribed statutory accounting practices differ from
NAIC statutory accounting practices or (b) permitted state statutory accounting practices differ from either
state prescribed statutory accounting practices or NAIC statutory accounting practices, and the use of pre
scribed or permitted statutory accounting practices (individually or in the aggregate) results in reported
statutory surplus or risk-based capital that is significantly different from the statutory surplus or risk-based
capital that would have been reported had NAIC statutory accounting practices been followed.

.06 Those disclosures should be applied by a U.S. insurance enterprise, a U.S. enterprise with a U.S.
insurance subsidiary, or a foreign enterprise with a U.S. insurance subsidiary if the enterprise prepares U.S.
generally accepted accounting principles (GAAP) financial statements. If a foreign insurance enterprise that
does not have a U.S. insurance subsidiary prepares U.S. GAAP financial statements or is included in its
parent's consolidated U.S. GAAP financial statements, the notes to the financial statements should disclose
permitted regulatory accounting practices that significantly differ from the prescribed regulatory accounting
practices of its respective regulatory authority and their monetary effects.
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.07 SOP 01-5 also includes the following auditing guidance that has been updated as a result of the
completion of the NAIC codification: SOP 95-5, Auditor's Reporting on Statutory Financial Statements of Insur
ance Enterprises (AICPA, Technical Practice Aids, AUD sec. 14,310); SOP 94-1, Inquiries of State Insurance Regu
lators (AICPA, Technical Practice Aids, AUD sec. 14,290); and Interpretation No. 12, "Evaluation of the Appro
priateness of Informative Disclosures in Insurance Enterprises' Financial Statements Prepared on a Statutory
Basis," of AU section 623, Special Reports (AICPA, Professional Standards, vol. 1, AU sec. 9623 par. .60-.81).
The included auditing guidance has been approved by the Auditing Standards Board.

FSP §20,100.07

Checklists—General

5

FSP Section 20,200
Checklists—General
.01 AICPA disclosure checklists have been designed as practice aids to assist accountants in the prepa
ration of financial statements and to assist auditors in their evaluation of the adequacy of disclosures in the
financial statements they audit. Authoritative literature does not require the use of checklists, nor does it
prescribe their format or content.
.02 Within these checklists is a number of questions or statements that are accompanied by references
to the established sources of generally accepted accounting principles in which the disclosure requirements
are found. These sources include Financial Accounting Standards Board (FASB) Statements of Financial Ac
counting Standards, FASB Interpretations, FASB Staff Positions, Accounting Principles Board Opinions, Ac
counting Research Bulletins, AICPA Audit and Accounting Guides, AICPA Statements of Position, and
FASB Emerging Issues Task Force Consensuses. Checklists are designed to serve as convenient memory aids
but should not be used as a substitute for direct reference to authoritative literature.

.03 The checklists provide spaces for checking off or initialing each question or point to indicate that it
has been considered. Carefully review the topics listed and consider whether they represent potential disclo
sure items for the reporting entity for which you are preparing or auditing financial statements. Users
should check or initial
•

Yes—If the disclosure is required and has been made appropriately.

•

No—If the disclosure is required but has not been made.

•

N/A (Not Applicable)—If the disclosure is not applicable to the entity.

.04 It is important that the effect of any "No" response be considered on the auditor's or accountant's
report. For audited financial statements, a "No" response that is material to the financial statements may
warrant a departure from an unqualified opinion as discussed in paragraphs .20-.64 of AU section 508,
Reports on Audited Financial Statements (AICPA, Professional Standards, vol. 1). For reviewed or compiled fi
nancial statements, a "No" response that is material to the financial statements may warrant a departure
from a standard report as discussed in paragraphs .51-53 of AR section 100A, Compilation and Review of
Financial Statements (AICPA, Professional Standards, vol. 2).
*

.05 At the beginning of certain sections, a □ appears in the "N/A" column. If the entire section is
deemed to be nonapplicable, place a check mark in the □ and proceed to the next section.
.06 Users may find it helpful to use the right margin for certain other remarks and comments as appro
priate, including
a.

for each disclosure for which a "Yes" is indicated, a notation explaining where the disclosure is

*In February 2008, the Accounting and Review Services Committee, a senior technical committee of the AICPA, issued Statement on
Standards for Accounting and Review Services (SSARS) No. 17, Omnibus Statement on Standards for Accounting and Review Services—2008
(AICPA, Professional Standards, vol. 2). SSARS No. 17 is effective for compilations and reviews of financial statements for periods ending
on or after December 15,2008, with early application permitted.
Due to the issuance of SSARS No. 17, AR section 100, Compilation and Review of Financial Statements; AR section 9100, Accounting and
Review Services Interpretations of Section 100; AR section 200, Reporting on Comparative Financial Statements; AR section 300, Compilation
Reports on Financial Statements Included in Certain Prescribed Forms; AR section 9300, Accounting and Review Services Interpretations of Section
300; and AR section 400, Communications Between Predecessor and Successor Accountants (as they existed prior to being amended by SSARS
No. 17) have been moved to AR sections 100A, 9100A, 200A, AR section 300A, 9300A, and 400A, respectively, of Professional Standards
until the effective date of SSARS No. 17.
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located in the financial statements and a cross-reference to the applicable working papers where the
support to a disclosure may be found.
b.

for items marked as "N/A," the reasons for which they do not apply in the circumstances of the
particular report.

c.

for each disclosure for which a "No" response is indicated, a notation explaining why the disclosure
was not made (for example, because the item was not considered to be material to the financial
statements).

.07 The use of these or any other checklists requires the exercise of individual professional judgment.
These checklists are not substitutes for the original authoritative pronouncements. Users of these checklists
and illustrative materials are urged to refer directly to applicable authoritative pronouncements when ap
propriate. The checklists and illustrative materials may not include all disclosures and presentation items
promulgated, nor do they represent minimum standards or requirements. Additionally, users of the check
lists and illustrative materials are encouraged to tailor them as required to meet specific circumstances of
each particular engagement.
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FSP Section 20,300
Financial Statements and Notes Checklist
.01 This checklist has been developed by the Accounting and Auditing Publications Team of the AICPA
as a nonauthoritative practice aid for use by preparers and auditors of financial statements. This checklist
includes disclosures commonly encountered in the financial statements of stock life insurance companies
and reporting issues likely to be encountered by accountants who audit, compile, and review those types of
financial statements. They do not include all disclosures required by generally accepted accounting princi
ples (GAAP) or address all reporting situations that may arise in performing engagements in accordance
with generally accepted auditing standards, Public Company Accounting Oversight Board standards, and
Statements on Standards for Accounting and Review Services.

.02

Explanation of References:
AAG =

AICPA Audit and Accounting Guide Life and Health Insurance Entities (with
conforming changes as of March 1, 2008)

ACC =

Reference to a section number in AICPA Technical Practice Aids, Statement of
Position—Accounting

APB =

Accounting Principles Board Opinion

ARB =

Accounting Research Bulletin

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

EITF =

Emerging Issues Task Force Consensus

FASB =

Financial Accounting Standards Board

FASCON =

FASB Concept Statement

FIN =

FASB Interpretation Number

FSP =

FASB Staff Position

PB =

AICPA Practice Bulletin

PCAOB =

Public Company Accounting Oversight Board

SFAS =

FASB Statement of Financial Accounting Standards

SOP =

AICPA Statement of Position

TB =

Technical Bulletin issued by FASB staff

Checklist Questionnaire:
This checklist is organized into the sections listed below. Carefully review the topics listed and consider
whether they represent potential disclosure items for the life and health insurance company.

FSP §20,300.03
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Place
by
Applicable Sections

•

•

Balance Sheet
A. General
B.
Cash
C. Investment Securities
D. Investments Accounted for by the Equity Method
E.
Impairment of a Loan
F.
Accounts and Notes Receivable and Agents' Balances
G. Reinsurance Receivables
H. Lease Finance Receivables
I.
Deferred Acquisition Costs
J.
Property and Equipment
K. Lessee Leases
L.
Intangible Assets and Goodwill
M. Separate Account Assets
N. Deposit Accounting
O. Policy Liabilities
P.
Income Taxes
Q. Current Liabilities, Notes Payable, and Long-Term Debt
R.
Other Liabilities
S.
Shareholders' Equity

•

Income Statement
A. Premium Revenue
B.
Investment Income
C. Other Income
D. Benefits and Expenses
E.
Income Taxes
F.
Extraordinary Items, Unusual Items, Infrequent Items
G. Earnings Per Share
H. Comprehensive Income
I.
Other
Statement of Changes in Shareholders' Equity

•

Statement of Cash Flows

•

General
A.
B.
C.
D.
E.
F.
G.
H.
I.
J.

K.
L.
L1.
M.
N.

Titles and References
Disclosure of Accounting Policies
Comparative Financial Statements
Accounting Changes and Error Corrections
Risks and Uncertainties
Contingencies and Commitments
Environmental Remediation Liabilities
Related-Party Transactions and Economic Dependency
Employee Stock Ownership Plans
Employers' Disclosures for Defined Benefit Pension and Other
Postretirement Benefits
Consolidated Financial Statements
Financial Instruments
Financial Instruments of Enterprises Subject to SFAS 161
Foreign Currency
Impairment of Long-Lived Assets to Be Held and Used

FSP §20,300.03

_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
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_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
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Place by
Applicable Sections
Long-Lived Assets and Disposal Groups to Be Disposed Of
Accounting for Servicing Financial Assets
Nonmonetary Transactions
Subsequent Events
Costs Associated With Exit or Disposal Activities
Business Combinations
Segment Information
Postemployment Benefits
Stock Compensation Plans
Asset Retirement Obligations
Demutualizations and Formations of Mutual Insurance Holding
Companies
Z.
Guarantees
AA. Fair Value Measurements
O.
P.
Q.
R.
S.
T.
U.
V.
W.
X.
Y.

Note: Reminder—A "No" answer is indicative of a potential GAAP depar
ture. The reason for the "No" answer and the resolution of the matter should
be documented in the working papers.
Yes

No

N/A

Balance Sheet
A. General

1.

For classified balance sheets, are assets and liabilities segregated into
current and noncurrent classifications, with totals presented for current
assets and current liabilities?
[ARB 43 ch. 3A par. 2-8; SFAS 78 par. 5 and 13; SFAS 6 par. 15; FIN 8
par. 3; TB 79-3 par. 2]

2.

Are assets not expected to be realized during the current operating cycle
classified as noncurrent?
[ARB 43 ch. 3A par. 5-6]

3.

Are valuation allowances for assets shown as deductions from their
related assets with appropriate disclosure?
[APB 12 par. 3]

B. Cash

1.

Is separate disclosure made of restricted cash?
[ARB 43 ch. 3A par. 6]

2.

Are restrictions on cash appropriately disclosed?
[SFAS 5 par. 18]

3.

Is the policy for determining cash equivalents disclosed?
[SFAS 95 par. 10]

4.

If the company has material bank overdrafts or material balance of
undelivered checks as of the balance sheet date, are:

a.

Bank overdrafts presented as a separate caption within current
liabilities?

FSP §20,300.03
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b.

Undelivered checks classified as accounts payable?
[Generally Accepted]

Yes

No

N/A

____

____

____

Practice Tip

Be sure that the amount of cash and cash equivalents displayed on the balance sheet equals the amount of
cash and cash equivalents displayed on the statement of cash flows.

C. Investment Securities
1.

2.

3.

4.

5.

6.

7.

Are there separate captions for each of the following investment cat
egories:

a.

Fixed-maturity securities?

____

b.

Mortgage loans on real estate?

____

c.

Investment real estate?

____

d.

Policy loans?

____

e.

Other long-term investments?
[AAG app. B]

____

Are mortgage loans reported at outstanding balances, net of the una
mortized balances of loan origination, commitment, other fees and
costs, purchase premiums and discounts, and allowance for losses?
[SFAS 60 par. 47, as amended by SFAS 114; SFAS 91 par. 21]
Are changes in the allowance for uncollectible amounts relating to
mortgage loans reported in income as prescribed in SFAS 114, Ac
counting by Creditors for Impairment of a Loan—an amendment of FASB
Statements No. 5 and 15?
[SFAS 60 par. 47, as amended by SFAS 114]

Are real estate investments reported at cost less accumulated depre
ciation?
[SFAS 60 par. 48, as amended by SFAS 121 and SFAS 144]
Are reductions in the carrying amounts of real estate investments re
sulting from the application of SFAS 144, Accounting for the Impairment
or Disposal of Long-Lived Assets, included in realized gains and losses?
[SFAS 60 par. 48, as amended by SFAS 121 and SFAS 144]

____

____

____

____

Are the carrying amounts of investment securities on deposit with
regulatory authorities disclosed?
[AAG app. C par. 1]

____

Are debt and equity securities classified as (a) held-to-maturity, (b)
available-for-sale, or (c) trading?
[SFAS 115 par. 6]

____

FSP §20,300.03
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Yes

No

N/A

Note: In February 2007, FASB issued SFAS 159, The Fair Value Option for
Financial Assets and Financial Liabilities—Including an amendment of FASB
Statement No. 115, which is effective as of the beginning of an entity's first
fiscal year that begins after November 15, 2007.
This statement applies to all entities, including not-for-profit organiza
tions. Most of the provisions of this statement apply only to entities that
elect the fair value option. However, the amendment to SFAS 115, Ac
counting for Certain Investments in Debt and Equity Securities, applies to all
entities with available-for-sale and trading securities. Some requirements
apply differently to entities that do not report net income. This checklist
has been updated to include the presentation and disclosure requirements
of SFAS 159. Readers can refer to the full text of the statement on the FASB
Web site at www.fasb.org.

See part AA, "Fair Value Measurements," for more information.

8.

Does the enterprise reports its investments in available-for-sale secu
rities and trading securities separately from similar assets that are
subsequently measured using another measurement attribute on the
face of the statement of financial position, does the entity either (a)
present the aggregate of those fair value and non-fair-value amounts
in the same line item and parenthetically disclose the amount of fair
value included in the aggregate amount or (b) present two separate
line items to display the fair value and non-fair-value carrying
amounts?
[SFAS 115 par. 17, as amended by SFAS 135 and SFAS 159]

9.

If an entity elects the fair value option for a held-to-maturity or avail
able-for-sale security in conjunction with the adoption of SFAS 159, is
the security then reported as a trading security under SFAS 115 but
not subjected to the accounting rules normally associated with trans
fers to the trading category?
[SFAS 159 par. 29]

10. In the statement of cash flows, are cash flows from purchases, sales,
and maturities of trading securities classified based on the nature and
purpose for which the securities were acquired?
[SFAS 115, par. 18]

11. If an enterprise presents a classified statement of financial position,
are all individual held-to-maturity securities, individual available-forsale securities, and individual trading securities reported as either
current or noncurrent, as appropriate, under the provisions of ARB 43
chapter 3A, "Working Capital—Current Assets and Current Liabili
ties"?
[SFAS 115 par. 17, as amended by SFAS 135 and SFAS 159]

FSP §20,300.03
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Yes

No

N/A

Practice Tips
SFAS 115 does not apply to investments in equity securities that, absent the election of the fair value option
in SFAS 159 would be required to be accounted for under the equity method, nor to investments in consol
idated subsidiaries.

Electing the fair value option pursuant to SFAS 159 for an existing held-to-maturity security will not call
into question the intent of the entity to hold other debt securities to maturity in the future.

Presentation of individual amounts for trading securities, held-to-maturity securities, and available-for-sale
securities on the face of the balance sheet is not required as long as the information is provided in the notes
to the financial statements.
12. For securities classified as available-for-sale, has the reporting entity
made the following disclosures by major-security type as of each date
for which a statement of financial position is presented:

a.

Aggregate fair value?

b.

Total gains for securities with net gains in accumulated other
comprehensive income (OCI)?

c.

Total losses for securities with net losses in accumulated OCI?
[SFAS 115 par. 19, as amended by SFAS 133]

13. For securities classified as held-to-maturity, has the reporting entity
made the following disclosures by major-security type as of each date
for which a statement of financial position is presented:

a.

Aggregate fair value?

b.

Gross unrecognized holding gains or losses?

c.

Net carrying amount?

d.

Gross gains and losses in accumulated OCI for any derivatives
that hedged the forecasted acquisition of the held-to-maturity
securities?
[SFAS 115 par. 19, as amended by SFAS 133]

14. Are cash flows from purchases, sales, and maturities of available-forsale securities and held-to-maturity securities classified as cash flows
from investing activities and reported gross for each security classifi
cation in the statement of cash flows?
[SFAS 115 par. 18]

15. Are cash flows from purchases, sales, and maturities of trading secu
rities classified as cash flows from operating activities in the statement
of cash flows?
[SFAS 115 par. 18]

16. For investments in debt securities classified as available-for-sale or
held-to-maturity:

a.

Is disclosure made about their contractual maturities as of the
date of the latest balance sheet presented (maturity information
may be combined in appropriate groupings)?

FSP §20,300.03
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b.

Yes

No

N/A

____

____

____

The proceeds from sales of available-for-sale securities and gross
realized gains and losses that have been included in earnings as a
result of those sales?

____

____

____

The basis on which the cost of a security sold or the amount re
classified out of accumulated OCI into earnings was determined
(that is, specified identification, average cost, or other method
used)?

____

____

____

The gross gains and losses included in earnings from transfers of
securities from the available-for-sale category to the trading cate
gory?

-------

-------

------

The amount of the net unrealized holding gain or loss on avail
able-for-sale securities for the period that has been included in
accumulated OCI and the amount of gains and losses reclassified
out of accumulated OCI into earnings for the period?

____

____

____

____

____

____

If securities not due at a single date (such as mortgage-backed
securities) are allocated over several maturity groupings, is the
basis for allocation disclosed?
[SFAS 115 par. 20, as amended by SFAS 133]

17. For each period for which an income statement is presented, are the
following disclosed:
a.

b.

c.

d.

e.

The portion of trading gains and losses for the period that relates
to trading securities still held at the reporting date?
[SFAS 115 par. 21, as amended by SFAS 133]

18. For any sales of or transfers from securities classified as held-to-ma
turity, are the following disclosed for each period for which an earn
ings statement is presented:

a.

Net carrying amount of the sold or transferred security?

____

____

____

b.

The net gain or loss in accumulated OCI for any derivative that
hedged the forecasted acquisition of the held-to-maturity secu
rity?

____

____

____

c.

Related realized or unrealized gain or loss?

____

____

____

d.

The circumstances leading to the decision to sell or transfer the
security?
[SFAS 115 par. 22, as amended by SFAS 133; EITF 96-11]

____

____

____

19. For all investments in an unrealized loss position, including those that
fall within the scope of EITF 99-20, "Recognition of Interest Income
and Impairment on Purchased and Retained Beneficial Interests in Se
curitized Financial Assets," for which other-than-temporary impair
ments have not been recognized, does an investor disclose the follow
ing in its annual financial statements:

FSP §20,300.03
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a.

As of each date for which a statement of financial position is pre
sented, quantitative information, aggregated by category of in
vestment—each category of investment that the investor discloses
in accordance with SFAS 115 and SFAS 124, Accounting for Certain
Investments Held by Not-for-Profit Organizations (refer to paragraph
4(b) in FSP FAS 115-1 and FAS 124-1, The Meaning of Other-ThanTemporary Impairment and Its Application to Certain Investments) and
cost-method investments—in tabular form:
(1) The aggregate related fair value of investments with unreali
zed losses?

(2) The aggregate amount of unrealized losses (that is, the
amount by which cost exceeds fair value)?

Notes: The disclosures in question 19a(1)-(2) should be segregated by those
investments that have been in a continuous unrealized loss position for
less than 12 months and those that have been in a continuous unrealized
loss position for 12 months or longer.
The reference point for determining how long an investment has been in
a continuous unrealized loss position is the balance sheet date of the re
porting period in which the impairment is identified. For entities that do
not prepare interim financial information, the reference point would be the
annual balance sheet date of the period during which the impairment was
identified. The continuous unrealized loss position ceases upon either (a)
the recognition of an other-than-temporary impairment or (b) the investor
becoming aware of a recovery of fair value up to (or beyond) the cost of
the investment during the period.
b.

As of the date of the most recent statement of financial position,
additional information (in narrative form) that provides sufficient
information to allow financial statement users to understand the
quantitative disclosures and the information that the investor con
sidered (both positive and negative) in reaching the conclusion
that the impairment(s) are not other than temporary? These dis
closures could include:

____

(1) The nature of the investment(s)?

____

(2) The cause(s) of the impairment(s)?

____

(3) The number of investment positions that are in an unrealized
loss position?

____

(4) The severity and duration of the impairment(s)?

____

(5) Other evidence considered by the investor in reaching its con
clusion that the investment is not other-than-temporarily im
paired, including, for example, industry analyst reports, sec
tor credit ratings, volatility of the security's fair value, and/
or any other information that the investor considers relevant?
[FSP FAS 115-1 and FAS 124-1 par. 17]

20. Are individually significant unrealized losses generally not aggre
gated?
[FSP FAS 115-1 and FAS 124-1 par. 17]
FSP §20,300.03
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21. For cost-method investments, does an investor disclose the following
additional information, if applicable, as of each date for which a state
ment of financial position is presented in its annual financial state
ments:
a.

The aggregate carrying amount of all cost-method investments?

____

____

____

b.

The aggregate carrying amount of cost-method investments that
the investor did not evaluate for impairment?

____

____

____

____

____

____

____

____

____

c.

The fact that the fair value of a cost-method investment is not es
timated if there are no identified events or changes in circum
stances that may have a significant adverse effect on the fair value
of the investment, and:
(1) The investor determined, in accordance with paragraphs
14-15 of SFAS 107, Disclosures about Fair Value of Financial In
struments, that it is not practicable to estimate the fair value of
the investment?
(2) The investor is exempt from estimating fair value under SFAS
126, Exemption from Certain Required Disclosures about Financial
Instruments for Certain Nonpublic Entities—an amendment to
FASB Statement No. 107?
[FSP FAS 115-1 and FAS 124-1 par. 18]

Note: FSP FAS 115-1 and FAS 124-1 includes a tabular example of the
quantitative disclosures (see appendix A of the FSP) as referred to in the
preceding question 19a.
22. For those entities that enter into options with no intrinsic value at
acquisition in order to purchase securities accounted for under SFAS
115, is disclosure made of the accounting policy for the premium paid
(time value) to acquire the option that is classified as held-to-maturity
or available-for-sale disclosed?
[EITF 96-11]

23. Are adjustments to deferred acquisition costs (DAC) and other assets
and liabilities as a result of including unrealized gains or losses as
part of shareholders equity in accordance with SFAS 115 disclosed?
[AAG app. C par. 4]

____

____

D. Investments Accounted for by the Equity Method

1.

2.

Are investments in common stock shown in the balance sheet of the
investor as a single amount, and is the investor's share of earnings or
losses of the investee shown in the income statement as a single
amount (except for extraordinary items or prior period adjustments)?
[APB 18 par. 19]

-------

Are the following disclosures made for investments in common stock
accounted for by the equity method:

a.

The name of each investee and their percentage of ownership of
common stock?

-------

FSP §20,300.03
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3.

4.

b.

The accounting policies of the investor with respect to invest
ments in common stock?

c.

The difference between the amount at which an investment is car
ried and the amount of underlying equity in net assets?

d.

The accounting treatment of the difference described in c?

e.

For investments in common stock for which a quoted market
price is available, the aggregate value of each identified invest
ment based on the quoted market price? (Note: This is not re
quired for investments in common stock of subsidiaries.)

f.

For investments in common stock, corporate joint ventures, or
other investments which are in the aggregate material in relation
to the financial position or results of operations of an investor,
summarized information as to assets, liabilities, and results of op
eration of the investees as appropriate?

g.

Material effects of conversions of outstanding convertible securi
ties, exercises, or contingent issuances?
[APB 18 par. 20]

If the reporting entity holds 20 percent or more of the voting stock of
a significant investee corporation but does not account for the invest
ment using the equity method, are the following disclosed:

a.

The name of such investee?

b.

The reasons why the equity method is not considered appropri
ate?
[APB 18 par. 20, fn. 13]

If the reporting entity holds less than 20 percent of the voting stock of
a significant investee corporation and accounts for the investment us
ing the equity method, are the following disclosed:

a.

The name of such investee?

b.

The reasons why the equity method is considered appropriate?
[APB 18 par. 20, fn. 13]

5.

Upon loss of significant influence, has the investor recorded the pro
portionate share of an investee's equity adjustments for OCI as offset
against the carrying value of the investment at the time significant
influence is lost?
[FSP APB 18-1 par. 4]

6.

To the extent that the offset results in a carrying value of the invest
ment that is less than zero has the investor (a) reduced the carrying
value of the investment to zero and (b) recorded the remaining bal
ance in income?
[FSP APB 18-1 par. 4]
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Note: FSP APB 18-1, Accounting by an Investor for Its Proportionate Share of
Accumulated Other Comprehensive Income of an Investee Accounted for under
the Equity Method in Accordance with APB Opinion No. 18 upon a Loss of Sig
nificant Influence, does not provide guidance for entities that have histori
cally not recorded their proportionate share of an investee's equity adjust
ments for OCI. These entities should refer to paragraph 25 of SFAS 154,
Accounting Changes and Error Corrections—a replacement of APB Opinion No.
20 and FASB Statement No. 3, for the appropriate guidance. FSP APB 18-1
also does not provide guidance on the measurement and recognition of a
gain or loss on the sale of all or a portion of the underlying investment.
7.

Does the life insurance entity disclose any contingent obligations or
commitments for additional funding or guarantees of obligations of
the investee?
[AAG 11.09]

8.

Is the selected policy disclosed for determining the amount of equity
method losses when previous losses have reduced the common stock
investment account to zero?
[EITF 99-10]

9.

If an equity method investor reports a change to (or the elimination
of) a previously existing difference between the reporting period of
an investor and the reporting period of an equity method investee in
the investor's consolidated financial statements as described in EITF
06-9, "Reporting a Change in (or the Elimination of) a Previously Ex
isting Difference between the Fiscal Year-End of a Parent Company
and That of a Consolidated Entity or between the Reporting Period of
an Investor and That of an Equity Method Investee," has the change
been reported as a change in accounting principle in accordance with
the provisions of SFAS 154, excluding retrospective application if it is
impracticable to do so?
[EITF 06-9 par. 4]

10. If the provisions of EITF 06-9 are applicable to the financial statements
of an investor in an equity method investee, are the disclosures re
quired by SFAS 154 made?
[EITF 06-9 par. 5]
11. If the organization has investments that would have been accounted
for under the equity method if the organization had not chosen to
apply the fair value option in SFAS 159 or in paragraph 16 of SFAS
133, Accounting for Derivative Instruments and Hedging Activities, has it
disclosed for each period for which a statement of financial position
is presented the information required by paragraph 20 of APB 18, The
Equity Method of Accounting for Investments in Common Stock, excluding
the disclosures in paragraphs 20(a)(3), 20(b), and 20(e) of that APB?
[SFAS 159 par. 18f]
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Practice Tip
The significance of an investment to the investor's financial position and results of operations should be
considered in evaluating the extent of disclosures relating to the financial position and results of operations
of an investee.
E. Impairment of a Loan
1.

Is the allowance deducted from the related assets?
[APB 12 par. 3]

2.

Is the following information disclosed, either in the body of the finan
cial statements or in the accompanying notes for impaired loans:

a.

As of the date of each balance sheet presented:

(1) Total recorded investment in the impaired loans at the end of
each period and the amount of the recorded investment for
which there is a related allowance for loan losses?
(2) The amount of the allowance?
(3) The amount of the recorded investment for which no allow
ance for loan losses was recorded?
(4) The company's policy for recognizing interest on impaired
loans, including how cash receipts are recorded?

b.

For each period for which a statement of income is presented:
(1) Average recorded investments?
(2) Related amount of interest income recognized using the cash
basis method of accounting during the time within the period
the loans were impaired?
(3) If practicable, the amount of interest income recognized using
the cash basis method of accounting during the time within
the period the loans were impaired?

(4) The activity in the allowance for loan losses related to im
paired loans including the following:
(i)

Opening balance?

(ii) Additions charged to operations?

(iii) Direct write-down charged against the allowance?
(iv) Recovery of amounts previously charged off?

(v) Ending balance?
[SFAS 118 par. 6i]
3.

In years after a restructuring, are loans that are restructured in a trou
bled debt restructuring (as defined in SFAS 15, Accounting by Debtors
and Creditors for Troubled Debt Restructurings) into two (or more) loan
agreements considered separately when assessing the applicability of
the disclosures described in the preceding question 2?
[EITF 96-22]
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4.

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

Is the discount or premium presented as a deduction from or ad
dition to the face amount of the note?

____

____

____

Does the disclosure include the effective interest rate and face
amount of the note?

____

____

____

Is amortization of discount or premium reported as interest in the
income statement?

____

____

____

Are issue costs reported on the balance sheet as deferred charges?
[APB 21 par. 16]

____

____

____

____

____

____

If the reporting entity is a Securities and Exchange Commission (SEC)
registrant, is adequate disclosure made of the impact of the multiple
loan structures on impaired loan disclosures for loans restructured in
troubled debt restructurings?
[EITF 96-22]

F. Accounts and Notes Receivable and Agents' Balances

1.

Are premiums due reported as assets?
[AAG table 3.1]

2.

Are deferred premiums offset against liabilities for future policy ben
efits?
[AAG table 3.1 and par. 7.19]

3.

Are hypothecation or other pledging of receivables disclosed?
[SFAS 5 par. 18-19]

4.

Are accounts and notes receivable from officers, employees, and affil
iated entities shown separately with appropriate disclosures?
[ARB 43 ch. 1A par. 5]

5.

If a note is noninterest bearing or has an inappropriate stated interest
rate:

a.

b.

c.
d.
6.

Is the unamortized balance of loan origination, commitment, and
other fees and costs and purchase premiums and discounts that is be
ing recognized as an adjustment of yield reported as part of the loan
balance to which it relates?
[SFAS 91 par. 21]

Note: Regarding SOP 01-6, Accounting by Certain Entities (Including Entities
With Trade Receivables) That Lend to or Finance the Activities of Others
(AICPA, Technical Practice Aids, ACC sec. 10,850), questions 7-16 that fol
low apply to organizations that (1) extend credit to customers (constitu
ents) to encourage them to purchase products and services, (2) make mort
gage loans, or (3) make secured or unsecured loans to constituents (for
example, tenant loans). This checklist includes only the disclosure require
ments for the more common activities within the scope of SOP 01-6. If the
organization purchases or sells loans or servicing rights, forecloses on a
loan, or engages in other more complex lending activities, the additional
disclosure requirements of SOP 01-6, SFAS 140, Accounting for Transfers and
Servicing of Financial Assets and Extinguishments of Liabilities—a replacement
ofFASB Statement No. 125, and SFAS 156, Accounting for Servicing of Finan
cial Assets—an amendment of FASB Statement No. 140, not included herein
also should be considered.
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7.

Does the accounting policy note include the following:

a.

The basis of accounting for loans, trade receivables, and lease fi
nancings, including those classified as held for sale?

b.

The method used in determining the lower of cost or fair value of
nonmortgage loans held for sale (that is aggregate or individual
asset basis)?

c.

The method for recognizing interest income on loan and trade re
ceivables, including the entity's policy for treatment of related
fees and costs and the method of amortizing net deferred fees or
costs?

d.

The classification and method of accounting for interest-only
strips, loans, other receivables, or retained interests in securitiza
tions that can be contractually prepaid or otherwise settled in a
way that the holder would not recover substantially all of its re
corded investment?

e.

A description of the accounting policies and methodology the en
tity used to estimate its allowance for loan losses, allowance for
doubtful accounts, any liability for off-balance sheet credit losses,
and any related charges for loan, trade receivable or other credit
losses, including a description of the factors that influenced man
agement's judgment?

f.

The policy for placing loans (and trade receivables if applicable)
on nonaccrual status (or discontinuing accrual of interest) and re
cording payments received on nonaccrual loans (and trade receiv
ables if applicable), and the policy for resuming accrual of inter
est?

g.

The policy for charging off uncollectible loans and receivables?

h.

The policy for determining past due or delinquency status (that
is, whether that status is based on most recent payment or on con
tractual terms)?
[SOP 01-6 par. 13a-c (ACC 10,850.13a-c]

8.

Is the aggregate amount of gains or losses on sales of loans or trade
receivables (including adjustments to record loans held for sale at the
lower of cost or fair value) presented separately in the financial state
ment or disclosed in the notes?
[SOP 01-6 par. 13d (ACC 10,850.13d)]

9.

Loans or trade receivables may be presented on the balance sheet as
aggregated amounts. However,
a.

Are loans or trade receivables held for sale should be presented
on the balance sheet in a separate balance sheet category?

b.

Are major categories of loans or trade receivables should be pre
sented separately either in the balance sheet or in the notes?

FSP §20,300.03
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c.

Are the allowance for credit losses, the allowance for doubtful ac
counts, and, as applicable, any unearned income, any unamorti
zed premiums and discounts, and any net unamortized deferred
fees and costs, should be disclosed in the financial statements?
[SOP 01-6 par. 13e (ACC 10,850.13e)]

10. Are foreclosed and repossessed assets classified as a separate balance
sheet amount or included in other assets on the balance sheet with
separate disclosures in the notes?
[SOP 01-6 par. 13f (ACC 10,850.13f)]
11. Are certain returned or repossessed assets, such as inventory, subse
quently to be utilized by the entity in operations, not classified sepa
rately?
[SOP 01-6 par. 13f (ACC 10,850.13f )]
12. Is the valuation allowance for loans prior to foreclosure not carried
over as a separate element of the cost basis in the foreclosed asset for
purposes of applying SFAS 144?
[FSP FAS 144-1]
13. Is the recorded investment in loans (and trade receivables if applica
ble) on nonaccrual status as of each balance sheet date disclosed in
the notes to the financial statements?
[SOP 01-6 par. 13g (ACC 10,850.13g)]
14. Is the recorded investment in loans (and trade receivables if applica
ble) past due ninety days or more and still accruing interest disclosed?
[SOP 01-6 par. 13g (ACC 10,850.13g)]

15. Insurance subsidiaries may be required to deposit securities with state
regulatory authorities. If so, is the carrying amount of securities de
posited disclosed?
[SOP 01-6 par. 13h (ACC 10,850.13h)]
16. Is the carrying amount of loans, trade receivables, securities and fi
nancial instruments that serve as collateral for borrowings disclosed
pursuant to paragraphs 18-19 of SFAS 5, Accounting for Contingencies?
[SOP 01-6 par. 13i (ACC 10,850.13i)]

No

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

N/A

Notes: SOP 03-3, Accounting for Certain Loans or Debt Securities Acquired in
a Transfer (AICPA, Technical Practice Aids, ACC sec. 10,880), addresses ac
counting for differences between contractual cash flows and cash flows
expected to be collected from an investor's initial investment in loans or
debt securities (loans) acquired in a transfer if those differences are attrib
utable, at least in part, to credit quality.

Readers may also refer to AICPA Technical Practice Aid Technical Ques
tions and Answers (TIS) section 2130.09-.37 (AICPA, Technical Practice
Aids) for additional nonauthoritative guidance pertaining to various topics
on the application of SOP 03-3.

17. Do the notes to financial statements describe how prepayments are
considered in the determination of contractual cash flows and cash
flows expected to be collected?
[SOP 03-3 par. 14 (ACC 10,880.14)]
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18. Is information about loans meeting the scope criteria of paragraph 3
of SOP 03-3 included in the disclosures required by paragraphs
20(a)-20(b) of SFAS 114, if the condition in paragraph 16 of SFAS 115
or paragraph 8(a) of SFAS 5 (as discussed in paragraphs 7(a)-8(a) of
SOP 03-3) is met?
[SOP 03-3 par. 15 (ACC 10,880.15)]
19. In addition to disclosures required by other GAAP, for each balance
sheet presented, does an investor disclose the following information
about loans within the scope of SOP 03-3:
a.

Separately for both those loans that are accounted for as debt se
curities and those loans that are not accounted for as debt securi
ties:
(1) The outstanding balance and related carrying amount at the
beginning and end of the period?

(2) The amount of accretable yield at the beginning and end of
the period, reconciled for additions, accretion, disposals of
loans, and reclassifications to or from nonaccretable differ
ence during the period?
(3) For loans acquired during the period, the contractually re
quired payments receivable, cash flows expected to be col
lected, and fair value at the acquisition date?

(4) For those loans within the scope of SOP 03-3 for which the
income recognition model in SOP 03-3 is not applied in accor
dance with paragraph 6, the carrying amount at the acquisi
tion date for loans acquired during the period and the carry
ing amount of all loans at the end of the period?

b.

Further, for those loans that are not accounted for as debt securi
ties, does an investor disclose:
(1) The amount of (a) any expense recognized pursuant to para
graph 8(a) of SOP 03-3 and (b) any reductions of the allow
ance recognized pursuant to paragraph 8(b)(1) of SOP 03-3 for
each period for which an income statement is presented?

(2) The amount of the allowance for uncollectible accounts at the
beginning and end of the period?
[SOP 03-3 par. 16 (ACC 10,880.16)]
G. Reinsurance Receivables

1.

Are fronting arrangements treated as reinsurance arrangements for
purposes of disclosures required by SFAS 60, Accounting and Reporting
by Insurance Enterprises and SFAS 113, Accounting and Reporting for Re
insurance of Short-Duration and Long-Duration Contracts?
[SFAS 113 par. 6, as amended by SFAS 120]

2.

Are the following disclosed in relation to ceded insurance transac
tions:

a.

Nature of the transaction(s)?

b.

Purpose of the transaction(s)?
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3.

4.

6.

7.

____

____

____

d.

The fact that the insurer is not relieved of its primary obligation
to the policyholder in a reinsurance transaction?
[SFAS 113 par. 27a]

____

____

____

Are the following disclosed for short-duration reinsurance contracts
on both a written and an earned basis:

a.

Premiums from direct business?

____

____

____

b.

Reinsurance assumed?

____

____

____

c.

Reinsurance ceded?
[SFAS 113 par. 27b]

____

____

____

Premiums and amounts assessed against policyholders from di
rect business?

____

____

____

b.

Reinsurance assumed?

____

____

____

c.

Reinsurance ceded?

____

____

____

d.

Premiums and amounts earned?
[SFAS 113 par. 27b]

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

Are the following disclosed for long-duration reinsurance contracts:

Are the methods used for income recognition on reinsurance contracts
disclosed?
[SFAS 113 par. 27c]
Are concentrations of credit risk associated with reinsurance receiva
bles and prepaid reinsurance premiums disclosed for a ceding enter
prise under the provisions of paragraph 15A of SFAS 107, as amended
by SFAS 133?
[SFAS 113 par. 28 as amended by SFAS 133]

Are the following items reported separately as assets for those com
panies participating in ceding transactions:

b.

9.

N/A

Effect of the transaction(s)?

a.

8.

No

c.

a.

5.

Yes

Estimated reinsurance receivables arising from ceding transac
tions?
Amounts paid to the reinsurer relating to the unexpired portion
of reinsured contracts (prepaid reinsurance premiums)?
[SFAS 113 par. 14]

Are amounts receivable and payable between the ceding company
and an individual reinsurer offset only when a right of offset exists as
defined in FIN 39, Offsetting of Amounts Related to Certain Contracts—an
interpretation of APB Opinion No. 10 and FASB Statement No. 105?
[SFAS 113 par. 15]
Are the amounts of earned premiums ceded and recoveries recog
nized under reinsurance contracts reported in the statements of earn
ings as separate line items or disclosed in the notes?
[SFAS 113 par. 16; AAG 12.30]

FSP §20,300.03

24

Life and Health Insurance Entities

Yes

H. Lease Finance Receivables

1.

Do disclosures include:

a.
b.

c.

I.

Appropriate components of the net investment in the leases as of
the date of each balance sheet presented?

____

Future minimum lease payments to be received for each of the
five succeeding fiscal years as of the date of the latest balance
sheet presented?

____

Total contingent rentals included in income for each period for
which a statement of income is presented?
[SFAS 13 par. 23a, as amended by SFAS 91]

____

2.

Are leasing arrangements described?
[SFAS 13 par. 23, as amended by SFAS 91; SFAS 13 par. 29; SFAS 98
par. 17-18]

____

3.

Are leveraged leases appropriately accounted for and reported?
[SFAS 13 par. 41-47, as amended by FSP FAS 13-2, SFAS 96, and SFAS
109]

____

Deferred Acquisition Costs
1.

2.

3.

Are the following disclosed relating to deferred acquisition costs:

a.

The nature of costs capitalized?

____

b.

The method of amortizing these costs?

____

c.

The amount of these costs amortized for the period?
[AAG app. C par. 7; SFAS 60 par. 60c]

____

d.

The accounting policy applied to internal replacements, including
whether or not the company has availed itself of the alternative
application guidance in paragraphs 18-19 of SOP 05-1, Accounting
by Insurance Enterprises for Deferred Acquisition Costs in Connection
With Modification or Exchanges of Insurance Contracts (AICPA, Tech
nical Practice Aids, ACC sec. 10,920 par. .18-.19), and if so, for
which kinds of internal replacement transactions?
[SOP 05-1 par. 28 (ACC 10,920.28)]

If the company considers anticipated investment income in determin
ing if a premium deficiency relating to short-duration contracts exists
disclosed?
[SFAS 60 par. 60e]

____

____

If a public company acquires a life insurance entity accounted for as
a purchase and the acquirer recognizes an asset for the present value
of future profits (PVP), is the following disclosed:
a.

A description of the company's accounting policy?
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b.

No

____

___

____

___

____

____

Depreciation expense for each period for which an income state
ment is presented?

____

___

Balances of major classes of depreciable assets, by nature or func
tion, at the balance sheet date?

____

____

Accumulated depreciation, either by major classes of depreciable
assets or in total, at the balance sheet date?

____

____

A general description of the method or methods used in comput
ing depreciation for major classes of depreciable assets?
[APB 12 par. 5]

____

____

Are pledged assets and material commitments for property expendi
tures disclosed?
[SFAS 5 par. 18-19]

____

____

____

____

____

____

c.

J.

An analysis of the PVP asset account for each year for which an
income statement is presented, including the PVP balance at the
beginning of the year, the amount of PVP additions during the
year arising from acquisitions of insurance entities, the amount of
interest accrued on the unamortized PVP balance during the year,
the interest accrual rate, the amount of amortization during the
year, the amount of any write-offs during the year attributable to
impairment and how those write-offs were determined, and the
PVP balance at the end of the year?
The estimated amount or percentage of the end of the year PVP
balance to be amortized during each of the next five years?
[AAG app. C par. 8]

N/A

Property and Equipment
1.

Is the carrying basis of property and equipment disclosed?
[AAG app. B; APB 12 par. 5]

2.

For depreciable assets, are the following disclosed:

a.
b.

c.
d.

3.

4.

5.

For any accounting period in which interest costs are capitalized, is
the total amount of interest cost incurred during the period, and the
amount thereof that is capitalized, disclosed?
[SFAS 34 par. 21]

Is the amount of interest cost incurred and charged to expense during
the period disclosed for an accounting period in which no interest cost
is capitalized?
[SFAS 34 par. 21]

Note: Subsequent to the adoption of SFAS 143, Accounting for Asset Retire
ment Obligations, the following consensus does not apply to obligations for
asbestos removal that are within the scope of SFAS 143.
6. For an existing property with an asbestos problem, are the costs in
curred to treat the problem, if charged to expense, not classified as an
extraordinary item?
[EITF 89-13]
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K. Lessee Leases
1.

Is the following information disclosed with respect to capital leases:

a.

The gross amount of assets recorded under capital leases as of the
date of each balance sheet presented by major classes according
to nature or function (this information may be combined with the
comparable information for owned assets)?

b.

Future minimum lease payments as of the date of the latest bal
ance sheet presented, in the aggregate and for each of the next
five fiscal years, with separate deductions from the total for exec
utory costs, including any profit thereon that is included in the
minimum lease payments and for the amount of the imputed in
terest necessary to reduce the net minimum lease payments to
present value?

c.

The total of minimum sublease rentals to be received in the future
under noncancelable subleases as of the date of the latest balance
sheet presented?

d.

Total contingent rentals actually incurred for each period for
which an income statement is presented?
[SFAS 13 par. 16, as amended by SFAS 29]

e.

Separate identification of:
(1) Assets recorded under capital leases?
(2) Accumulated amortization of capital leases?

(3) Obligations under capital leases?
(4) Amount of amortization of capital lease assets or the fact that
the amortization of capital lease assets is included in depreci
ation expense?
[SFAS 13 par. 13]

2.

Are the following disclosed for operating leases that have initial or
remaining noncancelable lease terms in excess of one year:

a.

Future minimum rental payments required, as of the date of the
latest balance sheet presented, in the aggregate, and for each of
the five succeeding fiscal years?

b.

The total of minimum rentals to be received in the future under
noncancelable subleases as of the date of the latest balance sheet
presented?
[SFAS 13 par. 16]

3.

For all operating leases, do disclosures include rental expense for each
period for which an income statement is presented, with separate
amounts for minimum rentals, contingent rentals, and sublease rent
als (rental payments under leases with terms of a month or less that
are not renewed need not be included)?
[SFAS 13 par. 16c]

4.

Do disclosures include a general description of the lessee's leasing ar
rangements including, but not limited to, the following:

a.

The basis on which contingent rental payments are determined?
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No

N/A

____

____

____

Restrictions imposed by lease agreements, such as those concern
ing dividends, additional debt, and further leasing?
[SFAS 13, par. 16]

____

____

____

Is the nature and extent of leasing transactions with related parties
disclosed?
[SFAS 13 par. 29]

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

b.

c.

5.

6.

7.

8.

If there is a modification of lease terms and the increase in lease pay
ments is a termination penalty, is the accounting policy disclosed in
accordance with APB 22?
[EITF 95-17; APB 22 par. 12-14]

Do the financial statements of a seller-lessee include a description of
the terms of the sale-leaseback transaction including future commit
ments, obligations, provisions, or circumstances that require or result
in the seller-lessee's continuing involvement?
[SFAS 98 par. 17]

For the financial statement of a seller-lessee when a sale-leaseback
transaction is accounted for using the deposit method or as a financ
ing arrangement, are the following disclosures made:

a.

b.

9.

The existence and terms of renewal or purchase options and es
calation clauses?

The obligation for future minimum lease payments as of the date
of the latest balance sheet presented in the aggregate and for each
of the five succeeding fiscal years?

The total of minimum sublease rentals, if any, to be received in
the future under noncancelable subleases in the aggregate and for
each of the five succeeding fiscal years?
[SFAS 98 par. 18]

When rental costs incurred during and after a construction period are
for the right to control the use of a leased asset during and after con
struction of a lessee asset, are the rental costs included in income from
continuing operations?
[FSP FAS 13-1 par. 6]

L. Intangible Assets and Goodwill

Notes: In April 2008, FASB issued FSP FAS 142-3, Determination of the Use
ful Life of Intangible Assets, to improve the consistency between the useful
life of a recognized intangible asset under SFAS 142, Goodwill and Other
Intangible Assets, and the period of expected cash flows used to measure
the fair value of the asset under SFAS 141 (revised 2007), Business Combi
nations, and other U.S. GAAP. This FSP applies to recognized intangible
assets that are accounted for pursuant to SFAS 142 and applies regardless
of the nature of the transaction that resulted in the recognition of the in
tangible asset, that is, whether acquired in a business combination or oth
erwise.
(continued)

FSP §20,300.03

28

Life and Health Insurance Entities
Yes

Among other significant provisions, FSP FAS 142-3 provides that, in deter
mining the useful life of the intangible asset for amortization purposes, an
entity shall consider the period of expected cash flows used to measure
the fair value of the recognized intangible asset, adjusted for the entityspecific factors in paragraph 11 of SFAS 142. This FSP contains several
disclosures requirements in addition to the required disclosures in para
graphs 44-45 of SFAS 142, including information that enables users of fi
nancial statements to assess the extent to which the expected future cash
flows associated with the intangible asset are affected by the entity's intent
or ability to renew or extend the arrangement.

FSP FAS 142-3 is effective for financial statements issued for fiscal years
beginning after December 15, 2008, and interim periods within those fiscal
years. Early adoption is prohibited. As such, this checklist has not been
updated to include the disclosure requirements of FSP FAS 142-3. Readers
can refer to the full text of the FSP on the FASB Web site at www.fasb.org.
1.

At a minimum, are all intangible assets aggregated and presented as
a separate line item in the statement of financial position? (This re
quirement does not preclude presentation of individual intangible as
sets or classes of intangible assets as separate line items.)
[SFAS 142 par. 42]

2.

Are amortization expense and impairment losses for intangible assets
presented in income statement line items within continuing opera
tions as deemed appropriate for each entity?
[SFAS 142 par. 42]

3.

Is the aggregate amount of goodwill presented as a separate line item
in the statement of financial position?
[SFAS 142 par. 43]

4.

Is the aggregate amount of goodwill impairment losses presented as
a separate line item in the income statement before the subtotal income
from continuing operations (or similar caption) unless a goodwill im
pairment loss is associated with a discontinued operation?
[SFAS 142 par. 43]

5.

Is a goodwill impairment loss associated with a discontinued opera
tion included (on a net-of-tax basis) within the results of discontinued
operations?
[SFAS 142 par. 43]

6.

For intangible assets acquired either individually or with a group of
assets, is the following information disclosed in the notes to the finan
cial statements in the period of acquisition:

a.

For intangible assets subject to amortization:
(1) The total amount assigned and the amount assigned to any
major intangible asset class?
(2) The amount of any significant residual value, in total and by
major intangible asset class?

(3) The weighted-average amortization period, in total and by
major intangible asset class?
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b.

c.

7.

b.

c.

9.

No

N/A

____

____

____

____

____

____

(1) The gross carrying amount and accumulated amortization, in
total and by major intangible asset class?

____

____

____

(2) The aggregate amortization expense for the period?

____

____

____

(3) The estimated aggregate amortization expense for each of the
five succeeding fiscal years?

____

____

____

For intangible assets not subject to amortization, the total carrying
amount and the carrying amount for each major intangible asset
class?

____

____

____

(1) The aggregate amount of goodwill acquired?

____

____

____

(2) The aggregate amount of impairment losses recognized?

____

____

____

(3) The amount of goodwill included in the gain or loss on dis
posal of all or a portion of a reporting unit?
[SFAS 142 par. 45]

____

____

____

____

____

____

____

____

____

A description of the impaired intangible asset and the facts and
circumstances leading to the impairment?

-------

-------

-------

The amount of the impairment loss and the method for determin
ing fair value?

-------

-------

-------

For intangible assets not subject to amortization, the total amount
assigned and the amount assigned to any major intangible asset
class?

The amount of research and development assets acquired and
written off in the period and the line item in the income statement
in which the amounts written off are aggregated?
[SFAS 142 par. 44]

Has the following information been disclosed in the financial state
ments or the notes to the financial statements for each period for
which a statement of financial position is presented:

a.

8.

Yes

For intangible assets subject to amortization:

The changes in the carrying amount of goodwill during the pe
riod including:

If the entity reports segment information in accordance with SFAS
131, Disclosures about Segments of an Enterprise and Related Information,
is the above information about goodwill provided in total and for
each reportable segment and are any significant changes in the allo
cation of goodwill by reportable segment disclosed?
[SFAS 142 par. 45]

If any portion of goodwill has not yet been allocated to a reporting
unit at the date the financial statements are issued, is that unallocated
amount and the reasons for not allocating that amount disclosed?
[SFAS 142 par. 45]

10. For each impairment loss recognized related to an intangible asset, is
the following information disclosed in the notes to the financial state
ments that include the period in which the impairment loss is recog
nized:

a.
b.
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c.

d.

Yes

No

N/A

____

____

____

____

____

____

A description of the facts and circumstances leading to the im
pairment?

____

____

____

The amount of the impairment loss and the method of determin
ing the fair value of the associated reporting unit (whether based
on quoted market prices, prices of comparable businesses, a pres
ent value or other valuation technique, or a combination thereof)?

____

____

____

____

____

____

____

____

____

The general nature of the contracts reporting in separate accounts,
including the extent and terms of minimum guarantees?

____

____

____

The basis of presentation for separate account assets and liabilities
and related separate account activity?

____

____

____

The aggregate fair value of assets, by major investment asset cat
egory, supporting separate accounts with additional insurance
benefits and minimum investment return guarantees as of each
date for which a statement of financial position is presented?

____

____

____

____

____

____

The caption in the income statement in which the impairment loss
is aggregated?
If applicable, the segment in which the impaired intangible asset
is reported under SFAS 131?
[SFAS 142 par. 46]

11. For each goodwill impairment loss recognized, is the following infor
mation disclosed in the notes to the financial statement that include
the period in which the impairment loss is recognized:

a.
b.

c.

If a recognized impairment loss is an estimate that has not yet
been finalized (refer to SFAS 142, paragraph 22), that fact and the
reasons therefore and, in subsequent periods, the nature and
amount of any significant adjustments made to the initial estimate
of the impairment loss?
[SFAS 142 par. 47]

M. Separate Account Assets

1.

2.

Are separate account assets reported as summary totals in the finan
cial statements?
[SFAS 60 par. 54]
Has the insurance company disclosed the following information re
garding separate accounts:
a.

b.
c.

d.

3.

The amount of gains and losses recognized on assets transferred
to separate accounts for the periods presented?
[SOP 03-1 par. 38 (ACC 10,870.38); AAG app. C par. 5]

If the separate account arrangement meets all of the following condi
tions, have the portion of separate account assets representing con
tract holder funds been measured at fair value and reported in the
insurance enterprise's financial statements as a summary total, with
an equivalent summary total reported for related liabilities:
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a.

b.

c.

d.

Yes

No

N/A

The separate account is legally recognized. That is, the separate
account is established, approved, and regulated under special
rules such as state insurance laws, federal securities laws, or sim
ilar foreign laws?

____

____

____

The separate account assets supporting the contract liabilities are
legally insulated from the general account liabilities of the insur
ance enterprise (that is, the contract holder is not subject to in
surer default risk to the extent of the assets held in the separate
account)?

____

____

____

The insurer must, as a result of contractual, statutory, or regula
tory requirements, invest the contract holder's funds within the
separate account as directed by the contract holder in designated
investment alternatives or in accordance with specific investment
objectives or policies?

____

____

____

All investment performance, net of contract fees and assessments,
must as a result of contractual, statutory, or regulatory require
ments be passed through to the individual contract holder. Con
tracts may specify conditions under which there may be a mini
mum guarantee, but not a ceiling, because a ceiling would
prohibit all investment performance from being passed through
to the contract holder?

____

____

____

____

____

____

-------

-------

------

For the portion of separate account arrangements meeting these cri
teria, the related investment performance (including interest, divi
dends, realized gains and losses, and changes in unrealized gains and
losses) and the corresponding amounts credited to the contract holder
should be offset within the same statement of operations line item
netting to zero. Contract fees and assessments should be reported in
accordance with SFAS 97, Accounting and Reporting by Insurance Enter
prises for Certain Long-Duration Contracts and for Realized Gains and
Losses from the Sale of Investments, paragraph 19. Any liabilities related
to minimum guarantees and insurance benefit liabilities under the
contracts in excess of the fair value of separate account assets repre
senting contract holder funds should be recognized as general ac
count liabilities.
[SOP 03-1 par. 11 (ACC 10,870.11)]
N. Deposit Accounting

1.

2.

Has a description of the contracts accounted for as deposits and the
separate amounts of total deposit assets and total deposit liabilities
reported in the statement of financial position been disclosed?
[SOP 98-7 par. 18 (ACC 10,760.18); AAG app. C par. 25]

Has the following information regarding the changes in the recorded
amount of the deposit arising from an insurance or reinsurance con
tract that transfers only significant underwriting risk been disclosed:

a.

The present values of initial expected recoveries that will be re
imbursed under the insurance or reinsurance contracts that have
been recorded as an adjustment to incurred losses?
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b.

Any adjustment of amounts initially recognized for expected re
coveries? (The individual components of the adjustment [meaning
interest accrual, the present value of additional expected recover
ies, and the present value of reductions in expected recoveries]
should be disclosed separately.)

c.

The amortization expense attributable to the expiration of cover
age provided under the contract?
[SOP 98-7 par. 19 (ACC 10,760.19); AAG app. C par. 25]

O. Policy Liabilities

1.

Is the basis for estimating the liabilities for unpaid claims and claim
adjustment expenses disclosed?
[SFAS 60 par. 60a; AAG app. C par. 10a]

2.

Are the methods and assumptions used in estimating the liability for
future policy benefits and the average rate of assumed investment
yields in effect for the current year disclosed?
[SFAS 60 par. 60b; AAG app. C par. 13]

3.

Is the carrying amount of liabilities for unpaid claims and claim ad
justment expenses relating to short-duration contracts that are pre
sented at present value in the financial statements and the range of
interest rates used to discount those liabilities disclosed?
[SFAS 60 par. 60d; AAG app. C par. 10b; SOP 92-4 (AUD 14,230)]

4.

For each fiscal year for which an income statement is presented, is the
following information about the liability for unpaid claims and claim
adjustment expenses disclosed:

5.

a.

The balance in the liability for unpaid claims and claim adjust
ment expenses at the beginning and end of the period presented
with, if net balances are presented, separate disclosure of the re
lated amount of reinsurance recoverable?

b.

Incurred claims and claim adjustment expenses with separate dis
closure of the provision of insured events of the current period
and for increases or decreases in the provision for insured events
of prior fiscal years?

c.

Payments of claims and claim adjustment expenses with separate
disclosure of payments of claims and claim adjustment expenses
attributable to insured events of the current fiscal year and to in
sured events of the prior period?
[SOP 94-5 par. 11 (ACC 10,630.11), as amended by SOP 01-5 (ACC
10,840); AAG app. C par. 11]

If changes in incurred claims and claim adjustment expenses recog
nized in the income statement are attributable to insured events of
prior periods, are the following disclosed in the financial statements:

a.

The reasons for the change?

b.

Whether additional premiums or return premiums have been ac
crued as a result of the prior-period effects?
[SOP 94-5 par. 11 (ACC 10,630.11), as amended by SOP 01-5 (ACC
10,840); AAG app. C par. 12]
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6.

7.

Whether that the company considers anticipated investment income
in determining if a premium deficiency relating to short-duration con
tracts exists disclosed?
[SFAS 60 par. 60e; AAG app. C par. 10c]

Yes

No

N/A

____

____

____

For participating insurance, does disclosure include:

a.

The relative percentage?

____

____

____

b.

The method of accounting for policyholders' dividends?

____

____

____

c.

The amount of dividends?

____

____

____

d.

The amount of any additional income allocated to participating
policyholders?
[SFAS 60 par. 60g; AAG app. C par. 19]

____

____

____

Note: SOP 95-1, Accounting for Certain Insurance Activities of Mutual Life In
surance Enterprises (AICPA, Technical Practice Aids, ACC sec. 10,650), ap
plies to life insurance contracts that have both of the following character
istics:1
• They are long-duration participating contracts that are expected to
pay dividends to policyholders based on actual experience of the
insurance enterprise.
• Annual policyholder dividends are paid in a manner that identifies
divisible surplus and distributes that surplus in approximately the
same proportion as the contracts are considered to have contributed
to divisible surplus (commonly referred to in actuarial literature as
the contribution principle).
8.

Are premiums from participating insurance contracts reported as rev
enue in the statement of income when due from policyholders?
[SOP 95-1 par. 12 (ACC 10,650.12)]

9.

Are death and surrender benefits incurred reported as expense in the
statement of income?
[SOP 95-1 par. 13 (ACC 10,650.13)]

10. Are annual policyholder dividends reported separately as an expense
in the statement of income?
[SOP 95-1 par. 14 (ACC 10,650.14)]
11. Are the following disclosed in the financial statements with respect to
participating contracts:
a.

The methods and assumptions used in estimating the liability for
future policy benefits?

b.

The average rate of assumed investment yields used in estimating
expected gross margins?1

1 SFAS 120, Accounting and Reporting by Mutual Life Insurance Enterprises and by Insurance Enterprisesfor Certain Long-Duration Participat
ing Contracts—an amendment of FASB Statements 60, 97, and 113 and Interpretation No. 40, permits stock life insurance enterprises with
participating life insurance contracts that meet the conditions listed above to account for those contracts in accordance with SOP 95-1,
Accountingfor Certain Insurance Activities ofMutual Life Insurance Enterprises (AICPA, Technical Practice Aids, ACC sec. 10,650).
[SFAS 120 par. 6]
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c.

The nature of acquisition costs capitalized, the method of amortiz
ing those costs, and the amount of those costs amortized for the
period?
[SOP 95-1 par. 24 (ACC 10,650.24); AAG app. C par. 20]

12. Has the entity disclosed a description of the liability valuation meth
ods and assumptions used in estimating the liabilities for additional
insurance benefits and minimum guarantees?
[SOP 03-1 par. 38 (ACC 10,870.38); AAG app. C par. 13]
13. Have the following been disclosed in relation to minimum guaran
tees:

a.

The separate account liability balances subject to various types of
benefits (for example, guaranteed minimum death benefit, guar
anteed minimum income benefit, guaranteed minimum accumu
lation benefit)? Disclosures within these categories of benefits for
the types of guarantees provided may also be appropriate (for ex
ample, return of net deposits, return of net deposits accrued at a
stated rate, return of highest anniversary value).

b.

The amount of liability reported for additional insurance benefits,
annuitization benefits and other minimum guarantees, by type of
benefit, for the most recent balance sheet date and the incurred
and paid amounts for all periods presented?

c.

For contracts for which an additional liability is disclosed in ques
tion 13b, net amount at risk and weighted average attained age
of contract holders?
[SOP 03-1 par. 38 (ACC 10,870.38); AAG app. C par. 13]

P. Income Taxes
1.

Are deferred tax assets and liabilities determined for each tax-paying
component (an individual company or group of companies that is
consolidated for tax purposes) in each tax jurisdiction presented sep
arately?
[SFAS 109 par. 17]

2.

Are the components of the net deferred tax liability or asset recog
nized in the balance sheet disclosed as follows:

a.

The total of all deferred tax liabilities?

b.

The total of all deferred tax assets?

c.

The total valuation allowance for deferred tax assets?
[SFAS 109 par. 43]

3.

Is the net change during the year in the total valuation allowance dis
closed?
[SFAS 109 par. 43]

4.

Is the following information disclosed whenever a deferred tax liabil
ity is not recognized because of the exceptions to comprehensive rec
ognition of deferred taxes for any of the areas addressed by APB 23,
Accounting for Income Taxes—Special Areas (as amended by SFAS 109,
Accounting for Income Taxes):
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Yes

No

N/A

A description of the types of temporary differences for which a
deferred tax liability is not recognized and the types of events that
would cause those temporary differences to become taxable?

____

____

____

b.

The cumulative amount of each type of temporary differences?

____

____

____

c.

The amount of the unrecognized deferred tax liability for tempo
rary differences related to investments in foreign subsidiaries and
foreign corporate joint ventures that are essentially permanent in
duration if determination of that liability is practicable, or a state
ment that determination is not practicable?

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

(1) All current deferred tax liabilities and assets?

____

____

____

(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109 par. 42]

____

____

____

-------

-------

------

-------

-------

------

a.

d.

5.

In a classified balance sheet:

a.

b.

c.

d.

6.

7.

The amount of the deferred tax liability for temporary differences
other than those in question 4c. (that is, undistributed domestic
earnings and the policyholders' surplus of a life insurance enter
prise) that is not recognized in accordance with the provisions of
paragraphs 31-32 of SFAS 109?
[SFAS 109 par. 44]
Are deferred tax assets and deferred tax liabilities classified as
current or noncurrent based on the classification of the related
asset or liability for financial reporting?
[SFAS 109 par. 41]
Are deferred tax assets or liabilities not related to an asset or lia
bility for financial reporting (including those related to carry-for
wards) classified according to the expected reversal date of the
temporary difference?
[SFAS 109 par. 41 and 288p]

Is the valuation allowance for a particular tax jurisdiction allo
cated between current and noncurrent deferred tax assets for that
tax jurisdiction on a pro rata basis?
[SFAS 109 par. 41]
Are the following items offset and presented as a single amount
for a particular taxpaying component and within a particular taxpaying jurisdiction:

Do the financial statements include disclosure of the portion of re
tained earnings in excess of statutory unassigned surplus upon which
no income tax provisions have been made and the reasons therefore?
[AAG app. C par. 14]
If the reporting entity is a public enterprise:

a.

Is the approximate tax-effect of each type of temporary difference
and carryforward that gives rise to a significant portion of de
ferred tax liabilities and deferred tax assets (before valuation al
lowances) disclosed?
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b.

8.

9.

If the reporting entity is not subject to income taxes because its
income is taxed directly to its owners, is that fact and the net dif
ferences between the tax bases and reported amounts of the enter
prises' assets and liabilities disclosed?
[SFAS 109 par. 43]

If the reporting entity is a nonpublic enterprise, are the types of signifi
cant temporary differences and carryforwards disclosed?
[SFAS 109 par. 43]

____

____

Are the following disclosures made:

a.

b.

Amounts and expiration dates of operating losses and tax carry
forwards for tax purposes?
Any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to
reduce goodwill or other noncurrent intangible assets of an ac
quired entity or directly to contributed capital?
[SFAS 109 par. 48]

____

____

Q. Current Liabilities, Notes Payable, and Long-Term Debt

1.

For classified balance sheets, do current liabilities include:

a.

Obligations for items that entered the operating cycle?

____

b.

Collections received in advance of the performance of services?

____

c.

Debts that arise from operations directly related to the operating
cycle?

____

Other liabilities whose regular and ordinary liquidation is likely
to occur within a relatively short time period?

____

d.

e.

2.

3.

4.

Obligations that, by their terms, are due on demand or will be
due within one year (or operating cycle, if longer) from the bal
ance sheet date, even though liquidation may not be expected
within that period?
[ARB 43 ch. 3A par. 7-8; SFAS 78 par. 5]

Do current liabilities exclude short-term obligations that the provider
intends to refinance on a long-term basis, provided the provider has
demonstrated the ability to consummate the long-term financing?
[SFAS 6 par. 8-15]
Is there adequate disclosure of interest rates, maturities, and other
terms and conditions provided in loan agreements and bond inden
tures (such as assets pledged as collateral, and covenants to reduce
debt and maintain working capital)?
[FASCON 5 par. 11; SFAS 5 par. 18]

____

____

____

Are the following disclosed for each of the five years following the
date of the latest balance sheet presented:

a.

The aggregate amount of payments for unconditional purchase
obligations that meet the criteria of SFAS 47, Disclosure of LongTerm Obligations, and that are recognized on the purchaser's bal
ance sheet?
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b.

The combined aggregate amount of maturities and sinking fund
requirements for all long-term borrowings?
[SFAS 47 par. 10, as amended by SFAS 129]

Yes

No

N/A

____

____

____

Notes: In May 2008, FASB issued FSP APB 14-1, Accounting for Convertible
Debt Instruments That May Be Settled in Cash upon Conversion (Including Par
tial Cash Settlement), which requires an issuer to separately account for the
liability and equity components of convertible debt instruments within its
scope. Convertible debt instruments, including instruments within the
scope of this FSP, consist of a liability component with a below-market
interest coupon (the debt instrument) and an equity component (the con
version option). Convertible debt instruments within the scope of this FSP
are required to be separated into its liability and equity components, with
each component accounted for pursuant to other U.S. GAAP applicable to
that component.
This FSP applies to convertible debt instruments that, by their stated
terms, may be settled in cash (or other assets) upon conversion, including
partial cash settlement, unless the embedded conversion option is required
to be separately accounted for as a derivative under SFAS 133. Other scope
limitations apply. This FSP shall be effective for financial statements is
sued for fiscal years beginning after December 15, 2008, and interim per
iods within those fiscal years. Early adoption is not permitted. As such,
this checklist has not been updated to include the presentation and disclo
sure requirements of FSP APB 14-1. Readers can refer to the full text of the
FSP on the FASB Web site at www.fasb.org.
5.

Are conversion features appropriately accounted for and disclosed?
[APB 14 par. 12]

6.

If a note is noninterest bearing or has an inappropriate stated interest
rate:

Is the discount or premium presented as a deduction from or ad
dition to the face amount of the note?

____

b.

Is the effective interest rate and face amount of the note disclosed?

____

c.

Is amortization of the discount or premium reported as interest
expense?

-------

a.

d.

7.

____

Are issue costs reported in the balance sheet as deferred charges?
[APB 21 par. 16]

-------

If a short-term obligation is to be excluded from current liabilities in
a classified balance sheet, do disclosures include:

a.

A general description of the financing agreement?

b.

The terms of any new obligation incurred or expected to be in
curred, or equity securities issued or expected to be issued as a
result of the refinancing?
[SFAS 6 par. 15]

-------

-------
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8.

Are long-term debt agreements subject to a subjective acceleration
clause disclosed unless the likelihood of the acceleration of the due
date is remote?
[TB 79-3]

9.

For a troubled debt restructuring occurring during a period for which
financial statements are presented, do disclosures include:

a.

Description of the principal changes in terms, the major features
of settlement, or both?

b.

Aggregate gain on restructuring of payables?

c.

Aggregate net gain or loss on transfers of assets recognized dur
ing the period?

d.

Per-share amount of the aggregate gain on restructuring of paya
bles?
[SFAS 15 par. 25, as amended by SFAS 145]

10. For periods after a troubled debt restructuring, do disclosures include:

a.

Extent to which amounts contingently payable are included in the
carrying amount of restructured payables?

b.

Total amounts that are contingently payable, if applicable, and
conditions under which those amounts would become payable or
forgiven?
[SFAS 15 par. 26]

11. If there is an early extinguishment of debt, is the difference between
reacquisition price and net carrying amount identified as income in
the period of extinguishment as gain or loss and identified as a sepa
rate item?
[APB 26 par. 20]

12. Is the following disclosed if debt was considered to be extinguished
by in-substance defeasance under the provisions of SFAS 76, Extin
guishment of Debt—an amendment of APB Opinion No. 26, prior to the
effective date of SFAS 125, Accounting for Transfers and Servicing of Fi
nancial Assets and Extinguishments of Liabilities:
a.

A general description of the transaction?

b.

The amount of debt that is considered extinguished at the end of
the period so long as that debt remains outstanding?
[SFAS 140 par. 17(b), as amended by SFAS 156]

13. If assets are set aside after January 1, 1997 solely for satisfying sched
uled payments of a specific obligation, is disclosure made describing
the nature of restrictions placed on those assets?
[SFAS 140 par. 17(c), as amended by SFAS 156]
14. Are long-term obligations that are or will be callable by the creditor,
either because the debtor's violation of the debt agreement at the bal
ance sheet date makes the obligation callable, or because the violation
(if not cured within a specified grace period) will make the obligation
callable, classified as current unless one of the following conditions is
met:
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a.

b.

The creditor waives or subsequently loses the right to demand
repayment for more than one year (or operating cycle, if longer)
from the balance sheet date?
The obligation contains a grace period within which the debtor
may cure the violation and it is probable that the violation will be
cured within that period, thus preventing the obligation from be
coming callable?
[SFAS 78 par. 5]

15. If an obligation under question 14b is included in long-term liabilities
(or in the case of an unclassified balance sheet is included as a long
term liability in the disclosure of debt maturities), are the circum
stances disclosed?
[SFAS 78 par. 5]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

16. If a covenant on a long-term loan agreement is not met, and thus, the
lender has the right to call the debt, and the lender waives that right
for a period of greater than one year but retains the future covenant
requirements, is the debt classified as noncurrent unless both of the
following are met:

a.
b.

The covenant violation occurred at the balance sheet date or
would have occurred absent a loan modification?
It is probable the company will not be able to comply with the
covenant at a measurement date within the next 12 months?
[EITF 86-30]

17. Are borrowings outstanding under a revolving credit agreement that
includes both a subjective acceleration clause and a requirement to
maintain a lock-box arrangement, whereby remittances from the bor
rower's customers reduce the debt outstanding, classified as short
term obligations?
[EITF 95-22]

18. In accordance with PB 15, Accounting by the Issuer of Surplus Notes, are
surplus notes classified as debt in the financial statements of the is
suer, and are existing disclosure requirements for debt instruments
complied with?
[AAG 14.15, app. C par. 15]
19. In accordance with PB 15, is the Insurance Commissioner's role and
ability to approve or disapprove any interest or principal payments
disclosed?
[AAG 14.15, app. C par. 16]
20. If the reclassification to earnings of the amount in accumulated com
prehensive income resulting from a cash flow hedge of debt is re
quired under SFAS 133 when the debt is extinguished, is the reclassi
fied amount not classified as extraordinary?
[EITF 00-9]
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R. Other Liabilities
1.

Are liabilities appropriately accrued and reported for employees'
compensation for future absences, including sabbatical leaves de
scribed in EITF 06-2, "Accounting for Sabbatical Leave and Other
Similar Benefits Pursuant to FASB Statement No. 43?"
[SFAS 43 par. 6; EITF 06-2 par. 5]

2.

If the reporting entity has not accrued compensated absences (SFAS
43) because the amount cannot be reasonably estimated, is that fact
disclosed?
[SFAS 43 par. 6]

3.

If an obligation for postemployment benefits is not accrued in accor
dance with SFAS 5 or SFAS 43, Accounting for Compensated Absences,
only because the amount cannot be reasonably estimated, is this fact
of nonaccrual disclosed in the financial statements?
[SFAS 112 par. 7]

4.

For insurance-related assessments:
a.

If amounts relating to insurance-related assessments have been
discounted pursuant to the provisions of SOP 97-3, Accounting by
Insurance and Other Enterprises for Insurance-Related Assessments
(AICPA, Technical Practice Aids, ACC sec. 10,710), has the entity
disclosed in the financial statements the undiscounted amounts of
the liability and any related asset for premium tax offsets or pol
icy surcharges as well as the discount rate used?

b.

If amounts have not been discounted, has the entity disclosed in
the financial statements the amounts of the liability, any related
asset for premium tax offsets or policy surcharges, the periods
over which the assessments are expected to be paid, and the pe
riod over which the recorded premium tax offsets or policy sur
charges are expected to be realized?
[SOP 97-3 par. 27 (ACC 10,710.27); AAG app. C par. 26]

S. Shareholders' Equity

1.

For each class of stock, do disclosures include the number of shares
authorized, issued, and outstanding, and par or stated value per
share?
[Generally Accepted]

2.

Are classes of capital stock presented in order of priority in liquida
tion?
[Generally Accepted]

3.

Do the financial statements include a description, in summary form,
sufficient to explain the pertinent rights and privileges of the various
securities outstanding (for example, dividend and liquidation prefer
ences, participation rights, call prices and dates, conversion or exer
cise prices or rates and pertinent dates, sinking fund requirements,
unusual voting rights, and significant terms of contracts to issue ad
ditional shares)?
[SFAS 129 par. 4]
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4.

5.

6.

Do disclosures include the number of shares issued upon conversion,
exercise, or satisfaction of required conditions during at least the most
recent annual fiscal period and any subsequent interim period pre
sented?
[SFAS 129 par. 5]

____

___

____

___

____

___

____

___

Events or changes in circumstances that would cause the contin
gency to be met and any significant features necessary to under
stand the conversion rights and the timing of those rights (for ex
ample, the periods in which (1) the contingency might be met and
(2) the securities may be converted if the contingency is met)?

____

___

The conversion price and the number of shares into which the
security is potentially convertible?

-------

------

Events or changes in circumstances, if any, that could adjust or
change the contingency, conversion price, or number of shares,
including significant terms of those changes?

-------

------

-------

-----

-------

------

The aggregate or per share amounts at which preferred stock may
be called or is subject to redemption through sinking-fund oper
ations or otherwise?
The aggregate and per share amounts of arrearages in cumulative
preferred dividends?
[SFAS 129 par. 7]

For redeemable stock, do disclosures include the amount of redemp
tion requirements, separately by issue or combined, for all issues of
capital stock that are redeemable at fixed or determinable prices on
fixed or determinable dates in each of the five years following the
date of the latest balance sheet?
[SFAS 129 par. 8]
Do disclosures for contingently convertible securities include the sig
nificant quantitative and qualitative terms of the conversion features
to enable users of the financial statements to understand the circum
stances of the contingency and the potential impact of conversion, in
cluding:
a.

b.
c.

d.

9.

___

N/A

Are the following disclosed on the face of the balance sheet or in the
notes:

b.

8.

____

For preferred stock or other senior stock that has a preference in in
voluntary liquidation considerably in excess of par or stated value of
the shares, is the liquidation preference disclosed in the equity section
of the balance sheet in the aggregate, either parenthetically or "in
short," rather than on a per share basis or in the notes to the financial
statements?
[SFAS 129 par. 6]

a.

7.

No

The manner of settlement upon conversion and any alternative
settlement methods (for example, cash, shares, or a combination)?
[FSP FAS 129-1 par. 3]

Do disclosures indicate whether the shares that would be issued if the
contingently convertible securities were converted are included in the
calculation of diluted EPS, and the reasons why or why not?
[FSP FAS 129-1 par. 4]
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10. Are appropriations of retained earnings for loss contingencies clearly
identified and included in shareholders' equity?
[SFAS 5 par. 15]
11. Are restrictions on payment of dividends disclosed?
[SFAS 5 par. 18-19]

12. After completion of a quasi-reorganization, is a new retained earnings
account established and dated with the date being disclosed in sub
sequent financial statements until it is no longer deemed significant?
[ARB 43 ch. 7A par. 10; ARB 46]
13. Are the carrying basis, cost and number of shares of any treasury
stock held by the reporting entity disclosed?
[Generally Accepted]

____
____

____

____

14. If treasury stock is purchased for purposes other than retirement or if
ultimate disposition has not yet been decided, is its cost:

a.
b.

Shown separately as a deduction from the total of capital stock,
additional paid-in capital, and retained earnings?

Accorded the accounting treatment appropriate for retired stock?
[APB 6 par. 12b, as amended by SFAS 135]

15. If state laws relating to acquisition of stock restrict the availability of
retained earnings for payment of dividends or other significant ef
fects, is appropriate disclosure made?
[APB 6 par. 13]
16. If treasury shares are purchased at a stated price significantly in ex
cess of current market price, is the allocation of amounts paid and the
accounting treatment for such amounts disclosed?
[TB 85-6 par. 1-3]
17. If the asset or liability that is recognized pursuant to SFAS 87, Employ
ers' Accounting for Pensions, paragraph 35 results in a temporary dif
ference, as defined in SFAS 109 is the deferred tax effects of any tem
porary differences recognized in income tax expense or benefit for the
year and allocated to various financial statement components, includ
ing other comprehensive income, pursuant to paragraphs 35-39 of
SFAS 109?
[SFAS 87 par. 37, as amended by SFAS 158]

18. If statutory surplus is below the minimum required by law, is disclo
sure of the relevant facts made?
[Generally Accepted]

____
____

____

____

____

____

19. Is the following information relating to stockholders' equity, statutory
capital and surplus, and the effects of statutory accounting practices
on the ability to pay dividends to stockholders disclosed:

a.

The amount of statutory capital and surplus?

____

b.

The amount of statutory capital and surplus necessary to satisfy
regulatory requirements (based on current operations) if signifi
cant in relation to the statutory capital and surplus?

____
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c.

The nature of statutory restrictions on the payment of dividends
and the amount of retained earnings that is not available for the
payment of dividends to stockholders?
[SFAS 60 par. 60h; AAG app. C par. 17]

20. If the company receives a note rather than cash as a contribution to
its equity, is the note classified as a reduction of stockholders' equity
unless (in the very limited circumstance) there is substantial evidence
of ability and intent to pay within a reasonably short period of time?
[EITF 85-1]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

Income Statement
A. Premium Revenue

1.

Are premiums from universal life contracts no longer included in rev
enue but recorded in the balance sheet policyholder accounts?
[SFAS 97 par. 59]

B. Investment Income
1.

2.

3.

Are amounts of interest income, loan origination, commitment, am
ortization amounts, and other fees and costs recognized as an adjust
ment of yield reported as part of interest income?
[SFAS 91 par. 22]
Are realized gains and losses on all investments (except investments
that are classified as trading securities and those that are accounted
for as either hedges of net investments in foreign operations or cash
flow hedges as described in SFAS 133) reported in the statement of
income as a component of other income, on a pretax basis?
[SFAS 97 par. 28, as amended by SFAS 115]

For all three categories of investments under SFAS 115, is interest and
dividend income, including amortization of premium and discount,
included in earnings?
[AAG 11.12]

C. Other Income

1.

Is amortization of other fees, such as commitment fees that are being
amortized on a straight-line basis over the commitment period or in
cluded in income when the commitment expires, reported as service
fee income?
[SFAS 91 par. 22]

D. Benefits and Expenses
1.

Do disclosures for advertising costs include:
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a.

The accounting policy selected from the two alternatives in para
graph 26 of SOP 93-7, Reporting on Advertising Costs (AICPA, Tech
nical Practice Aids, ACC sec. 10,590 par. .26), for reporting adver
tising, indicating whether such costs are expensed as incurred or
the first time the advertising takes place?

b.

A description of the direct-response advertising reported as assets
(if any), the accounting policy, and the amortization period?

c.

The total amount charged to advertising expense for each income
statement presented, with separate disclosure of amounts, if any,
representing a write-down to net realizable value?

d.

The total amount of advertising reported as assets in each balance
sheet?
[SOP 93-7 par. 49 (ACC 10,590.49)]

2.

Are payments to policyholders that represent a return of policyholder
balances not reported as expenses in the statement of earnings?
[AAG 9.30; SFAS 97 par. 21]

3.

Do amounts reported as expenses include benefit claims in excess of
the related policyholder balances, expenses of contract administration,
interest accrued to policyholders, and amortization of capitalized ac
quisition costs?
[AAG 9.30]

4.

Are depreciation and other related charges or credits related to real
estate investments recorded as investment expense or operating ex
pense depending on the balance sheet classification of the underlying
assets?
[SFAS 60 par. 48]

E. Income Taxes

1.

Are the types of significant temporary differences and carryforwards
disclosed?
[SFAS 109 par. 43]

2.

Are the following significant components of income tax expense at
tributable to continuing operations for each year presented disclosed
in the financial statements or notes thereto:
a.

Current tax expense or benefit?

b.

Deferred tax expense or benefit (exclusive of the effects of other
components listed below)?

c.

Investment tax credits?

d.

Government grants (to the extent recognized as a reduction of
income tax expense)?

e.

The benefits of operating loss carryforwards?

f.

Tax expense that results from allocating certain benefits, either di
rectly to contributed capital or to reduce goodwill or other noncurrent intangible assets, of an acquired entity?
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g.

h.

i.
j.

3.

4.

5.

6.

7.

Adjustments of a deferred tax liability or asset for enacted
changes in tax laws or rates or a change in the tax status of the
reporting entity?
Adjustments of the beginning-of-the-year balance of a valuation
allowance because of a change in circumstances that causes a
change in judgment about the realizability of the related deferred
tax asset in future years?
[SFAS 109 par. 45a-h]
The amounts and expiration dates of operating loss and tax credit
carryforwards for tax purposes?

Any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to
reduce goodwill or other noncurrent intangible assets of an ac
quired entity or directly to contributed capital?
[SFAS 109 par. 48]

Is the amount of income tax expense or benefit allocated to discontin
ued operations, extraordinary items, items charged directly to share
holders' equity, and prior period adjustments disclosed for each year
for which those items are presented?
[SFAS 109 par. 46]
If the company is a public enterprise, do the financial statements dis
close a reconciliation using percentages or dollar amounts of (i) the
reported amount of income tax expense attributable to continuing op
erations for the year to (ii) the amount of income tax expense that
would result from applying domestic federal statutory tax rates to
pretax income from continuing operations?
[SFAS 109 par. 47]

If the company is a public enterprise, are the estimated amount and
the nature of each significant reconciling item disclosed?
[SFAS 109 par. 47]
If the company is a nonpublic enterprise, is the nature of significant
reconciling items disclosed (a numerical reconciliation may be omit
ted)?
[SFAS 109 par. 47]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

-------

-------

------

If the company is a member of a group that files a consolidated tax
return, are the following items disclosed in its separately issued finan
cial statements:
a.

b.

The aggregate amount of current and deferred tax expense for
each statement of income presented and the amount of any taxrelated balances due to or from affiliates as of the date of each
statement of financial position presented?

The principal provisions of the method by which the consolidated
amount of current and deferred tax expense is allocated to mem
bers of the group and the nature and effect of any changes in that
method (and in determining related balances to or from affiliates)
during the years for which the disclosures in question 7a are pre
sented?
[SFAS 109 par. 49a-b]
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8.

9.

If an entity is involved in the sale or purchase of tax benefits through
tax leases, are the accounting policies or practices followed for those
transactions disclosed in accordance with APB 22, Disclosure of Ac
counting Polices? Do the disclosures include the following:

____

a.

The method of accounting for those transactions?

____

b.

The methods of recognizing revenue?

____

c.

The method of allocating income tax benefits and asset costs to
current and future periods?
[TB 82-1 par. 4, as amended by SFAS 95]

____

If material and unusual or infrequent to the entity, are the nature and
financial effects of transactions involving the sale or purchase of tax
benefits through tax leases disclosed on the face of the income state
ment or, alternatively, in the notes to the financial statements in ac
cordance with APB 30, Reporting the Results of Operations?
[TB 82-1 par. 6, as amended by SFAS 145]

10. Are disclosures included if significant contingencies exist with respect
to the sale or purchase of tax benefits through tax leases in accordance
with SFAS 5?
[TB 82-1 par. 7, as amended by SFAS 96 and SFAS 109]

11. Are disclosures included for any change in the method of accounting
for sales or purchases of tax benefits through tax leases that signifi
cantly affects comparability if comparative financial statements are
presented in accordance with paragraph 2 of chapter 2A of ARB 43?
[TB 82-1 par. 7, as amended by SFAS 96 and SFAS 109]
Notes: FSP FIN 48-2, Effective Date of FASB Interpretation No. 48 for Certain
Nonpublic Enterprises, amends paragraph 22 of FIN 48, Accounting for Un
certainty in Income Taxes—an interpretation of FASB Statement No. 109, to
defer the effective date of FIN 48 to fiscal years beginning after December
15, 2007, for nonpublic enterprises as defined by paragraph 289 of SFAS
109 including nonpublic not-for-profit organizations. Nonpublic enter
prises subject to the provisions of FIN 48 that are consolidated with a pub
lic enterprise or that have issued a full set of U.S. GAAP annual financial
statements prior to the issuance of this FSP using the recognition, meas
urement, and disclosure requirements of FIN 48 are not eligible for the
deferral.

At the October 15, 2008, meeting, FASB decided to issue a proposed FSP
to defer FIN 48 for all nonpublic entities until fiscal years beginning after
December 15, 2008, The proposed FSP will include a request for comments
on issues that private pass-through entities have encountered related to
FIN 48. FASB expects to issue this proposed FSP in the first quarter of
2009. FASB will then subsequently issue a separate proposed FSP that will
provide guidance for pass-through entities and provide amendments to
the existing disclosure requirements for nonpublic entities.
For those nonpublic entities to which the deferral provisions of FSP FIN
48-2 apply, skip questions 12-15 that follow.
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Yes

No

N/A

____

____

____

(1) The gross amounts of the increases and decreases in unrecog
nized tax benefits as a result of tax positions taken during a
prior period?

____

____

____

(2) The gross amounts of increases and decreases in unrecogni
zed tax benefits as a result of tax positions taken during the
current period?

____

____

____

(3) The amounts of decreases in the unrecognized tax benefits re
lating to settlements with taxing authorities?

____

____

____

(4) Reductions to unrecognized tax benefits as a result of a lapse
of the applicable statute of limitations?

____

____

____

The total amount of unrecognized tax benefits that, if recognized,
would affect the effective tax rate?

____

____

____

The total amounts of interest and penalties recognized in the
statement of operations and the total amounts of interest and pen
alties recognized in the statement of financial position?

____

____

____

(1) The nature of the uncertainty?

____

____

____

(2) The nature of the event that could occur in the next 12 months
that would cause the change?

____

____

____

(3) An estimate of the range of the reasonably possible change or
a statement that an estimate of the range cannot be made?

____

____

____

-------

-------

------

-------

-------

------

12. Does an enterprise disclose its policy on classification of interest and
penalties in accordance with paragraph 19 of FIN 48 in the footnotes
to the financial statements?
[FIN 48 par. 20]
13. Does an enterprise disclose the following at the end of each annual
reporting period presented:

a.

b.
c.

d.

e.

A tabular reconciliation of the total amounts of unrecognized tax
benefits at the beginning and end of the period, which shall in
clude at a minimum:

For positions for which it is reasonably possible that the total
amounts of unrecognized tax benefits will significantly increase
or decrease within 12 months of the reporting date:

A description of tax years that remain subject to examination by
major tax jurisdictions?
[FIN 48 par. 21]

14. If an enterprise presents a classified statement of financial position,
does the entity classify a liability associated with an unrecognized tax
benefit as a current liability (or the amount of a net operating loss
carryforward or amount refundable is reduced) to the extent the en
terprise anticipates payment (or receipt) of cash within one year or
the operating cycle, if longer? Furthermore, has the liability for unre
cognized tax benefits (or reduction in amounts refundable) not been
combined with deferred tax liabilities or assets?
[FIN 48 par. 17]
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15. Is a liability that has been recognized as a result of applying FIN 48,
not classified as a deferred tax liability unless it arises from a taxable
temporary difference?
[FIN 48 par. 18]

F.

____

Extraordinary Items, Unusual Items, Infrequent Items

1.

2.

3.

4.

5.

6.

7.

Do extraordinary items meet both criteria of (1) unusual nature and
(2) infrequency of occurrence?
[APB 30 par. 20]

Are extraordinary items segregated and shown (including applicable
income taxes) following income before extraordinary items and before
net income?
[APB 30 par. 11]
Are descriptive captions and amounts (including applicable income
taxes) presented for individual extraordinary events or transactions,
preferably on the face of the income statement?
[APB 30 par. 11]
Do disclosures include descriptions of an extraordinary event or
transaction and the principal items entering into determination of ex
traordinary gain or loss?
[APB 30 par. 11]
Are the income taxes applicable to extraordinary events disclosed on
the face of the statement of operations or in related notes?
[APB 30 par. 11]

Is each adjustment in the current period of an element of an extraor
dinary item that was reported in a prior period separately disclosed
as to year of origin, nature, and amount and classified separately in
the current period as an extraordinary item?
[SFAS 16 par. 16c]

____

____

____

____

____

Are material events or transactions that are either unusual in nature
or of infrequent occurrence, but not both (and therefore not meeting
criteria for extraordinary items):

a.
b.

8.

____

Reported as a separate component of income from continuing op
erations?

Accompanied by disclosure of the nature and financial effects of
each event?
[APB 30 par. 26]

____
____

Is the following information disclosed in the notes to the financial
statements in the period(s) in which business interruption (BI) insur
ance recoveries are recognized:

a.

The nature of the event resulting in business interruption losses?

b.

The aggregate amount of BI insurance recoveries recognized dur
ing the period and the line item(s) in the statement of operations
in which those recoveries are classified (including amounts re
ported as an extraordinary item pursuant to APB 30)?
[EITF 01-13]

FSP §20,300.03

____

____

No

N/A

49

Financial Statements and Notes Checklist

Yes

No

N/A

G. Earnings Per Share

Notes: SFAS 128, Earnings per Share, applies only to entities with publicly
held common stock or potential common stock.
FASB issued SFAS 160, Noncontrolling Interests in Consolidated Financial
Statements—an amendment of ARB No. 51, in March 2008, to establish ac
counting and reporting standards for the noncontrolling interests in a sub
sidiary and for the de-consolidation of a subsidiary, areas for which lim
ited guidance previously existed. In addition to the overview of this
statement provided in a note appearing earlier in this checklist, readers
should be aware that SFAS 160 clarifies that, for purposes of computing
EPS in consolidated financial statements (both basic and diluted), if one or
more less-than-wholly-owned subsidiaries are included in the consoli
dated group, income from continuing operations and net income shall ex
clude the income attributable to the noncontrolling interest in subsidiaries.
SFAS 160 is effective for fiscal years, and interim periods within those fis
cal years, beginning on or after December 15, 2008 (that is, January 1,2009,
for entities with calendar year-ends). Earlier adoption is prohibited. As
such, this checklist has not been updated to include the presentation and
disclosure requirements of SFAS 160. Readers can refer to the full text of
the statement on the FASB Web site at www.fasb.org.

1.

2.

3.

4.

5.

If the reporting entity has a simple capital structure (only common
stock outstanding), are basic per share amounts for income from con
tinuing operations and for net income presented on the face of the
income statement for all periods for which an income statement or
summary of earnings is presented?
[SFAS 128 par. 36 and 38]

If the reporting entity has other than a simple capital structure, are
basic and diluted per share amounts for income from continuing op
erations and for net income presented on the face of the income state
ment with equal prominence for all periods for which an income
statement or summary of earnings is presented? (Note: If diluted EPS
data are reported for at least one period, they should be reported for
all periods presented, even if they are the same amounts as basic EPS.)
[SFAS 128 par. 36 and 38]
If discontinued operations, extraordinary items, or the cumulative ef
fect of accounting changes are reported in the period, are the basic
and diluted per share amounts for those line items presented on the
face of the income statement or in the notes?
[SFAS 128 par. 37, as amended by SFAS 154]

If per share amounts not required to be presented by SFAS 128 are
disclosed, are they disclosed only in the notes and do the disclosures
indicate whether the per share amounts are pretax or net of tax?
[SFAS 128 par. 37, as amended by SFAS 154]

____

____

-------

-------

Are the following disclosed for each period for which an income state
ment is presented:
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a.

b.

c.

6.

7.

8.

9.

A reconciliation of the numerators and denominators of the basic
and diluted per share computations for income from continuing
operations?

____

The effect that has been given to preferred dividends in arriving
at income available to common shareholders' in computing basic
EPS?

____

Securities (including those issuable pursuant to contingent stock
agreements) that could potentially dilute basic EPS in the future
that were not included in the computation of diluted EPS because
to do so would have been antidilutive for the period(s) presented?
[SFAS 128 par. 40]

For the latest period for which an income statement is presented, do
disclosures include a description of any transaction that occurs after
the end of the most recent period but before issuance of the financial
statements that would have changed materially the number of com
mon shares or potential common shares outstanding at the end of the
period if the transaction had occurred before the end of the period?
[SFAS 128 par. 41]
If the number of common shares outstanding increases as a result of
a stock dividend or stock split or decreases as a result of a reverse
stock split, the computations of basic and diluted EPS should be ad
justed retroactively for all periods presented to reflect that change in
capital structure. If per share computations reflect such changes in the
number of shares, is that fact disclosed?
[SFAS 128 par. 54]
If changes in common stock resulting from stock dividends, stock
splits, or reverse stock splits occur after the close of the period but
before issuance of the financial statements, the per share computa
tions for those and any prior-period financial statements presented
should be based on the new number of shares. If per share computa
tions reflect such changes in the number of shares, is that fact dis
closed?
[SFAS 128 par. 54]

When prior earnings per share amounts have been restated in com
pliance with an accounting standard requiring restatement, is the ef
fect of the restatement, expressed in per share terms, disclosed in the
period of restatement?
[SFAS 128 par. 57]

10. Are prior period earnings per share amounts presented for compara
tive purposes restated to conform to the consensus guidance in EITF
03-6, "Participating Securities and the Two-Class Method under FASB
Statement No. 128", Earnings per Share?
[EITF 03-6]
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11. For contingently convertible instruments outstanding at the date of
adoption of EITF 04-8, "The Effect of Contingently Convertible Instru
ments on Diluted Earnings per Share," and whose terms have not
been modified since the date of issuance, are prior-period diluted
earnings per share restated to conform to the guidance in the consen
sus for comparative purposes?
[EITF 04-8]
12. For contingently convertible instruments outstanding at the date of
adoption of EITF 04-8 and whose terms have been modified, are priorperiod diluted earnings per share restated to conform to the guidance
in the consensus for comparative purposes based on the modified
terms of the instrument at the date of adoption of EITF 04-8?
[EITF 04-8]

Yes

No

N/A

____

____

____

____

____

____

H. Comprehensive Income
Notes: FASB issued SFAS 160 in March 2008 to establish accounting and
reporting standards for the noncontrolling interests in a subsidiary and for
the deconsolidation of a subsidiary, areas for which limited guidance pre
viously existed.

In addition to the overview of this statement provided in a note appearing
earlier in this checklist, readers should be aware that SFAS 160 clarifies
that, if an entity has an outstanding noncontrolling interest (minority in
terest), amounts for both comprehensive income attributable to the parent
and comprehensive income attributable to the noncontrolling interest in a
less-than-wholly-owned subsidiary are reported on the face of the finan
cial statement in which comprehensive income is presented in addition to
presenting consolidated comprehensive income. Additionally, if an entity
has an outstanding noncontrolling interest, the components of other com
prehensive income attributable to the parent and noncontrolling interest
in a less-than wholly-owned subsidiary are required to be disclosed as
part of its equity reconciliation.
SFAS 160 is effective for fiscal years, and interim periods within those fis
cal years, beginning on or after December 15, 2008 (that is, January 1,2009,
for entities with calendar year-ends). Earlier adoption is prohibited. As
such, this checklist has not been updated to include the presentation and
disclosure requirements of SFAS 160. Readers can refer to the full text of
the statement on the FASB Web site at www.fasb.org.

1.

Are all components of comprehensive income reported in the finan
cial statements in the period in which they are recognized?
[SFAS 130 par. 14]

2.

Is a total amount for comprehensive income displayed in the financial
statement where the components of OCI are reported?
[SFAS 130 par. 14]

3.

Is an amount for net income displayed and included as a component
of comprehensive income?
[SFAS 130 par. 15 and 22]
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Yes

4.

Are items included in OCI classified separately into foreign currency
items, gains or losses associated with pension or other postretirement
benefits, prior service costs or credits associated with pension or other
postretirement benefits, transition assets or obligations associated
with pension or other postretirement benefits, and unrealized gains
and losses on certain investments in debt and equity securities?
[SFAS 130 par. 17, as amended by SFAS 158]

5.

Are reclassification adjustments made that avoid double counting in
comprehensive income of items that are displayed as part of net in
come for a period that also had been displayed as part of OCI in that
period or other periods presented on the face of the financial state
ment in which comprehensive income is reported or disclosed in the
notes?
[SFAS 130 par. 18, as amended by SFAS 158]

6.

Are comprehensive income and its components displayed in a finan
cial statement that is displayed with the same prominence as the other
financial statements? (Note: SFAS 130, Reporting Comprehensive Income,
encourages but does not require that the components of OCI and total
comprehensive income be displayed below the total for net income in
a statement that reports results of operations or in a separate state
ment of comprehensive income that begins with net income.)
[SFAS 130 par. 22-23]

7.

Are the components of OCI displayed either net of related tax effects,
or before related tax effects with one amount shown for the aggregate
tax effect related to the total of OCI items?
[SFAS 130 par. 24]

8.

Is the amount of income tax expense or benefit allocated to each com
ponent of OCI (including reclassification adjustments) displayed on
the face of the statement in which those components are displayed or
disclosed in the notes to the financial statements?
[SFAS 130 par. 25]

9.

Is the total of OCI for a period transferred to a component of equity
that is displayed separately from retained earnings and additional
paid-in-capital in the balance sheet with a descriptive title such as ac
cumulated other comprehensive income?
[SFAS 130 par. 26]

10. Are accumulated balances for each classification within accumulated
OCI disclosed on the face of the balance sheet, in the statement of
changes in shareholders' equity, or in the notes?
[SFAS 130 par. 26]
11. Has the enterprise reported a total for comprehensive income in con
densed financial statements of interim periods?
[SFAS 130 par. 27, as amended by SFAS 135]
12. Has the entity displayed as a separate classification within OCI the
net gain or loss on derivative instruments designated and qualifying
as cash flow hedging instruments that are reported in comprehensive
income pursuant to paragraphs 30 and 41 of SFAS 133?
[SFAS 133 par. 46]
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Yes

No

N/A

____

____

____

Adjustments or charges or credits resulting from transactions in
the company's own capital stock?

____

____

____

Transfers to and from accounts properly designated as appropri
ated retained earnings?

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

-------

-------

------

13. As part of the disclosures of accumulated OCI, pursuant to paragraph
26 of SFAS 130, has the entity separately disclosed the beginning and
ending accumulated derivative gain or loss, the related net change
associated with current period hedging transactions, and the net
amount of any reclassification into earnings?
[SFAS 133 par. 47]
1.

Other

1.

Are the following excluded from determination of net income or re
sults of operations under all circumstances:

a.

b.
c.

2.

3.

4.

5.

6.

Adjustments made pursuant to a quasi reorganization?
[APB 9 par. 28]

Is the amount of revenue and expense recognized from advertising
barter transactions disclosed for each income statement period pre
sented?
[EITF 99-17]

If the entity engages in advertising barter transactions for which the
fair value is not determinable within the limits of EITF 99-17, "Ac
counting for Advertising Barter Transactions," is information regard
ing the volume and type of advertising surrendered and received
(such as the number of equivalent pages, the number of minutes, or
the overall percentage of advertising volume) disclosed for each in
come statement period presented?
[EITF 99-17]
At a minimum, is a description of the nature and amounts of losses
and costs recognized as a result of the September 11 events and the
amount of related insurance recoveries (if any) recognized disclosed
in the notes to the financial statements in all periods affected by the
September 11,2001, attacks?
[EITF 01-10]
Are losses and costs incurred as a result of the September 11, 2001
attacks classified as part of income from continuing operations?
[EITF 01-10]
Does a vendor disclose the following in regard to revenue arrange
ments with multiple deliverables:

a.

b.

Its accounting policy for recognition of revenue from multipledeliverable arrangements (for example, whether deliverables are
separable into units of accounting)?
The description and natures of such arrangements, including per
formance, cancellation, termination, or refund-type provisions?
[EITF 00-21]
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7. Is the income statement classification of the expense associated with a
"free" product or service delivered at the time of sale of another prod
uct or service classified as cost of sales?
[EITF 01-9]
Notes: EITF 06-3, "How Taxes Collected from Customers and Remitted to
Governmental Authorities Should Be Presented in the Income Statement
(That Is, Gross Versus Net Presentation)," provides guidance on the pre
sentation of taxes in the income statement. The EITF reached a consensus
that the presentation of taxes within the scope of the issue, either on either
a gross basis (included in revenues and costs) or a net basis (excluded
from revenues), is an accounting policy decision that should be disclosed
pursuant to APB 22.

Included in the scope of this issue is any tax assessed by a governmental
authority that is both imposed on and concurrent with a specific revenueproducing transaction between a seller and a customer, and may include,
but is not limited to, sales, use, value added, and some excise taxes. The
issue excludes tax schemes that are based on gross receipts and taxes that
are imposed during the inventory procurement process.
The consensuses in EITF 06-3 should be applied to financial reports for
interim and annual reporting periods beginning after December 15, 2006.
This checklist has been updated to include the disclosure requirements of
EITF 06-3. Readers can refer to the full text of the issue on the FASB Web
site at www.fasb.org

8.

Is the accounting policy decision regarding the presentation of taxes
within the scope of EITF 06-3 either on a gross basis (included in rev
enues and costs) or a net basis (excluded from revenues) disclosed
pursuant to APB 22? (Note: An entity is not required to reevaluate its
existing policies related to taxes assessed by a governmental authority
as a result of this consensus.)
[EITF 06-3 par. 4]

9.

For any such taxes that are reported on a gross basis, does the entity
disclose the amounts of those taxes in interim and annual financial
statements for each period for which an income statement is pre
sented if those amounts are significant? (Note: The disclosure of those
taxes can be done on an aggregate basis.)
[EITF 06-3 par. 4]

Notes: EITF 07-1, "Accounting for Collaborative Arrangements," estab
lishes accounting and disclosure requirements for participants in a collab
orative arrangement. The issue defines a collaborative arrangement as a
contractual arrangement that involves a joint operating activity and two
(or more) parties who are both (a) active participants in the activity and
(b) exposed to significant risks and rewards dependent on the commercial
success of the activity. The scope of this issue does not include arrange
ments for which the accounting is specifically addressed within the scope
of other authoritative accounting literature such as ARB 51, Consolidated
(continued)
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N/A

Financial Statements, SFAS 94, Consolidation of All Majority-owned Subsidar
ies—an amendment of ARB No. 51, with related amendments of APB Opinion
No. 18 and ARB No. 43, Chapter 12, APB 18, and FIN 46(R), Consolidation of
Variable Interest Entities—an interpretation of ARB No. 51, for example.

The issue requires a participant to a collaborative arrangement to make
certain disclosures in the initial period (which may be an interim period).
EITF 07-1 is effective for financial statements issued for fiscal years begin
ning after December 15, 2008, and interim periods within those fiscal
years. Furthermore, EITF 07-1 shall be applied retrospectively to all prior
periods presented for all collaborative arrangements existing as of the ef
fective date. This checklist has not been updated to include the disclosure
requirements of EITF 07-1. Readers can refer to the full text of the issue on
the FASB Web site at www.fasb.org.

Statement of Changes in Shareholders' Equity
1.

Are changes in the separate accounts of shareholders' equity dis
closed?
[APB 12 par. 10]

2.

Are changes in the number of shares of equity securities disclosed?
[APB 12 par. 10]

3.

If prior-period adjustments have been recorded during the current
year, are their resulting effects (both gross and net of applicable
income taxes and including the amounts of income tax applicable to
the prior period adjustments) appropriately disclosed:

a.

For single-period statements, does the disclosure indicate the ef
fects of such restatement on the balance of retained earnings at
the beginning of the period and on the net income of the imme
diately preceding period?

b.

If financial statements of more than one period are presented,
does disclosure include the effects for each of the periods pre
sented in the statements?
[APB 9 par. 26]

Practice Tip

Disclosure of restatements in annual reports issued subsequent to the first such post-revision disclosure
would ordinarily not be required.
4. If the reporting entity is a publicly traded company and if interim
financial data and disclosures are not separately reported for the
fourth quarter, are accounting changes made during the fourth quar
ter, disposals of components of an entity, extraordinary, unusual, or
infrequently occurring items recognized in the fourth quarter, and the
aggregate effect of year end adjustments that are material to the re
sults of that quarter disclosed in a note to the financial statements?
[APB 28 par. 31]
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Statement of Cash Flows
1.

2.

Is a statement of cash flows presented as a basic financial statement
(for each period for which a statement of income is presented) if fi
nancial statements present both financial position and results of op
erations?
[SFAS 95 par. 3, as amended by SFAS 102 and SFAS 117]
Does the statement of cash flows report net cash provided or used by
the operating, investing, and financing activities and the effect of
those flows on cash and cash equivalents during the period in a man
ner that reconciles beginning and ending cash and cash equivalents?
[SFAS 95 par. 26]

3.

Is the policy for defining cash equivalent disclosed?
[SFAS 95 par. 10]

4.

If applicable, is the effect of exchange rate changes on cash balances
held in foreign currencies shown separately on statement of cash
flows?
[SFAS 95 par. 25]

5.

Is the change in cash and cash equivalents shown?
[SFAS 95 par. 7 and 26]

6.

Are noncash investing and financing activities, such as converting
debt to equity, either summarized in a separate schedule or in narra
tive format?
[SFAS 95 par. 32]

____

____
____

____
____

____

Operating Activities
7.

8.

9.

Are cash receipts and cash payments from operating activities shown
separately on the statement of cash flows?
[SFAS 95 par. 27-28, as amended by SFAS 123(R)]
If SFAS 159 has been adopted, are cash receipts and cash payments
resulting from purchases and sales of securities classified as trading
securities as discussed in SFAS 115, classified pursuant to SFAS 95 (as
amended) based on the nature and purpose for which the securities
were acquired as operating cash flows?
[SFAS 102 par. 8, as amended by SFAS 115, SFAS 145, and SFAS 159]
If SFAS 159 has not been adopted, are cash receipts and cash pay
ments resulting from purchases and sales of securities classified as
trading securities as discussed in SFAS 115 classified as operating
cash flows?
[SFAS 102 par. 8, as amended by SFAS 115 and SFAS 145]

10. Are cash receipts and cash payments from purchases and sales of se
curities and other assets acquired for resale and carried at market
value in a trading account classified as operating cash flows?
[SFAS 102 par. 8, as amended by SFAS 115]
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Yes

11. Are cash receipts and cash payments resulting from purchases, acqui
sitions and sales of loans, if those loans are acquired specifically for
resale and are carried at market value or the lower of cost or market,
classified as operating cash flows?

12. Is cash payment made to settle an asset retirement obligation classi
fied in the statement of cash flows as an operating activity?
[EITF 02-6]

No

____

___

____

___

N/A

Direct Method of Reporting Net Cash Flow from
Operating Activities
13. If the direct method of reporting net cash flow from operating activi
ties is used, do cash flows from operating activities separately report:

a.

Cash receipts from customers?

b.

Cash receipts from interest and dividends?

c.

All other cash receipts that do not stem from transactions defined
as investing or financing activities?

d.

Cash payments to suppliers and employees, such as benefits paid
to policyholders, surrender benefits, and dividends paid to poli
cyholders?

e.

Cash payments to governments for taxes, duties, fines, and other
fees or penalties and the cash that would have been paid for
income taxes if increases in the value of equity instruments issued
under share-based payment arrangements that are not included
in the cost of goods or services recognizable for financial report
ing purposes also had not been deductible in determining taxable
income (paragraph 19(e) of SFAS 95)?

f.

Cash payments to lenders and other creditors for interest?

g.

All other cash payments that do not stem from transactions de
fined as investing or financing activities?
[SFAS 95 par. 22-23, as amended by SFAS 123(R)]

14. Is a separate schedule provided to reconcile net income to net cash
flow from operating activities?
[SFAS 95 par. 30]

Indirect Method of Reporting Net Cash Flow from
Operating Activities
15. Is the net cash flow from operating activities reported indirectly by
adjusting net income to reconcile it to net cash flow from operating
activities?
16. Is the reconciliation of net income to net cash flows from operating
activities reported, either within the statement of cash flows or pro
vided in a separate schedule (the reconciliation should separately re
port all major reconciling items pertaining to operating activities)?
[SFAS 95 par. 28-29]
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17. Are the amounts of interest paid (net of amounts capitalized) and
income taxes paid during the period(s) disclosed?
[SFAS 95 par. 29]
Investing Activities

18. Are cash receipts and cash payments from investing activities shown
separately on statement of cash flows?
[SFAS 95 par. 31]
19. Are cash receipts and cash payments for the following transactions
classified as cash flows from investing activities:

a.

Receipts from collections or sales of loans?

b.

Receipts from sales of property, plant, and equipment?

c.

Loans to others?

d.

Payments to acquire property, plant, and equipment?

e.

Receipts from sales of equity instruments of other enterprises ex
clusive of those carried in the trading account?

f.

Receipts and payments from purchases, sales, and maturities of
available for sale and held to maturity securities

g.

Payments to acquire equity instruments of other enterprises, ex
clusive of those carried in a trading account?
[SFAS 95 par. 16-17, as amended by SFAS 102, SFAS 145, SFAS
159]

Financing Activities

20. Are cash receipts and cash payments from financing activities shown
separately on the statement of cash flows?
[SFAS 95 par. 31]
21. Are cash receipts and cash payments for the following transactions
classified as cash flows from financing activities:

a.

Proceeds from issuing equity instruments?

b.

Proceeds from issuing bonds, mortgages, and notes, and from
other short- or long-term borrowing?

c.

Repayment of amounts borrowed?

d.

Dividend payments to stockholders?

e.

Acquisition of treasury stock?

f.

Other principal payments to creditors who have extended long
term credit?

g.

Debt issue costs?
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h.

i.

Proceeds received from derivative instruments and distributions
to counterparties of derivative instruments that include financing
elements at inception?
[SFAS 95 par. 19-20, as amended by SFAS 117, SFAS 123(R), SFAS
149; EITF 95-13]

Cash retained as a result of the tax deductibility of increases in
the value of equity instruments issued under share-based pay
ment arrangements that are not included in the cost of goods or
services that is recognizable for financial reporting purposes? For
this purpose, excess tax benefits shall be determined on an indi
vidual award (or a portion thereof) basis?
[SFAS 123(R) par. 68a; SFAS 95 par. 19(e), as amended by SFAS
117, SFAS 123(R), SFAS 149]

Yes

No

N/A

____

____

____

____

____

____

Practice Tip

Any change in policy for determining which items are treated as cash equivalents is a change in accounting
principle.

22. If an other-than-insignificant financing element is present at incep
tion, other than a financing element inherently included in an at-themarket derivative instrument with no prepayments (that is, the for
ward points in an at-the-money forward contract), does the borrower
report all cash inflows and outflows associated with that derivative
instrument in a manner consistent with financing activities as de
scribed in paragraphs 18-20 of SFAS 95?
[SFAS 133 par. 45A, as amended by SFAS 149 and SFAS 155]

General
A. Titles and References
1.

For a full presentation in conformity with GAAP, are the following
financial statements presented:

a.

Balance sheet?

b.

Statement of income (operations)?

c.

Statement of retained earnings or changes in shareholders' eq
uity?

d.

Statement of cash flows?

e.

Description of accounting policies?

f.

Notes to the financial statements?
[Generally Accepted]

2.

Are the financial statements suitably titled?
[Generally Accepted]

3.

Does each statement include a general reference indicating that the
notes are an integral part of the financial statement presentation?
[Generally Accepted]

FSP §20,300.03

60

Life and Health Insurance Entities

Yes

B. Disclosure of Accounting Policies

1.

Is a description of significant accounting policies of the reporting en
tity presented as either a separate summary preceding the notes to the
financial statements or as the initial note:
[APB 22 par. 15]
a.

Principles of consolidation?

____

b.

Basis of presentation?

____

c.

Basis of investments?

------

d.

Realized gains and losses?

------

e.

Cash equivalents?

____

f.

Recognition of premium revenues?

____

g.

Deferred policy acquisition costs?

____

h.

Property and equipment?

____

i.

Insurance liabilities?

____

j.

Participating policies?

____

k.

Reinsurance?

____

l.

Income taxes?

____

m. Foreign reinsurance?
[APB 22 par. 8; FIN 40 par. 5, as amended by SFAS 115 and SFAS
135]

2.

3.

Do the summary or notes identify and describe all significant account
ing principles followed by the reporting entity and the methods of
applying those principles that materially affect the determination of
financial position, cash flows, and results of operations?
[APB 22 par. 12]

5.

____

Do those principles and methods identified in question 2 include all
instances in which there:

a.

Is a selection from existing acceptable alternatives?

____

b.

Are principles and methods peculiar to the industry in which the
reporting entity operates, even if such principles and methods are
predominantly followed in that industry?

____

c.
4.

____

Are unusual or innovative applications of GAAP?
[APB 22 par. 12]

Is an explanation that the preparation of financial statements in con
formity with GAAP requires the use of management's estimates in
cluded?
[SOP 94-6 par. 11; FSP SOP 94-6-1 par. 10]
Does disclosure of significant accounting policies include appropriate
reference to details presented elsewhere (in the statements and notes
thereto) so duplication of details is avoided?
[APB 22 par. 14]
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6.

7.

8.

9.

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

If an insurance enterprise's risk-based capital would have trig
gered a regulatory event had it not used a permitted practice, is
that fact disclosed in the financial statements?

____

____

____

A description of the prescribed or permitted statutory accounting
practice by insurance enterprises at the date each financial state
ment is presented?

____

____

____

____

____

____

Is the company's accounting policy with respect to vendor's sales in
centive arrangements disclosed?
[EITF 03-10]
Is the policy for requiring collateral or other security disclosed if the
entity has entered into repurchase agreements or securities lending
transactions?
[SFAS 140 par. 17(a), as amended by SFAS 156]
If material, is the accounting policy used in recognizing amounts re
lated to a modification of an operating lease (that does not change the
lease classification) disclosed?
[EITF 95-17]

Do mutual life insurance companies disclose the principles and meth
ods used to account for marketable securities and insurance activities?
[FIN 40 par. 5, as amended by SFAS 115 and SFAS 135]

10. If (a) state prescribed statutory accounting practices differ from the
National Association of Insurance Commissioners (NAIC) statutory
accounting practices or (b) permitted state statutory accounting prac
tices differ from either state prescribed statutory accounting practices
or NAIC statutory accounting practices, is the following information
about the use of prescribed or permitted statutory accounting prac
tices (individually or in the aggregate) results in reported statutory
surplus or risk-based capital that is significantly different from the
statutory surplus or risk-based capital that would have been reported
had NAIC statutory accounting practices been followed, disclosed:

a.

b.

c.

The related monetary effect on statutory surplus of using an ac
counting practice that differs from either state prescribed statu
tory accounting practices or NAIC statutory accounting practices
by insurance enterprises at the date each financial statement is
presented?2
[SOP 94-5 par. 9 (ACC 10,630.09), as amended by SOP 01-5 (ACC
10,840)]

2 Disclosures in this question should be applied by a U.S. insurance enterprise, a U.S. enterprise with a U.S. insurance subsidiary, or a
foreign enterprise with a U.S. insurance subsidiary, if the enterprise prepares U.S. generally accepted accounting principles (GAAP)
financial statements. If a foreign insurance enterprise that does not have a U.S. insurance subsidiary prepares U.S. GAAP financial
statements or is included in its parent's consolidated U.S. GAAP financial statements, the notes to the financial statements should disclose
permitted regulatory accounting practices that significantly differ from the prescribed regulatory accounting practices of its respective
regulatory authority and their monetary effects.
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11. Are managements' policies and methodologies for estimating a liabil
ity for unpaid claims and claim adjustment expenses for difficult-toestimate liabilities such as for claims for toxic waste cleanup, asbestosrelated illnesses, or other environmental remediation exposures
disclosed?
[SOP 94-5 par. 12 (ACC 10,630.12), as amended by SOP 01-5 (ACC
10,840)]

Yes

No

N/A

-------

-------

------

12. Do the notes to the accompanying insurance enterprise's statutory fi
nancial statements contain a summary of significant accounting poli
cies that discuss the following:

a.

Statutory accounting practices?

-------

-------

------

b.

Describe how this basis differs from GAAP?
[SOP 95-5 par. 20 (AUD 14,310.20), as amended by SOP 01-5]

-------

-------

------

-------

-------

------

-------

-------

------

13. For general-use statutory financial statements, are the effects of the
differences between statutory accounting practices and GAAP, if
quantified, disclosed?
[SOP 95-5 par. 20 (AUD 14,310.20), as amended by SOP 01-5]

14. Has the insurance company disclosed its accounting policy for inter
nal replacements, including whether or not the company has availed
itself of the alternative application guidance in paragraphs 18-19 of
SOP 05-1, and if so, for which types of internal replacement transac
tions?
[SOP 05-1 par. 28 (ACC 10,920.28)]

15. Has the insurance company disclosed its accounting policy for sales
inducements, including:

a.

The nature of the costs deferred?

-------

-------

------

b.

The method of amortizing those costs?
[SOP 03-1 par. 39 (ACC 10,870.39)]

-------

-------

------

____

____

____

____

____

____

____

____

____

____

____

____

16. For sales inducements, are the amount of costs deferred and amor
tized for each of the periods presented and the unamortized balance
as of each balance sheet date disclosed?
[SOP 03-1 par. 39 (ACC 10,870.39)]
17. Has the insurance company disclosed its accounting policy for sepa
rate accounts, including:

a.
b.

The general nature of the contracts reporting in separate accounts,
including the extent and terms of minimum guarantees?
The basis of presentation for separate account assets and liabilities
and related separate account activity?
[SOP 03-1 par. 38 (ACC 10,870.38)]

18. Has the insurance company included a description of the liability val
uation methods and assumptions used in estimating the liabilities for
additional insurance benefits and minimum guarantees?
[SOP 03-1 par. 38 (ACC 10,870.38)]
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Yes

No

N/A

____

____

____

____

____

____

____

____

____

(1) A description of the prior-period information that has been
retrospectively adjusted, if any?

____

____

____

(2) The effect of the change on income from continuing opera
tions, net income (or other appropriate captions of changes in
the applicable net assets or performance indicator), any other
affected financial statement line item, and any affected per
share amounts for the current period and any prior periods
retrospectively adjusted? Presentation of the effect on finan
cial statement subtotals and totals other than income from
continuing operations and net income (or other appropriate
captions of changes in the applicable net assets or perfor
mance indicator) is not required.

____

____

____

(3) The cumulative effect of the change on retained earnings or
other components of equity or net assets in the statement of
financial position as of the beginning of the earliest period
presented?

____

____

____

(4) If retrospective application to all prior periods (paragraph 7
of SFAS 154) is impracticable, disclosure of the reasons there
fore, and a description of the alternative method used to re
port the change (paragraphs 8-9 of SFAS 154)?

-------

-------

------

C. Comparative Financial Statements

1.

2.

If comparative statements are presented, are the notes and other dis
closures included in the financial statements of the preceding year(s)
repeated, or at least referred to, to the extent that they continue to be
of significance?
[ARB 43 ch. 2A par. 2]
If changes occurred in the manner of or basis for presenting corre
sponding items for two or more periods, are appropriate explanations
of the changes disclosed?
[ARB 43 ch. 2A par. 3, as amended by APB 20 and SFAS 154]

D. Accounting Changes and Error Corrections3

Change in Accounting Principle
1.

Is the following disclosed in the fiscal period in which a change in
accounting principle is made:

a.

b.

c.

The nature of and reason for the change in accounting principle,
including an explanation of why the newly adopted accounting
principle is preferable?
The method of applying the change, and:

If indirect effects of a change in accounting principle are recog
nized:

3 For issuers, as prescribed by the rules of the Securities and Exchange Commission (SEC), see the SEC issued Staff Accounting Bulletin
(SAB) 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements (Codifica
tion of Staff Accounting Bulletins, Topic 1—Financial Statements, Section N—Considering the Effects of Prior Year Misstatements when
Quantifying Misstatements in Current Year Financial Statements).
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(1) A description of the indirect effects of a change in accounting
principle, including the amounts that have been recognized
in the current period, and the related per share amounts, if
applicable?

(2) Unless impracticable, the amount of the total recognized in
direct effects of the accounting change and the related per
share amounts, if applicable, that are attributable to each
prior period presented?
[SFAS 154 par. 17]

Note: Financial statements of subsequent periods need not repeat the dis
closures required by this paragraph.
[SFAS 154 par. 17]
2.

If a change in accounting principle has no material effect in the period
of change but is reasonably certain to have a material effect in later
periods, are the disclosures required by question la provided when
ever the financial statements of the period of change are presented?
[SFAS 154 par. 17]

3.

In the fiscal year in which a new accounting principle is adopted, does
financial information reported for interim periods after the date of
adoption include disclosure of the effect of the change on income
from continuing operations, net income (or other appropriate captions
of changes in the applicable net assets or performance indicator), and
related per share amounts, if applicable, for those post-change interim
periods?
[SFAS 154 par. 18]

4.

If a public company that regularly reports interim information makes
an accounting change during the fourth quarter of its fiscal year and
does not report the data specified by paragraph 30 of APB 28, Interim
Financial Reporting (as amended), in a separate fourth-quarter report or
in its annual report, does the entity include disclosure of the effects of
the accounting change on interim-period results, as required by para
graph 17 of SFAS 154, in a note to the annual financial statements for
the fiscal year in which the change is made?
[SFAS 154 par. 16]

5.

If an entity chooses to apply the consensus in EITF 06-2 as a change
in accounting principle through a cumulative-effect adjustment to re
tained earnings, does the entity disclose the cumulative effect of the
change on retained earnings or other components of equity or net as
sets in the statement of financial position?
[EITF 06-2 par. 7]

6.

If an entity chooses to apply the consensus in EITF 06-2 as a change
in accounting principle through retrospective application to all prior
periods, does the entity include the recognition of:

a.

The cumulative effect of the change to the new accounting prin
ciple on periods prior to those presented reflected in the carrying
amounts of assets and liabilities as of the beginning of the first
period presented?
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Yes

b.

c.

7.

____

___

____

___

A description of the prior-period information that has been ret
rospectively adjusted?

____

____

The effect of the change on income from continuing operations,
net income (or other appropriate captions of changes in the appli
cable net assets or performance indicator), any other affected fi
nancial statement line item, and any affected per share amounts
for any prior periods retrospectively adjusted?

____

____

____

____

____

____

Adjustments to financial statements for each individual prior pe
riod presented to reflect the period-specific effects of applying the
new accounting principle?
[EITF 06-2 par. 8]

N/A

If an entity chooses to apply the consensus reached in this EITF 06-2
as a change in accounting principle through retrospective application
to all prior periods, are the following disclosed:

a.
b.

c.

8.

The cumulative effect of the change on retained earnings or on
other components of equity or net assets in the statement of finan
cial position?

No

The cumulative effect of the change on retained earnings or on
other components of equity or net assets in the statement of finan
cial position as of the beginning of the earliest period presented?
[EITF 06-2 par. 9]

If the scope of EITF 06-9 applies, does the entity make the disclosures
required pursuant to SFAS 154?
[EITF 06-9 par. 5]

Note: EITF 06-11, "Accounting for Income Tax Benefits of Dividends on
Share-Based Payment Awards," should be applied prospectively to the in
come tax benefits of dividends on equity-classified employee share-based
payment awards that are declared in fiscal years beginning after Septem
ber 15, 2007.
9.

Does the entity disclose the nature of any change in their accounting
policy for income tax benefits of dividends on share-based payment
awards resulting from the adoption of EITF 06-11?
[EITF 06-11 par. 7]

Change in Accounting Estimate

10. Is the effect on income from continuing operations, net income (or
other appropriate captions of changes in the applicable net assets or
performance indicator), and any related per share amounts of the cur
rent period disclosed for a change in estimate that affects several fu
ture periods, such as a change in service lives of depreciable assets?
Disclosure of those effects is not necessary for estimates made each
period in the ordinary course of accounting for items such as uncol
lectible accounts or inventory obsolescence; however, if the effect of a
change in the estimate is material, is it disclosed?
[SFAS 154 par. 22]
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11. When an entity effects a change in estimate by changing an account
ing principle, are the disclosures required by preceding questions 1-3
made?
[SFAS 154 par. 22]
12. If a change in estimate does not have a material effect in the period of
change but is reasonably certain to have a material effect in later per
iods, is a description of that change in estimate disclosed whenever
the financial statements of the period of change are presented?
[SFAS 154 par. 22]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

Change in the Reporting Entity
13. When there has been a change in the reporting entity, do the financial
statements of the period of the change describe the nature of the
change and the reason for it?

a.

Is the effect of the change on income before extraordinary items,
net income (or other appropriate captions of changes in the appli
cable net assets or performance indicator), OCI, and any related
per share amounts disclosed for all periods presented?
[SFAS 154 par. 24]

Note: Financial statements of subsequent periods need not repeat the dis
closures required by this paragraph.
[SFAS 154 par. 24]
14. If a change in reporting entity does not have a material effect in the
period of change but is reasonably certain to have a material effect in
later periods, is the nature of and reason for the change disclosed
whenever the financial statements of the period of change are pre
sented?
[SFAS 154 par. 24]

Note: Paragraphs 51-58 of SFAS 141 describe the manner of reporting and
the disclosures required for a business combination.
[SFAS 154 par. 24]
Correction of an Error in Previously Issued Financial Statements
15. When financial statements are restated to correct an error, does the
entity disclose that its previously issued financial statements have
been restated, along with a description of the nature of the error?
Does the entity also disclose the following:
a.

The effect of the correction on each financial statement line item
and any per share amounts affected for each prior period pre
sented?

b.

The cumulative effect of the change on retained earnings or other
appropriate components of equity or net assets in the statement
of financial position, as of the beginning of the earliest period pre
sented?
[SFAS 154 par. 26]

FSP §20,300.03

67

Financial Statements and Notes Checklist

Yes

No

N/A

16. In addition, does the entity make the disclosures of prior-period ad
justments and restatements required by paragraph 26 of APB 9, Re
porting the Results of Operations?

____

____

____

The resulting effects (both gross and net of applicable income tax)
on the net income of prior periods in both the annual report for
the year in which the adjustments are made? And in interim re
ports issued during that year subsequent to the date of recording
the adjustments (recommended but not required)?

____

____

____

For single period financial statements, the effects of such restate
ment on the balance of retained earnings at the beginning of the
period and on the net income of the immediately preceding
period?

____

____

____

____

____

____

a.

b.

c.

When financial statements for more than one period are pre
sented, the effects for each of the periods included in the state
ments? Such disclosures should include the amounts of income
tax applicable to the prior period adjustments.
[APB 9 par. 26; SFAS 154 par. 26]

Notes: Financial statements of subsequent periods need not repeat the dis
closures required by this paragraph. An entity that issues interim financial
statements shall provide the required disclosures in the financial state
ments of both the interim period of the change and the annual period of
the change.
[SFAS 154 par. 26]

EITF 06-6, "Debtor's Accounting for a Modification or Exchange of Con
vertible Debt Instruments," applies to modifications or exchanges of debt
instruments occurring in interim or annual reporting periods beginning
after board ratification (November 29, 2006). The scope of this issue in
cludes modifications and exchanges of debt instruments that (a) either add
or eliminate an embedded conversion option or (b) affect the fair value of
an existing embedded conversion option. Earlier application of this issue
is permitted for modifications or exchanges of debt instruments in periods
for which financial statements have not yet been issued. Retrospective ap
plication to previously issued financial statements is not permitted. The
guidance in this issue supersedes EITF 05-7, "Accounting for Modifica
tions to Conversion Options Embedded in Debt Instruments and Related
Issues."
17. For debt instruments that were converted (or extinguished) in prior
periods that fall within the scope of EITF 00-27, "Application of Issue
No. 98-5 to Certain Convertible Instruments," but are still presented
in the financial statements, has the entity retrospectively applied
SFAS 154 and recorded SFAS 109 temporary differences as adjust
ments to paid-in-capital?
[EITF 05-8 par. 5-6]

18. Does an issuer disclose the following information for the period in
which an embedded conversion option previously accounted for as a
derivative under SFAS 133 that no longer meets the separation criteria
under that statement:
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a.

A description of the principal changes causing the embedded con
version option to no longer require bifurcation under SFAS 133?

b.

The amount of the liability for the conversion option reclassified
to stockholders' equity?
[EITF 06-7 par. 6]

Investments in Real Estate Ventures
19. When accounting for a controlling interest in a partnership and apply
ing the guidance of FSP SOP 78-9-1, Interaction of AICPA Statement of
Position 78-9 and EITF Issue No. 04-5, pertaining to Transition Method
A of FSP SOP 78-9-1, does the entity disclose in the year of adoption
the effect on the opening balance sheet of adopting the new account
ing principle?
[FSP SOP 78-9-1 par. 8]

20. When accounting for a controlling interest in a partnership and apply
ing the guidance of FSP SOP 78-9-1 pertaining to Transition Method
B of FSP SOP 78-9-1, if the entity applies the guidance in FSP SOP 789-1 through retrospective application, does it apply the guidance in
paragraphs 7-8 and 10 of SFAS 154, and the disclosures required by
paragraph 17 of SFAS 154?
[FSP SOP 78-9-1 par. 10]
E. Risks and Uncertainties

Notes: The guidance in FSP SOP 94-6-1, Terms of Loan Products That May
Give Rise to a Concentration of Credit Risk, addresses the adequacy of disclo
sures for all lending products (including both secured and unsecured
loans) and the effect of changes in market or economic conditions on the
adequacy of those disclosures. An entity shall provide the disclosures re
quired by SFAS 107 for products that are determined to represent a con
centration of credit risk in accordance with the guidance in question 1 of
the FSP for all periods presented.
[FSP SOP 94-6-1 par. 17]
Question 2 of the FSP references only existing effective literature; there
fore, no effective date or transition guidance is required.
[FSP SOP 94-6-1 par. 18]
The type and extent of information provided shall be determined by
whether the entity is the originator, holder, investor, guarantor, or servicer
and also by the significance of the loan product(s) to the reporting entity.
[FSP SOP 94-6-1 par. 9 question 2]
1.

2.

Is a description of the major products and services the entity sells or
provides and the principal markets, including the location of those
markets, disclosed?
[SOP 94-6 par. 10 (ACC 10,640.10); FSP SOP 94-6-1 par. 10]
If the company operates in more than one business, are the relative
importance of its operations in each business and the basis for the
determination (for example, assets, revenues, or earnings) disclosed?
[SOP 94-6 par. 10 (ACC 10,640.10); FSP SOP 94-6-1 par. 10]
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3.

4.

Is an explanation that the preparation of financial statements in con
formity with GAAP requires the use of management's estimates in
cluded in the financial statements?
[SOP 94-6 par. 11 (ACC 10,640.11); FSP SOP 94-6-1 par. 10]

b.

6.

7.

It is at least reasonably possible that the estimate of the effect on
the financial statements of a condition, situation, or set of circum
stances that existed at the date of the financial statements will
change in the near term due to one or more future confirming
events?

The effect of the change will be material?
[SOP 94-6 par. 13 (ACC 10,640.13); FSP SOP 94-6-1 par. 10]

Does the disclosure in question 4, indicate the nature of the uncer
tainty and include an indication that it is reasonably possible that a
change in estimate will occur in the near term?4
[SOP 94-6 par. 14 (ACC 10,640.14); FSP SOP 94-6-1 par. 10]
If the estimate in question 4 involves a loss contingency covered by
SFAS 5, do disclosures include an estimate of the possible loss or
range of loss, or state that such an estimate cannot be made?*
[SOP 94-6 par. 13-14 (ACC 10,640.13-14); FSP SOP 94-6-1 par. 10-11]

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

Is disclosure of the concentrations described in paragraph 22 of SOP
94-6, Disclosure of Certain Significant Risks and Uncertainties (AICPA,
Technical Practice Aids, ACC sec. 10,640 par. .22), made if, based on
information known to management before the financial statements
are issued, all of the following criteria are met:
a.

The concentration exists at the date of the financial statements?

____

____

____

b.

The concentration makes the enterprise vulnerable to the risk of a
near-term severe impact?

____

____

____

____

____

____

c.

8.

No

Is the disclosure regarding an estimate made when known informa
tion available prior to the issuance of the financial statements indi
cates that both of the following criteria have been met:

a.

5.

Yes

It is at least reasonably possible that the events that could cause
the severe impact will occur in the near term?
[SOP 94-6 par. 21-22 (ACC 10,640.21-.22); FSP SOP 94-6-1 par.
10-11]

For those concentrations of labor subject to collective bargaining
agreements and concentrations of operations located outside of the
company's home country that meet the criteria of paragraph 21 of
SOP 94-6, are the following disclosed:

4 If risk reduction techniques are used to mitigate losses or the uncertainty that may result from certain events, these disclosures are
encouraged but not required.
* See note in part F, "Contingencies and Commitments," for an important notice regarding a proposed SFAS titled Disclosure of Certain
Loss Contingencies—an amendment ofFASB Statements No. 5 and 141(R) that would replace the disclosure requirements in SFAS 5, Account
ing for Contingencies. If finalized and issued as currently drafted, this statement would change the requirements of this question and
would be effective for annual financial statements issued for fiscal years ending after December 15,2008, and interim and annual periods
in subsequent fiscal years. This checklist has not been updated to include the presentation and disclosure requirements of this proposed
statement. Readers may continue to check the status of this proposed statement on the FASB Web site at www.fasb.org.
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a.

b.

9.

The percentage of labor force covered by a collective agreement
and the percentage of the labor force covered by a collective bar
gaining agreement that will expire in one year?
The carrying amounts of net assets and the geographic areas in
which they are located for operations located outside the com
pany's home country?
[SOP 94-6 par. 24 (ACC 10,640.24); FSP SOP 94-6-1 par. 10-11]

Have the optional disclosures in paragraphs 14-15 of SOP 94-6 been
considered?
[SOP 94-6 par. 14-15 (ACC 10,640.14-.15)]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

10. Are major categories of loans, including unusual risk concentrations
disclosed, such as:

a.

Commercial, financial, and agricultural?

____

____

____

b.

Real estate construction?

____

____

____

c.

Real estate mortgage?

____

____

____

d.

Installment loans to individuals?

____

____

____

e.

Lease financing?

____

____

____

f.

Foreign?

____

____

____

g.

Loans in process?

____

____

____

h.

Other?
[FSP SOP 94-6-1 par. 11]

____

____

____

11. Are major concentrations of loan products whose contractual features
may increase credit risk disclosed, such as:

a.

Negative amortization?

____

____

____

b.

Loans with a high loan-to-value ratio?

____

____

____

c.

Multiple loans on the same collateral that, when combined, result
in a high loan-to-value ratio?

____

____

____

Option adjustable rate mortgages or similar products that may ex
pose the borrower to future increases in repayments?

____

____

____

An initial interest rate that is below the market interest rate for
the initial period of a loan term and that may increase signifi
cantly when that period ends?

____

____

____

____

____

____

____

____

____

d.

e.

f.

Interest only loans?
[FSP SOP 94-6-1 par. 2 and 7; SFAS 107 par. 15A, as amended by
SFAS 133]

12. Are foreign loans, foreign nonaccrual loans, and foreign operations, if
any of these foreign activities exceed a material percentage of activi
ties, disclosed?
[FSP SOP 94-6-1 par. 7; SFAS 107 par. 15A, as amended by SFAS 133]
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Yes

No

N/A

F. Contingencies and Commitments (See also part Z, "Guarantees.")

Notes: In June 2008, FASB issued a proposed SFAS titled Disclosure of Cer
tain Loss Contingencies—an amendment of FASB Statements No. 5 and 141(R),
that would replace the disclosure requirements in SFAS 5 for loss contin
gencies that are recognized as liabilities in a statement of financial position
and for unrecognized loss contingencies that would be recognized as lia
bilities if the criteria for recognition in paragraph 8 of SFAS 5 were met.
Loss contingencies that are (or would be) recognized as asset impairments
would continue to be disclosed in accordance with SFAS 5. This proposed
statement would also amend SFAS 141(R) to require the disclosures in
cluded in this statement for loss contingencies recognized in a business
combination. This proposed statement would not change the recognition
and measurement guidance for loss contingencies contained in SFAS 5 and
in SFAS 141(R).
On September 24, 2008, FASB decided on a plan for redeliberations and
directed the staff to prepare an alternative model that will attempt to ad
dress the concerns that certain constituents raised about this proposed
statement. This alternative model will be field tested along with the model
in the exposure draft. The board also decided that any final statement on
this topic will be effective no sooner than for fiscal years ending after De
cember 15, 2009.
This checklist has not been updated to include the presentation and disclo
sure requirements of this proposed statement. Readers may continue to
check the status of this proposed statement on the FASB Web site at
www.fasb.org.
1.

Is disclosure made of the nature of estimated loss contingencies ac
crued when (a) information available prior to issuance of the financial
statements indicates that it is probable that an asset has been impaired
or a liability incurred at the date of the financial statements and (b)
the amount of loss can be reasonably estimated?

2.

If necessary to keep the financial statements from being misleading,
are the amounts of contingencies accrued as described in question 1
disclosed?
[SFAS 5 par. 9]

3.

For loss contingencies not accrued, do disclosures indicate:

4.

a.

Nature of the contingency?

b.

Estimate of possible loss or range of loss, or a statement that such
estimate cannot be made?
[SFAS 5 par. 10]

Are the nature and amount of guarantees disclosed (for example,
guarantees of indebtedness of others, guarantees to repurchase receiv
ables [or, in some cases, the related property] that have been sold or
otherwise assigned) even though the possibility of loss may be re
mote?
[SFAS 5 par. 12; FIN 45 par. 13; EITF 85-20]
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Yes

5.

Are gain contingencies adequately disclosed with care to avoid any
misleading implications about likelihood of realization?
[SFAS 5 par. 17]

6.

Is there adequate disclosure of commitments, such as those for plant
acquisition or an obligation to reduce debts, maintain working capital,
or restrict dividends, for long term leases, for assets pledged as secu
rity for loans, and unused letters of credit?

7.

For long-term unconditional purchase obligations that are not re
corded in the purchaser's balance sheet, are the following disclosed:

a.

Nature and term of the obligations?

b.

Amount of the fixed and determinable portion of the obligations
as of the date of the latest balance sheet presented in the aggre
gate and, if determinable, for each of the next five years?

c.

Nature of any variable components of the obligation?

d.

Amounts of purchases under the obligations for each year for
which an income statement is presented?
[SFAS 5 par. 18-19, as amended by SFAS 111]

8.

If the company as guarantor "lends" its creditworthiness to another
party (borrower) for a fee, is the guarantee disclosed in a note, if ma
terial?
[EITF 85-20]

9.

If exposure to loss exists in excess of the amount accrued for a loss
contingency, do disclosures include the excess amount or state that no
estimate is possible?
[SFAS 5 par. 10]

10. Is disclosure made if a subsidiary entity has guaranteed parent com
pany debt?
[SFAS 57 par. 1-2, as amended by SFAS 96 and SFAS 109]
11. When, after considering management's plans, the auditor concludes
there is substantial doubt about the entity's ability to continue as a
going concern for a reasonable period of time, is adequate disclosure
of the situation made in the financial statements?
[AU 341.10]
12. Is a description of contingencies resulting from the September 11
events that have not yet been recognized in the financial statements
but that are reasonably expected to impact the entity's financial state
ments in the near term disclosed in the notes to the financial state
ments in all periods affected by the September 11, 2001 attacks?
[EITF 01-10]

Note: SFAS 5 states that it does not discourage disclosure of uninsured
risks in appropriate circumstances. It is recommended that, though oper
ational criteria have not been developed for such disclosures as stated in
SFAS 5, they should be encouraged rather than simply not discouraged.
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Yes

No

N/A

(1) Torts?

____

____

____

(2) Theft of, damage to, expropriation of, or destruction of assets?

____

____

____

(3) Business interruption?

____

____

____

(4) Errors or omissions?

____

____

____

(5) Injuries to employees?

____

____

____

(6) Acts of God?

____

____

____

Those risks have not been transferred to unrelated third parties
through insurance? (Encouraged, but not required.)
[EITF 03-8]

____

____

____

The actual and potential effects of losses from such risks on the
entities historical or planned operations, including exposure to
losses from claims, curtailment of research and development or
manufacturing, or contraction or cessation of other activities, such
as discontinuance of a product line?

____

____

____

Comparison of current insurance coverage by major categories of
risk to coverage in prior periods, without necessarily quantifying
such coverage or change in coverage?

____

____

____

c.

Recent claims experience?

____

____

____

d.

A description of the reporting entity's risk management pro
grams?
[EITF 03-8]

____

____

____

13. For publicly held entities and entities with public accountability, such
as governments, are circumstances disclosed in which (Encouraged,
but not required):

a.

b.

They are exposed to risks of future material loss related to:

14. In considering those matters to be disclosed that relate to certain un
insured risks of future material loss as described in EITF 03-8, "Ac
counting for Claims-Made Insurance and Retroactive Insurance Con
tracts by the Insured Entity," has the entity considered the following:

a.

b.

Notes: In May 2008, the FASB issued SFAS 163, Accounting for Financial
Guarantee Insurance Contracts—an interpretation of FASB Statement No. 60.
The scope of SFAS 163 is limited to financial guarantee insurance and re
insurance contracts issued by enterprises included in SFAS 60. This state
ment does not apply to enterprises excluded from SFAS 60, to financial
guarantee insurance contracts that are accounted for as derivative instru
ments within the scope of SFAS 133 and to some insurance contracts that
are similar to financial guarantee insurance contracts issued by insurance
enterprises (such as mortgage guaranty insurance and credit insurance on
trade receivables). The changes to current practice are around premium
revenue, claim liabilities, and disclosure requirements. The provisions of
SFAS 163 shall be applied on a contract-by-contract basis.
SFAS 163 is effective for financial statements issued for fiscal years begin
ning after December 15, 2008, and all interim periods within those fiscal
years, except for some disclosures about the insurance enterprise's risk(continued)
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management activities. This statement requires that disclosures about the
risk-management activities of the insurance enterprise be effective for the
first period (including interim periods) beginning after issuance of this
statement. Except for those disclosures, earlier application is not permit
ted.

The statement notes that an insurance enterprise shall disclose information
that enables users of its financial statements to understand the factors af
fecting the present and future recognition and measurement of financial
guarantee insurance contracts. Given the immediate effectiveness of the
disclosure requirements, this checklist has been updated to include the re
quired disclosures in SFAS 163.

Readers are encouraged to review the full SFAS 163 statement before ap
plying its guidance, which can be found on the FASB Web site at
www.fasb.org.
15. In each annual period (and in an interim period if a significant change
has occurred in that interim period), for financial guarantee insurance
contracts where premiums are received as payments over the period
of the contract, rather than at inception, has the insurance enterprise
disclosed:

a.

The premium receivable and the unearned premium revenue as
of the date(s) of the statement of financial position and the line
item in the statement of financial position where those amounts
are reported (if not presented separately)?

b.

The amount of accretion on the premium receivable and the line
item in the statement of income where that amount is reported (if
not presented separately)?

c.

The weighted-average risk-free rate used to discount the premi
ums expected to be collected and the weighted-average period of
the premium receivable?
[SFAS 163 par. 30a]

16. In each annual period (and in an interim period if a significant change
has occurred in that interim period) has the insurance enterprise dis
closed a schedule of premiums expected to be collected related to the
premium receivable which details the following:

a.

The four quarters of the subsequent annual period and each of the
next four annual periods?

b.

The remaining periods aggregated in five-year increments?
[SFAS 163 par. 30b]

17. In each annual period (and in an interim period if a significant change
has occurred in that interim period) has the insurance enterprise dis
closed a rollforward of the premium receivable for the period, includ
ing:

a.

The beginning premium receivable?

b.

Premium payments received?

c.

New business written?
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d.

e.

Yes

No

N/A

-------

-------

------

____

____

____

-------

-------

------

-------

-------

------

____

____

____

-------

-------

------

-------

-------

------

A description of each grouping or category used to track and
monitor deteriorating insured financial obligations?

-------

-------

------

The insurance enterprise's policies for placing an insured financial
obligation in, and monitoring, each grouping or category?

-------

-------

------

Adjustments to the premium receivable, including at a minimum:
adjustments for changes in the period of a financial guarantee in
surance contract and an explanation of why those adjustments oc
curred, accretion of the premium receivable discount, and other
adjustments with explanations provided for significant or recur
ring adjustments?
The ending premium receivable?
[SFAS 163 par. 30c]

18. In each annual period (and in an interim period if a significant change
has occurred in that interim period), for premium revenue recognition
that has been accelerated, has the insurance enterprise disclosed the
amount and reasons for acceleration?
[SFAS 163 par. 30d]

19. In each annual period (and in an interim period if a significant change
has occurred in that interim period) has the insurance enterprise dis
closed a schedule of the future expected premium revenue as of the
latest date of the statement of financial position detailing the follow
ing:
a.
b.

The four quarters of the subsequent annual period and each of the
next four annual periods?
The remaining periods aggregated in five-year increments?
[SFAS 163 par. 30e]

20. In each annual period (and in an interim period if a significant change
has occurred in that interim period) has the insurance enterprise dis
closed the following for the claim liability:

a.
b.

The weighted-average risk-free rate used to discount the claim li
ability?
The significant component(s) of the change in the claim liability
for the period (such as changes in the discount rate, the accretion
of the discount on the claim liability, changes in the timing,
changes in the likelihood of default), the amount relating to that
component(s), and the line item in the statement of income where
that amount or amounts are reported (unless separately dis
closed)?
[SFAS 163 par. 30f]

21. In each annual period (and in an interim period if a significant change
has occurred in that interim period) has the insurance enterprise dis
closed a description of the insurance enterprise's risk-management ac
tivities used to track and monitor deteriorating insured financial ob
ligation, including the following:

a.
b.
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c.

The insurance enterprise's policies for avoiding or mitigating
claim liabilities, the related expense and liability reported during
the period for those risk mitigation activities (not including rein
surance), and a description of where that expense and that liabil
ity are reported in the statement of income and the statement of
financial position, respectively?
[SFAS 163 par. 30g]

____

22. In each annual and interim period related to the claim liability, has
the insurance enterprise disclosed a schedule of insured financial ob
ligations at the end of each interim period detailing, at a minimum,
the following for each category or grouping of these financial obliga
tions:
Number of issued and outstanding financial guarantee insurance
contracts?

____

b.

Remaining weighted-average contract period?

____

c.

Insured contractual payments outstanding, segregating principal
and interest?

____

d.

Gross claim liability?

____

e.

Gross potential recoveries?

____

f.

Discount, net (both claim liability and potential recoveries)?

____

g.

Net claim liability?

____

h.

Reinsurance recoverables?

____

i.

Unearned premium revenue?
[SFAS 163 par. 31a]

____

a.

G. Environmental Remediation Liabilities
Note: SOP 96-1, Environmental Remediation Liabilities (AICPA, Technical
Practice Aids, ACC sec. 10,680), does not provide guidance on recognizing
liabilities of insurance companies for unpaid claims.

1.

2.

Is there disclosure of the following accounting policies:

a.

Whether accruals for environmental remediation liabilities are
measured on a discounted basis?

b.

The policy concerning the timing of recognition of recoveries?
(Encouraged, but not required.)
[SOP 96-1 par. .152-.153 (ACC 10,680.152-.153)]

Do the financial statements disclose the event, situation, or set of cir
cumstances that triggered recognition of loss contingencies that arose
out of the reporting entity's environmental remediation-related obli
gations? (Encouraged, but not required.)
[SOP 96-1 par. .153 (ACC 10,680.153)]
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Yes

No

N/A

Recognized Losses and Recoveries of Losses, and Reasonably Possible
Loss Exposures

3.

With respect to recorded accruals for environmental remediation loss
contingencies and assets for third-party recoveries related to environ
mental remediation obligations, are the following disclosed:

a.

b.

c.

4.

The nature of the accruals, if such disclosure is necessary for the
financial statements not to be misleading, and, in situations where
disclosure of the nature of the accruals is necessary, the total
amount accrued for the remediation obligation, if such disclosure
is also necessary for the financial statements not to be misleading?

____

___

If any portion of the accrued obligation is discounted, the undis
counted amount of the obligation and the discount rate used in
the present-value determinations?

____

___

____

___

The nature of the reasonably possible loss contingency, that is, a
description of the reasonably possible remediation obligation, and
an estimate of the possible loss exposure or the fact that such an
estimate cannot be made?

____

___

If the criteria of SOP 94-6 are met with respect to estimated loss
(or gain) contingencies, an indication that it is at least reasonably
possible that a change in the estimate will occur in the near term?

____

____

The estimated time frame of disbursements for recorded amounts
if expenditures are expected to continue over the long term? (En
couraged, but not required.)

____

____

The estimated time frame for realization of recognized probable
recoveries, if realization is not expected in the near term? (En
couraged, but not required.)

____

____

If the criteria of SOP 94-6 are met with respect to the accrued ob
ligation, to any recognized asset for third-party recoveries, or to
reasonably possible loss exposures or disclosed gain contingen
cies, the factors that cause the estimate to be sensitive to change?
(Encouraged, but not required.)

------

-----

If an estimate of the probable or reasonably possible loss or range
of loss cannot be made, the reasons why it cannot be made? (En
couraged, but not required.)

------

-----

If the criteria of SOP 94-6 (it is at least reasonably possible that an
estimate of the effect on the financial statements of a matter that
existed at the balance sheet date will change in the near term and
the effect of the change would be material to financial statements)
are met with respect to the accrued obligation or to any recog
nized asset for third-party recoveries, an indication that it is at
least reasonably possible that a change in the estimate of the ob
ligation or of the asset will occur in the near term?
[SOP 96-1 par. .161 (ACC 10,680.161)]

With respect to reasonably possible loss contingencies, including rea
sonably possible loss exposures in excess of the amount accrued, are
the following disclosed:

a.

b.

c.

d.

e.

f.
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g.

If information about the reasonably possible loss or the recog
nized and additional reasonably possible loss for an environmen
tal remediation obligation related to an individual site is relevant
to an understanding of the financial position, cash flows, or re
sults of operations of the entity, the following with respect to the
site: (Encouraged, but not required.)

(1) The total amount accrued for the site?

____

(2) The nature of any reasonably possible loss contingency or ad
ditional loss, and an estimate of the possible loss or the fact
that an estimate cannot be made and the reasons why it can
not be made?

____

(3) Whether other potentially responsible parties are involved
and the entity's estimated share of the obligation?

____

(4) The status of regulatory proceedings?

____

(5) The estimated time frame for resolution of the contingency?
[SOP 96-1 par. .162-.163 (ACC 10,680.162-.163)]

____

Probable But Not Reasonably Estimable Losses

5.

6.

If the reporting entity's probable but not reasonably estimable envi
ronmental remediation obligations may be material, are the nature of
the probable contingency (that is, a description of the remediation ob
ligation) and the fact that a reasonable estimate cannot currently be
made disclosed?
[SOP 96-1 par. .166 (ACC 10,680.166)]

Is the estimated time frame for resolution of the uncertainty as to the
amount of the loss disclosed? (Encouraged, but not required.)
[SOP 96-1 par. .166 (ACC 10,680.166)]

____

____

Environmental Remediation Costs Recognized Currently
7.

Is the amount of environmental remediation costs recognized in the
income statement disclosed in the following detail: (Encouraged, but
not required.)
a.
b.

c.

The amount recognized for environmental remediation loss con
tingencies in each period?

____

The amount of any recovery from third parties that is credited to
environmental remediation costs in each period?

____

The income statement caption in which environmental remedia
tion costs and credits are included?
[SOP 96-1 par. .170 (ACC 10,680.170)]

____

Other Matters

8.

Do the financial statements include a contingency conclusion that ad
dresses the estimated total unrecognized exposure to environmental
remediation and other loss contingencies? (Optional.)
[SOP 96-1 par. .171 (ACC 10,680.171)]
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9.

Yes

No

N/A

____

____

____

____

____

____

The nature of the relationship(s) involved (for example, parent,
subsidiary, and affiliate companies, officers, and stockholders)?

____

____

____

A description of the transactions, including transactions to which
no amounts or nominal amounts were ascribed, for each of the
periods for which an income statement is presented, and such
other information deemed necessary to an understanding of the
effects of the transactions on the financial statements?

____

____

____

The dollar amounts of transactions for each of the periods for
which an income statement is presented and the effects of any
change in the method of establishing the terms from that used in
the preceding period?

____

____

____

____

____

____

____

____

____

A description of the plan, the basis for determining contributions,
including the employee groups covered, and the nature and effect
of significant matters affecting comparability of information for
all periods presented?

-------

-------

------

(1) For leveraged ESOPs and pension reversion ESOPs, does the
description include the basis for releasing shares and how
dividends on allocated and unallocated shares are used?

-------

-------

------

Is there a description of the general applicability and impact of envi
ronmental laws and regulations upon their business and how the ex
istence of such laws and regulations may give rise to loss contingen
cies for future environmental remediation? (Optional.)
[SOP 96-1 par. .172 (ACC 10,680.172)]

10. Are applicable disclosures about environmental obligations (and re
coveries) related to the attacks of September 11 disclosed in the notes
to the financial statements in all periods affected by the September 11,
200,1 attacks, pursuant to SOP 96-1?
[EITF 01-10]

H. Related-Party Transactions and Economic Dependency

1.

For material related-party transactions, do disclosures include:

a.
b.

c.

d.

2.

I.

Amounts due from or to related parties as of the date of each bal
ance sheet presented and, if not otherwise apparent, the terms
and manner of settlement?
[SFAS 57 par. 2]

Is the nature of a controlled relationship disclosed, even though there
are no transactions between the enterprises, if the reporting company
and one or more other enterprises are under common ownership or
management control, and the existence of that control could result in
operating results or financial position of the reporting company being
significantly different from those that would have resulted if the com
panies were autonomous?
[SFAS 57 par. 4]

Employee Stock Ownership Plans
1.

If an employer sponsors an employee stock ownership plan (ESOP),
do the employer's disclosures include:
a.
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A description of the accounting policies followed for ESOP trans
actions, including the method of measuring compensation, the
classification of dividends on ESOP shares, and the treatment of
ESOP shares for EPS computations?

____

____

____

(1) If the entity has both old ESOP shares for which it does not
adopt the guidance in SOP 93-6, Employers' Accountingfor Em
ployee Stock Ownership Plans (AICPA, Technical Practice Aids,
ACC sec. 10,580), and new ESOP shares for which the guid
ance in SOP 93-6 is required, are the accounting policies for
both blocks of shares disclosed?

____

____

____

c.

The amount of compensation cost recognized during the period?

____

____

____

d.

The number of allocated shares, committed-to-be-released shares,
and suspense shares held by the ESOP at the balance sheet date?

____

____

____

(1) If the entity has both old ESOP shares for which it does not
adopt the guidance in SOP 93-6 and new ESOP shares for
which the guidance in SOP 93-6 is required, is the above dis
closure made separately for both blocks of shares?

____

____

____

The fair value of unearned ESOP shares at the balance sheet date
for shares accounted for under SOP 93-6?5

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

b.

e.

f.

2.

3.

4.

5.

The existence and nature of any repurchase obligation, including
disclosure of the fair value of the shares allocated as of the bal
ance sheet date, which are subject to a repurchase obligation?6
[SOP 93-6 par. 53 (ACC 10,580.53)]

Are all the items listed in question 1 disclosed even if the employer
with an ESOP does not adopt SOP 93-6 for shares held by the ESOP
on December 31,1992?
[SOP 93-6 par. 55 (ACC 10,580.55)]

For leveraged ESOPs and for nonleveraged ESOPs where the assets
from the pension plan are used by the ESOP to purchase shares, when
the employer reports the issuance of shares or the sale of treasury
shares to the ESOP, is the charge to unearned ESOP shares presented
as a separate item in the balance sheet as a contra-equity account?
[SOP 93-6 par. 13 and 46 (ACC 10,580.13 and .46)]
If the employer sponsors an ESOP with an indirect loan, is the outside
loan reported as a liability and the receivable from the ESOP not re
ported on the employer's balance sheet?
[SOP 93-6 par. 26 (ACC 10,580.26)]
If the employer sponsors an ESOP with an employer loan, is the
ESOP's note payable and the employer's note receivable from the
ESOP not reported in the employer's balance sheet?
[SOP 93-6 par. 27 (ACC 10,580.27)]

5 This disclosure need not be made for old ESOP shares for which the entity does not apply the guidance in SOP 93-6, Employers’
Accounting for Employee Stock Ownership Plans (AICPA, Technical Practice Aids, ACC sec. 10,580).

6 Employers may wish to disclose additional information about the obligation, particularly information about the timing of payments.
[SOP 93-6 par. 95 (ACC 10,580.95)]
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6.

J.

If SOP 76-3, Accounting Practices for Certain Employee Stock Ownership
Plans (AICPA, Technical Practice Aids, ACC sec. 10,130) is still being
followed for ESOP shares purchased before December 31,1992 and if
the reporting entity has guaranteed the debt of an ESOP or made a
commitment to make future contributions to the ESOP sufficient to
meet debt service requirements, are the compensation element and
the interest element of annual contributions reported separately, and
are the interest rate and debt terms disclosed in the notes to the finan
cial statements?
[SOP 76-3 par. 10 (ACC 10,130.10)]

Yes

No

N/A

____

____

____

Employers' Disclosures for Defined Benefit Pension and Other Post
retirement Plans7

Note: In September 2006, FASB issued SFAS 158, Employers' Accounting for
Defined Benefit Pension and Other Postretirement Plans—an amendment of
FASB Statements No. 87, 88, 106, and 132(R). SFAS 158 requires, among
other provisions, an employer to recognize the overfunded or under
funded status of a defined benefit postretirement plan (other than a mul
tiemployer plan) as an asset or liability in its statement of financial posi
tion and to recognize changes in that funded status in the year in which
the changes occur through comprehensive income. This statement also re
quires an employer to measure the funded status of a plan as of the date
of its year-end statement of financial position, with limited exceptions.
Effective Dates for Recognition and Related Disclosure Provisions

The required date of adoption of the recognition and disclosure provisions
of SFAS 158 differs for an employer that is an issuer of publicly traded
equity securities (as defined) and an employer that is not. Readers should
refer to the complete statement for any of the conditions that need to be
met for an employer to be deemed to have publicly traded equity securi
ties.

An employer with publicly traded equity securities is required to initially
recognize the funded status of a defined benefit postretirement plan (see
paragraph 4 of SFAS 158) and to provide the required disclosures (see par
agraph 7 of SFAS 158) as of the end of the fiscal year ending after Decem
ber 15, 2006.
An employer without publicly traded equity securities is required to rec
ognize the funded status of a defined benefit postretirement plan (see par
agraphs 4 and 8 of SFAS 158) and to provide the required disclosures (see
paragraphs 7 and 10 of SFAS 158) as of the end of the fiscal year ending
after June 15, 2007.

7 EITF 03-4, "Determining the Classification and Benefit Attribution Method for a 'Cash Balance' Pension Plan," states that a cash
balance plan should be considered a defined benefit plan.
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However, an employer without publicly traded equity securities is re
quired to disclose additional information in the notes to financial state
ments for a fiscal year ending after December 15, 2006, but before June 16,
2007, unless it has applied the recognition provisions of the statement in
preparing those financial statements. See the following question 2 for
those additional disclosure requirements.
The requirement to measure plan assets and benefit obligations as of the
date of the employer's fiscal year-end statement of financial position (see
paragraphs 5-6, and 9 of SFAS 158) is effective for fiscal years ending after
December 15, 2008. If in the last quarter of the preceding fiscal year an
employer enters into a transaction that results in a settlement or experi
ences an event that causes a curtailment of the plan, the related gain or
loss pursuant to SFAS 88, Employers' Accounting for Settlements and Curtail
ments of Defined Benefit Pension Plans and for Termination Benefits, or 106,
Employers' Accounting for Postretirement Benefits Other Than Pensions, is re
quired to be recognized in earnings or changes in unrestricted net assets
of that quarter. The requirement in paragraphs 5(k) and 8(j) of SFAS
132(R), Employers' Disclosures about Pensions and Other Postretirement Bene
fits—an amendment of FASB Statements No. 87, 88, and 106, to disclose the
measurement date is eliminated, effective in the year the employer initially
adopts the measurement date provisions of this statement.

Earlier application of the recognition or measurement date provisions is
encouraged; however, early application must be for all of an employer's
benefit plans. Retrospective application of the statement is not permitted.
This checklist has been updated to include the presentation and disclosure
requirements of SFAS 158. Readers can refer to the full text of SFAS 158 at
www.fasb.org.

1.

Does a business entity that sponsors one or more benefit plans dis
close the following information in the notes to its annual financial
statements, separately for pension plans and other postretirement
benefit plans:

a.

For each annual statement of income presented, the amounts rec
ognized in OCI, showing separately the net gain or loss and net
prior service cost or credit. Those amounts shall be separated into
amounts arising during the period and reclassification adjust
ments of OCI as a result of being recognized as components of net
periodic benefit cost for the period?

b.

For each annual statement of income presented, the net transition
asset or obligation recognized as a reclassification adjustment of
OCI as a result of being recognized as a component of net peri
odic benefit cost for the period?

c.

For each annual statement of financial position presented, the
amounts in accumulated OCI that have not yet been recognized
as components of net periodic benefit cost, showing separately the
net gain or loss, net prior service cost or credit, and net transition
asset or obligation?
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d.

e.

2.

The amounts in accumulated OCI expected to be recognized as
components of net periodic benefit cost over the fiscal year that
follows the most recent annual statement of financial position pre
sented, showing separately the net gain or loss, net prior service
cost or credit, and net transition asset or obligation?
The amount and timing of any plan assets expected to be returned
to the business entity during the 12-month period, or operating
cycle if longer, that follows the most recent annual statement of
financial position presented?
[SFAS 158 par. 7]

No

____

___

____

___

N/A

Does an employer without publicly traded equity securities disclose
the following information in the notes to the financial statements for
a fiscal year ending after December 15, 2006, but before June 16, 2007,
unless it has applied the recognition provisions of the statement in
preparing those financial statements:

a.

A brief description of the provisions of the statement?

____

___

b.

The date that adoption is required?

____

___

c.

The date the employer plans to adopt the recognition provisions
of the statement, if earlier?
[SFAS 158 par. 14]

____

___

____

___

____

___

Disclosures Required in the Year of Application
3.

4.

In the year that the recognition provisions of SFAS 158 are initially
applied, does the employer disclose, in the notes to the annual finan
cial statements, the incremental effect of applying this statement on
individual line items in the year-end statement of financial position?
[SFAS 158 par. 20]
In the year that the measurement date provisions of SFAS 158 are in
itially applied, does a business entity disclose the separate adjust
ments of retained earnings and accumulated OCI from applying the
statement?
[SFAS 158 par. 21]

Note: The disclosures specified by paragraphs 17-18 of SFAS 154 are not
required.
[SFAS 158 par. 22]

5. If an employer sponsors one or more defined benefit pension plans or
one or more defined benefit postretirement plans, has the following
information been provided separately for pension plans and other
postretirement benefit plans:
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a.

b.

c.

d.

Yes

No

N/A

____

____

____

____

____

____

____

____

____

(1) For each major category of plan assets, which shall include,
but is not limited to, equity securities, debt securities, real es
tate, and all other assets, the percentage of the fair value of
total plan assets held as of the measurement date used for
each statement of financial position presented?

____

____

____

(2) A narrative description of investment policies and strategies,
including target allocation percentages or range of percent
ages for each major category of plan assets presented on a
weighted-average basis as of the measurement date(s) of the
latest statement of financial position presented, if applicable,
and other factors that are pertinent to an understanding of the
policies or strategies such as investment goals, risk manage
ment practices, permitted and prohibited investments includ
ing the use of derivatives, diversification, and the relationship
between plan assets and benefit obligations?

____

____

____

(3) A narrative description of the basis used to determine the
overall expected long-term rate-of-retum-on-assets assump
tion, such as the general approach used, the extent to which
the overall rate-of-retum-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?

____

____

____

A reconciliation of beginning and ending balances of the benefit
obligation8 showing separately, if applicable, the effects during
the period attributable to each of the following: service cost, inter
est cost, contributions by plan participants, actuarial gains and
losses, foreign currency exchange rate changes,9 benefits paid,
plan amendments, business combinations, divestitures, curtail
ments, settlements, and special termination benefits?
[SFAS 132(R) par. 5a, as amended by SFAS 158]
A reconciliation of beginning and ending balances of the fair
value of plan assets showing separately, if applicable, the effects
during the period attributable to each of the following: actual re
turn on plan assets, foreign currency exchange rate changes,10
contributions by the employer, contributions by plan participants,
benefits paid, business combinations, divestitures, and settle
ments?
[SFAS 132(R) par. 5b, as amended by SFAS 158]
The funded status of the plans and the amounts recognized in the
statement of financial position showing separately the assets and
current and noncurrent liabilities recognized?
[SFAS 132(R) par. 5c, as amended by SFAS 158]
Information about plan assets:

8 For defined benefit pension plans, the benefit obligation is the projected benefit obligation. For defined postretirement plans, the
benefit obligation is the accumulated postretirement benefit obligation.
9 The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation
whose functional currency is not the reporting currency pursuant to SFAS 52, Foreign Currency Translation.
10 Refer to footnote 9.
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(4) Disclosure of additional asset categories and additional infor
mation about specific assets within a category is encouraged
if that information is expected to be useful in understanding
the risks associated with each asset category and the overall
expected long-term rate of return on assets?
[SFAS 132(R) par. 5d, as amended by SFAS 158]
e.

f.

g.

h.

i.

j.

For defined benefit pension plans, the accumulated benefit obli
gation?
[SFAS 132(R) par. 5e, as amended by SFAS 158]
The benefits (as of the date of the latest statement of financial po
sition presented) expected to be paid in each of the next five fiscal
years, and in the aggregate for the five fiscal years thereafter? The
expected benefits should be estimated based on the same assump
tions used to measure the company's benefit obligation at the end
of the year and should include benefits attributable to estimated
future employee service.
[SFAS 132(R) par. 5f, as amended by SFAS 158]
The employer's best estimate, as soon as it can reasonably be de
termined, of contributions expected to be paid to the plan during
the next fiscal year beginning after the date of the latest statement
of financial position presented. Estimated contributions may be
presented in the aggregate combining (1) contributions required
by funding regulations or laws, (2) discretionary contributions,
and (3) noncash contributions?
[SFAS 132(R) par. 5g, as amended by SFAS 158]

The amount of net periodic benefit cost recognized, showing sep
arately the service cost component, the interest cost component,
the expected return on plan assets for the period, the gain or loss
component, the prior service cost or credit component, the tran
sition asset or obligation component, and the gain or loss recog
nized due to settlements or curtailments?
[SFAS 132(R) par. 5h, as amended by SFAS 158]
Separately the net gain or loss and net prior service cost or credit
recognized in OCI for the period pursuant to paragraphs 25 and
29 of SFAS 87 and paragraphs 52 and 56 of SFAS 106, as
amended, and reclassification adjustments of OCI for the period,
as those amounts, including amortization of the net transition as
set or obligation, are recognized as components of net periodic
benefit cost?
[SFAS 132(R) par. 5i, as amended by SFAS 158]
The amounts in accumulated OCI that have not yet been recog
nized as components of net periodic benefit cost, showing sepa
rately the net gain or loss, net prior service cost or credit, and net
transition asset or obligation?
[SFAS 132(R) par. 5ii, as amended by SFAS 158]

Yes

No

N/A

____

____

____

-------

-------

------

____

____

____

____

____

____

____

____

____

-------

-------

------

-------

-------

------
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k. On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rate, rates of com
pensation increase (for pay-related plans), and expected long
term rates of return on plan assets specifying, in a tabular format,
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost?
[SFAS 132(R) par. 5j, as amended by SFAS 158]

l.

The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan
(gross eligible charges) and a general description of the direction
and pattern of change in the assumed trend rates thereafter, to
gether with the ultimate trend rate(s) and when that rate is ex
pected to be achieved?
[SFAS 132(R) par. 51, as amended by SFAS 158]

m. The effect of a one-percentage-point increase and the effect of a
one-percentage-point decrease in the assumed health care cost
trend rates on (1) the aggregate of the service and interest cost
components of net periodic postretirement health care benefit cost
and (2) the accumulated postretirement benefit obligation for
health care benefits? (For purposes of this disclosure, all other as
sumptions shall be held constant, and the effects shall be meas
ured based on the substantive plan that is the basis for the ac
counting.)
[SFAS 132(R) par. 5m, as amended by SFAS 158]

n.

o.

p.

q.

r.

If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related par
ties and the plan during the period?
[SFAS 132(R) par. 5n, as amended by SFAS 158]
If applicable, any alternative method used to amortize prior ser
vice amounts or net gains and losses pursuant to paragraphs 26
and 33 of SFAS 87 or paragraphs 53 and 60 of SFAS 106?
[SFAS 132(R) par. 5o, as amended by SFAS 158]
If applicable, any substantive commitment such as past practice
or a history of regular benefit increases used as the basis for ac
counting for the benefit obligation?
[SFAS 132(R) par. 5p, as amended by SFAS 158]

If applicable, the cost of providing special or contractual termi
nation benefits recognized during the period and a description of
the nature of the event?
[SFAS 132(R) par. 5q, as amended by SFAS 158]
An explanation of any significant change in the benefit obligation
or plan assets not otherwise apparent in the other disclosures re
quired by SFAS 132(R)?
[SFAS 132(R) par. 5r, as amended by SFAS 158]
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s.

t.

6.

7.

The amounts in accumulated OCI expected to be recognized as
components of net periodic benefit cost over the fiscal year that
follows the most recent annual statement of financial position pre
sented, showing separately the net gain or loss, net prior service
cost or credit, and net transition asset or obligation?
[SFAS 132(R) par. 5s, as amended by SFAS 158]
The amount and timing of any plan assets expected to be returned
to the employer during the 12-month period, or operating cycle if
longer, that follows the most recent annual statement of financial
position presented?
[SFAS 132(R) par. 5t, as amended by SFAS 158]

Are amounts related to the employer's results of operations disclosed
for each period for which an income statement is presented?
[SFAS 132(R) par. 5, as amended by SFAS 158]

Are amounts related to the employer's statement of financial position
disclosed as of the date of each statement of financial position pre
sented?
[SFAS 132(R) par. 5, as amended by SFAS 158]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

Employers With Two or More Plans

8.

9.

Are the disclosures required by SFAS 132(R) aggregated for all of an
employer's defined benefit pension plans and for all of an employer's
other defined benefit postretirement plans unless disaggregating in
groups is considered to provide useful information or is otherwise
required by paragraph 6-7 of SFAS 132(R)?
[SFAS 132(R) par. 6]

Are disclosures as of the date of each statement of financial position
presented?
[SFAS 132(R) par. 6, as amended by SFAS 158]

Note: Disclosures about pension plans with assets in excess of the accu
mulated benefit obligation generally may be aggregated with disclosures
about pension plans with accumulated benefit obligations in excess of as
sets. The same aggregation is permitted for other postretirement benefit
plans.
[SFAS 132(R) par. 6]
10. If aggregate disclosures are presented, does the employer disclose:

a.

The aggregate benefit obligation and aggregate fair value of plan
assets for plans with benefit obligations in excess of plan assets as
of the measurement date of each statement of financial position
presented?

b.

The aggregate pension accumulated benefit obligation and aggre
gate fair value of plan assets for pension plans with accumulated
benefit obligations in excess of plan assets?
[SFAS 132(R) par. 6]

FSP §20,300.03

88

Life and Health Insurance Entities

11. If a U.S. reporting entity combines disclosures about pension plans or
other postretirement benefit plans outside the United States with
those for U.S. plans, are the benefit obligations of the plans outside
the United States not significant relative to the total benefit obligation,
and do those plans not use significantly different assumptions?
[SFAS 132(R) par. 7]

Yes

No

N/A

____

____

____

Note: A foreign reporting entity that prepares financial statements in con
formity with U.S. GAAP shall apply the preceding guidance to its domes
tic and foreign plans.
Reduced Disclosure Requirements for Nonpublic Entities

Note: A nonpublic entity is not required to disclose the information re
quired by paragraphs 5(a)-(c), 5(h), 5(m), and 5(o)-(r) of SFAS 132(R). See
the preceding related disclosure questions.
12. For a nonpublic entity11 that sponsors one or more defined benefit
pension plans or one or more other defined benefit postretirement
plans, has the following information been disclosed, separately for
pension plans and other postretirement benefit plans:

a.

The benefit obligation, fair value of plan assets, and funded status
of the plan?
[SFAS 132(R) par. 8a, as amended by SFAS 158]

b.

Employer contributions, participant contributions, and benefits
paid?
[SFAS 132(R) par. 8b, as amended by SFAS 158]

c.

Information about plan assets:
(1) For each major category of plan assets which shall include,
but is not limited to, equity securities, debt securities, real es
tate, and all other assets, the percentage of the fair value of
total plan assets held as of the measurement date used for
each statement of financial position presented?
[SFAS 132(R) par. 8c(l), as amended by SFAS 158]
(2) A narrative description of investment policies and strategies,
including target allocation percentages or range of percent
ages for each major category of plan assets presented on a
weighted-average basis as of the measurement date(s) of the
latest statement of financial position presented, if applicable,
and other factors that are pertinent to an understanding of the
policies or strategies such as investment goals, risk manage
ment practices, permitted and prohibited investments includ
ing the use of derivatives, diversification, and the relationship
between plan assets and benefit obligations?
[SFAS 132(R) par. 8c(2), as amended by SFAS 158]11

11 A nonpublic entity is any entity other than one (a) whose debt or equity securities trade in a public market either on a stock exchange
(domestic or foreign) or in the over-the-counter market including securities quoted only locally or regionally, (b) that is a conduit bond
obligor for conduit debt securities that are traded in a public market (a domestic or foreign stock exchange or an over-the-counter market,
including local or regional markets), (c) that makes a filing with a regulatory agency in preparation for the sale of any class of debt or
equity securities in a public market, or (d) that is controlled by an entity covered by (a), (b), or (c).
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(3) A narrative description of the basis used to determine the
overall expected long-term rate-of-return-on-assets assump
tion, such as the general approach used, the extent to which
the overall rate-of-return-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?
[SFAS 132(R) par. 8c(3), as amended by SFAS 158]

Yes

No

N/A

____

____

____

Note: Disclosure of additional asset categories and additional information

about specific assets within a category is encouraged if that information is
expected to be useful in understanding the risks associated with each asset
category and the overall expected long-term rate of return on assets.
[SFAS 132(R) par. 8c(4), as amended by SFAS 158]

d.

For defined benefit pension plans, the accumulated benefit obli
gation?
[SFAS 132(R) par. 8d, as amended by SFAS 158]

e.

The benefits (as of the date of the latest statement of financial po
sition presented) expected to be paid in each of the next five fiscal
years, and in the aggregate for the five fiscal years thereafter?
(The expected benefits should be estimated based on the same as
sumptions used to measure the company's benefit obligation at
the end of the year and should include benefits attributable to es
timated future employee service.)
[SFAS 132(R) par. 8e, as amended by SFAS 158]

f.

The employer's best estimate, as soon as it can reasonably be de
termined, of contributions expected to be paid to the plan during
the next fiscal year beginning after the date of the latest statement
of financial position presented? (Estimated contributions may be
presented in the aggregate combining (1) contributions required
by funding regulations or laws, (2) discretionary contributions,
and (3) noncash contributions.)
[SFAS 132(R) par. 8f, as amended by SFAS 158]

g.

The amounts recognized in the statements of financial position,
showing separately the postretirement benefit assets and current
and noncurrent postretirement benefit liabilities?
[SFAS 132(R) par. 8g, as amended by SFAS 158]

h.

Separately, the net gain or loss and net prior service cost or credit
recognized in OCI for the period pursuant to paragraphs 25 and
29 of SFAS 87 and paragraphs 52 and 56 of SFAS 106, as
amended, and reclassification adjustments of OCI for the period,
as those amounts, including amortization of the net transition as
set or obligation, are recognized as components of net periodic
benefit cost?
[SFAS 132(R) par. 8h, as amended by SFAS 158]
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i.

j.

k.

l.

The amounts in accumulated OCI that have not yet been recog
nized as components of net periodic benefit cost, showing sepa
rately the net gain or loss, net prior service cost or credit, and net
transition asset or obligation?
[SFAS 132(R) par. 8hh, as amended by SFAS 158]

On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rates, rates of
compensation increase (for pay-related plans), and expected long
term rates of return on plan assets specifying, in a tabular format,
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost?
[SFAS 132(R) par. 8i, as amended by SFAS 158]
The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan
(gross eligible charges) and a general description of the direction
and pattern of change in the assumed trend rates thereafter, to
gether with the ultimate trend rate(s) and when that rate is ex
pected to be achieved?
[SFAS 132(R) par. 8k, as amended by SFAS 158]
If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related par
ties and the plan during the period?
[SFAS 132(R) par. 81, as amended by SFAS 158]

m. The nature and effect of significant non-routine events, such as
amendments, combinations, divestitures, curtailments, and settle
ments?
[SFAS 132(R) par. 8m, as amended by SFAS 158]

n.

o.

The amounts in accumulated OCI expected to be recognized as
components of net periodic benefit cost over the fiscal year that
follows the most recent annual statement of financial position pre
sented, showing separately the net gain or loss, net prior service
cost or credit, and net transition asset or obligation?
[SFAS 132(R) par. 8n, as amended by SFAS 158]
The amount and timing of any plan assets expected to be returned
to the employer during the 12-month period, or operating cycle if
longer, that follows the most recent annual statement of financial
position presented?
[SFAS 132(R) par. 8o, as amended by SFAS 158]

13. Are amounts related to the employer's results of operations disclosed
for each period for which a statement of income is presented?
[SFAS 132(R) par. 8]
14. Are amounts related to the employer's statement of financial position
disclosed as of the date of each statement of financial position pre
sented?
[SFAS 132(R) par. 8, as amended by SFAS 158]
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Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

Disclosures in Interim Financial Reports
15. If the entity is publicly traded, does it disclose the following infor
mation in its interim financial statements that include a statement of
income:

a.

b.

The amount of net periodic benefit cost recognized for each pe
riod for which a statement of income is presented, showing sepa
rately the service cost component, the interest cost component, the
expected return on plan assets for the period, the gain or loss
component, the prior service cost or credit component, the tran
sition asset or obligation component, and the gain or loss recog
nized due to a settlement or curtailment?

The total amount of the employer's contributions paid, and ex
pected to be paid, during the current fiscal year, if significantly
different from amounts previously disclosed pursuant to para
graph 5(g) of SFAS 132? (Estimated contributions may be pre
sented in the aggregate combining (1) contributions required by
funding regulations or laws, (2) discretionary contributions, and
(3) noncash contributions.)
[SFAS 132(R) par. 9, as amended by SFAS 158]

16. If the entity is nonpublic, does it disclose in interim periods, for which
a complete set of financial statements is presented, the total amount
of the employer's contributions paid, and expected to be paid, during
the current fiscal year, if significantly different from amounts previ
ously disclosed pursuant to paragraph 8(f) of SFAS 132? (Estimated
contributions may be presented in the aggregate combining (a) contri
butions required by funding regulations or laws, (b) discretionary
contributions, and (c) noncash contributions.)
[SFAS 132(R) par. 10]

Entities That Do Not Report Other Comprehensive Income

17. Did the entity comply with the following instructions: For employers
that do not report OCI in accordance with SFAS 130, the references to
the net gain or loss, net prior service cost or credit, and net transition
asset or obligation recognized in OCI in paragraphs 5(i) and 8(h) of
SFAS 132(R) shall instead be to such amounts recognized as changes
in unrestricted net assets arising from a defined benefit plan but not
yet included in net periodic benefit cost?
[SFAS 132(R) par. 10A, as amended by SFAS 158]
18. Did the entity comply with the following instructions: For those em
ployers, the references to reclassification adjustments of OCI in para
graphs 5(i) and 8(h) of SFAS 132(R) shall instead be to reclassifications
to net periodic benefit cost of amounts previously recognized as
changes in unrestricted net assets arising from a defined benefit plan
but not included in net periodic benefit cost when they arose?
[SFAS 132(R) par. 10B, as amended by SFAS 158]
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19. Did the entity comply with the following instructions: For those em
ployers, the references to the net gain or loss, net prior service cost or
credit, and net transition asset or obligation recognized in accumu
lated OCI in paragraphs 5(ii), 5(s), 8(hh), and 8(n) of SFAS 132(R) shall
instead be to such amounts that have been recognized as changes in
unrestricted net assets arising from a defined benefit plan but not yet
reclassified as components of net periodic benefit cost?
[SFAS 132(R) par. 10C, as amended by SFAS 158]

20. Did the entity comply with the following instructions: For those em
ployers, the references to results of operations (including items of
OCI) in paragraphs 5 and 8 of SFAS 132(R) shall instead be to changes
in unrestricted net assets and the references to a statement of income
in those paragraphs shall instead be to a statement of activities?
[SFAS 132(R) par. 10D, as amended by SFAS 158]

____

____

Defined Contribution Plans

21. Does the employer disclose the amount of cost recognized for defined
contribution pension plans and for other defined contribution postre
tirement benefit plans for all periods presented separately from the
amount of cost recognized for defined benefit plans?
[SFAS 132(R) par. 11]

22. Do the disclosures include a description of the nature and effect of
any significant changes during the period affecting comparability,
such as a change in the rate of employer contributions, a business
combination, or a divestiture?
[SFAS 132(R) par. 11]

____

____

Multiemployer Plans

23. Has the employer disclosed the amount of contributions to multiem
ployer plans for each annual period for which a statement of income
is presented?
[SFAS 132(R) par. 12]
24. If the employer chooses to disclose total contributions to multiem
ployer plans without disaggregating the amounts attributable to pen
sion plans and other postretirement benefit plans, do the disclosures
include a description of the nature and effect of any changes affecting
comparability, such as a change in the rate of employer contributions,
a business combination, or a divestiture?
[SFAS 132(R) par. 12]
25. In some situations, withdrawal from a multiemployer plan may result
in an employer having an obligation to the plan for a portion of the
unfunded benefit obligation of the pension plans and other postreti
rement benefit plans. If withdrawal under circumstances that would
give rise to an obligation is either probable or reasonably possible,
have the provisions of SFAS 5 been applied in accordance with SFAS
87 paragraph 70?
[SFAS 132(R) par. 13]
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26. If it is either probable or reasonably possible that (a) an employer
would withdraw from the plan under circumstances that would give
rise to an obligation or (b) an employer's contribution to the fund
would be increased during the remainder of the contract period to
make up a shortfall in the funds necessary to maintain the negotiated
level of benefit coverage (a "maintenance of benefits" clause), has the
employer applied the provisions of SFAS 5 in accordance with SFAS
106 paragraph 83?
[SFAS 132(R) par. 13]†

Yes

No

N/A

____

____

____

____

____

____

____

____ ______

____

____

____

____ _______

____

____

Other Matters

27. If the matters addressed in EITF 03-2, "Accounting for the Transfer to
the Japanese Government of the Substitutional Portion of Employee
Pension Fund Liabilities," apply, are the disclosure requirements of
that issue complied with?
[EITF 03-2]
28. If the matters addressed in EITF 06-4, "Accounting for Deferred Com
pensation and Postretirement Benefit Aspects of Endorsement SplitDollar Life Insurance Arrangements," relating to benefits that extend
into postretirement periods apply, are the disclosure requirements of
that issue complied with?
[EITF 06-4]
29. If the matters addressed in EITF 06-10, "Accounting for Deferred
Compensation and Postretirement Benefit Aspects of Collateral As
signment Split-Dollar Life Insurance Arrangements," relating to ben
efits that extend into postretirement periods apply, are the disclosure
requirements of that issue complied with?
[EITF 06-10]

____

30. Until an employer is able to determine whether benefits provided by
its plan are actuarially equivalent, does it disclose the following in
financial statements for interim or annual periods:

a.

The existence of the act?

b.

The fact that measures of the accumulated postretirement benefit
obligation (APBO) or net periodic postretirement benefit cost do
not reflect any amount associated with the subsidy because the
employer is unable to conclude whether the benefits provided by
the plan are actuarially equivalent to Medicare Part D under the
act?
[FSP FAS 106-2]

___ —

† See note in part F, "Contingencies and Commitments," for an important notice regarding a proposed FASB SFAS titled Disclosure of
Certain Loss Contingencies—an amendment of FASB Statements No. 5 and 141(R) that would replace the disclosure requirements in SFAS 5.
If finalized and issued as currently drafted, this statement would change the requirements of this question and would be effective for
annual financial statements issued for fiscal years ending after December 15, 2008, and interim and annual periods in subsequent fiscal
years. This checklist has not been updated to include the presentation and disclosure requirements of this proposed statement. Readers
may continue to check the status of this proposed statement on the FASB Web site at www.fasb.org.
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31. In interim and annual financial statements for the first period in
which an employer includes the effects of the subsidy in measuring
the APBO and the first period in which an employer includes the ef
fects of the subsidy in measuring net periodic postretirement benefit
cost, does it disclose the following:

a.

The reduction in the APBO for the subsidy related to benefits at
tributed to past service?

b.

The effect of the subsidy on the measurement of net periodic pos
tretirement benefit cost for the current period? That effect in
cludes (1) any amortization of the actuarial experience gain in a
as a component of the net amortization called for by paragraph
59 of SFAS 106, (2) the reduction in current period service cost
due to the subsidy, and (3) the resulting reduction in interest cost
on the APBO as a result of the subsidy.

c.

Any other disclosures required by paragraph 5(r) of SFAS 132(R)?
Paragraph 5(r) of SFAS 132(R) requires disclosure of "an expla
nation of any significant change in the benefit obligation or plan
assets not otherwise apparent in the other disclosures required by
this Statement."
[FSP FAS 106-2]

32. For purposes of the disclosures required by paragraphs 5(a) and 5(f)
of SFAS 132(R), does an employer disclose gross benefit payments
(paid and expected, respectively), including prescription drug bene
fits, and separately the gross amount of the subsidy receipts (received
and expected, respectively)?
[FSP FAS 106-2]
K. Consolidated Financial Statements
Notes: In March 2008, FASB issued SFAS 160 to establish accounting and
reporting standards for the noncontrolling interests in a subsidiary and for
the deconsolidation of a subsidiary, areas for which limited guidance pre
viously existed. SFAS 160 clarifies that a noncontrolling interest in a sub
sidiary is an ownership interest in the consolidated entity that should be
reported as equity in the consolidated financial statements. This statement
amends authoritative accounting literature to change the term minority in
terest to noncontrolling interest. SFAS 160 does not change the requirements
in FIN 46 (revised December 2003).

This statement changes the way the consolidated income statement is pre
sented. It requires consolidated net income to be reported at amounts that
include the amounts attributable to both the parent and the noncontrolling
interest. It also requires disclosure, on the face of the consolidated state
ment of income, of the amounts of consolidated net income attributable to
the parent and to the noncontrolling interest.

SFAS 160 establishes a single method of accounting for changes in a par
ent's ownership interest in a subsidiary that do not result in deconsolida
tion and clarifies that all of those transactions are equity transactions if the
parent retains its controlling financial interest in the subsidiary.
(continued)
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This statement requires expanded disclosures in the consolidated financial
statements that clearly identify and distinguish between the interests of
the parent's owners and the interests of the noncontrolling owners of a
subsidiary. Those expanded disclosures include a reconciliation of the be
ginning and ending balances of the equity attributable to the parent and
the noncontrolling owners and a schedule showing the effects of changes
in a parent's ownership interest in a subsidiary on the equity attributable
to the parent.

SFAS 160 is effective for fiscal years, and interim periods within those fis
cal years, beginning on or after December 15, 2008 (that is, January 1,2009,
for entities with calendar year-ends). Earlier adoption is prohibited. As
such, this checklist has not been updated to include the presentation and
disclosure requirements of SFAS 160. Readers can refer to the full text of
the statement on the FASB Web site at www.fasb.org.
1.

If consolidated statements are presented, is the consolidation policy
disclosed?
[ARB 51 par. 5; APB 22 par. 13]

2.

Are the accounts of all majority-owned subsidiaries (except those for
which control is likely to be temporary or does not rest with the ma
jority owner) consolidated?
[SFAS 94 par. 13]
Practice Tip

Paragraph 1 of ARB No. 51 notes the presumption in GAAP that consolidated financial statements are more
meaningful than parent company-only financial statements, but paragraph 24 of ARB No. 51 acknowledges
that parent company financial statements may be needed in addition to consolidated financial statements.
However, it does not suggest that parent company financial statements may be prepared in place of consol
idated financial statements. TIS section 1400.32, "Parent-Only Financial Statements and Relationship to
GAAP" (AICPA, Technical Practice Aids) clarifies that, even if a legal or regulatory agreement requires an
entity to submit "restricted" or "special use" parent-only financial statements without related consolidated
financial statements, the restricted or special use parent-only financial statements are not in accordance with
GAAP.
3. If the financial reporting periods of any subsidiaries are different from
that of the parent, are intervening events that materially affect finan
cial position or results of operations disclosed?
[ARB 51 par. 4]
Note: EITF 06-9 clarifies that a parent company should report a change to
(or the elimination of) a previously existing difference between the par
ent's reporting period and the reporting period of a consolidated entity in
the parent's consolidated financial statements as a change in accounting
principle in accordance with the provisions of SFAS 154. This issue does
not apply in situations in which a parent company or an investor changes
its fiscal year-end. This issue is effective for changes occurring in interim
(continued)
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or annual reporting periods beginning after board ratification (November
29, 2006). Readers can refer to the full text of EITF 06-9 on the FASB Web
site at www.fasb.org.
4.

5.

6.

If a parent company reports a change to (or the elimination of) a pre
viously existing difference between the parent's reporting period and
the reporting period of a consolidated entity in the parent's consoli
dated financial statements as described in EITF 06-9, has the change
been reported as a change in accounting principle in accordance with
the provisions of SFAS 154, excluding retrospective application if it is
impracticable to do so?
[EITF 06-9 par. 4]
If the provisions of EITF 06-9 are applicable to the financial statements
of a parent company, are the disclosures required by SFAS 154 made?
[EITF 06-9 par. 5]

Are material intercompany transactions and accounts, and any in
come or losses on assets that are eliminated disclosed (Encouraged,
but not required)?
[ARB 51 par. 6]

Consolidation of Variable Interest Entities

Notes: FIN 46(R) clarifies the application of ARB 51, Consolidated Financial
Statements, and replaces the original FIN 46 issued in January 2003. This
Interpretation provides guidance for identifying entities for which analysis
of voting interests, and the holdings of those voting interests, is not effec
tive in determining whether a controlling financial interest exists because
the entity does not have adequate equity capital or the equity instruments
do not have the normal characteristics of equity that provide its holders
with a potential controlling financial interest. Those entities are called var
iable interest entities.
This interpretation also provides guidance for determining whether an en
terprise shall consolidate a variable interest entity. An enterprise that con
solidates a variable interest entity is called the primary beneficiary of that
variable interest entity. The guidance in this Interpretation identifies the
primary beneficiary as a holder of variable interests in a variable interest
entity that absorb or receive a majority of the entity's expected losses or
expected residual returns.

FIN 46(R) contains scope exceptions that should be considered in deter
mining whether its provisions apply to a particular entity.

Additionally, FSP FIN 46(R)-7, Application of FASB Interpretation No. 46(R)
to Investment Companies, amends FIN 46(R) by clarifying that investments
accounted for at fair value in accordance with the specialized accounting
guidance in the AICPA Audit and Accounting Guide Investment Companies
are not subject to consolidation according to the requirements of that in
terpretation. Readers can refer to the full text of FIN 46(R) on the FASB
Web site at www.fasb.org.
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7.

b.
c.

N/A

The nature, purpose, size, and activities of the variable interest
entity?

____

____

____

The carrying amount and classification of consolidated assets that
are collateral for the variable interest entity's obligations?

____

____

____

____

____

____

The nature of its involvement with the variable interest entity and
when that involvement began?

____

____

____

The nature, purpose, size, and activities of the variable interest
entity?

____

____

____

____

____

____

____

____

____

____

____

____

The number of entities to which this interpretation is not being
applied and the reason why the information required to apply
this interpretation is not available?

-------

-------

------

The nature, purpose, size (if available), and activities of the entity(ies) and the nature of the enterprise's involvement with the
entity(ies)?

-------

-------

------

The reporting enterprise's maximum exposure to loss because of
its involvement with the entity(ies)?

-------

-------

------

Lack of recourse if creditors (or beneficial interest holders) of a
consolidated variable interest entity have no recourse to the gen
eral credit of the primary beneficiary?
[FIN 46(R) par. 23]

Does an enterprise that holds a significant variable interest in a vari
able interest entity but is not the primary beneficiary disclose:
a.

b.
c.

9.

No

Does the primary beneficiary of a variable interest entity disclose the
following (unless the primary beneficiary also holds a majority voting
interest):

a.

8.

Yes

The enterprise's maximum exposure to loss as a result of its in
volvement with the variable interest entity?
[FIN 46(R) par. 24]

Does a reporting enterprise that is not the primary beneficiary but
holds a significant implicit variable interest in a variable interest en
tity disclose the information in question 8?
[FSP FIN 46(R)-5 par. 6]

10. Are disclosures required by SFAS 140, about a variable interest entity
included in the same note to the financial statements as the informa
tion required by FIN 46(R)?
[FIN 46(R) par. 25]
11. If an entity does not apply FIN 46(R) to one or more variable interest
entities or potential variable interest entities because of the condition
described in paragraph 4(g) of FIN 46(R), is the following information
disclosed:

a.

b.

c.
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d.

The amount of income, expense, purchases, sales, or other meas
ure of activity between the reporting enterprise and the entity(ies)
for all periods presented? (However, if it is not practicable to
present that information for prior periods that are presented in
the first set of financial statements for which this requirement ap
plies, the information for those prior periods is not required.)
[FIN 46(R) par. 26]

L. Financial Instruments
Note: For issuers, as prescribed by the rules of the SEC, the SEC issued
SAB 109, Codification of Staff Accounting Bulletins, Topic 5—Miscellaneous
Accounting, Section DD—Written Loan Commitments Recorded at Fair Value
Through Earning, which replaces SAB 105, Application of Accounting Princi
ples to Loan Commitments.

Derivative Instruments and Hedging Activities

Notes: In March 2008, FASB issued SFAS 161, Disclosures about Derivative
Instruments and Hedging Activities—an amendment of FASB Statement No.
133, to enhance the current disclosure framework in SFAS 133. This state
ment has the same scope as SFAS 133 and, accordingly, applies to all en
tities.
This statement changes the disclosure requirements for derivative instru
ments and hedging activities. Entities are required to provide enhanced
disclosures about (a) how and why an entity uses derivative instruments,
(b) how derivative instruments and related hedged items are accounted for
under SFAS 133 and its related interpretations, and (c) how derivative in
struments and related hedged items affect an entity's financial position,
financial performance, and cash flows.
SFAS 161 is effective for financial statements issued for fiscal years and
interim periods beginning after November 15, 2008. Early application is
encouraged. This statement encourages but does not require disclosures
for earlier periods presented for comparative purposes at initial adoption.
In years after initial adoption, it requires comparative disclosures only for
periods subsequent to initial adoption. Readers can refer to the full text of
SFAS 161 on the FASB Web site at www.fasb.org.

Organizations that have chosen to early adopt SFAS 161 or otherwise meet
the effective date criteria of that statement should skip questions 1-7 of
part L, "Financial Instruments," and complete part L1, "Financial Instru
ments Subject to SFAS 161." Questions 8-37 of part L still apply. Organi
zations that have not yet adopted SFAS 161 should complete part L and
skip part L1.
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Yes

1.

2.

3.

4.

5.

6.

If an entity holds or issues derivative instruments (or nonderivative
instruments that are designated and qualify as hedging instruments
pursuant to paragraphs 37 and 42 of SFAS 133, as amended by SFAS
138, Accounting for Certain Derivative Instruments and Certain Hedging
Activities-an amendment ofFASB Statement No. 133 and SFAS 159), has
disclosure been made of its objectives for holding or issuing those in
struments, the context needed to understand those objectives, and its
strategies for achieving those objectives?
[SFAS 133 par. 44]
Does the description distinguish between derivative instruments (and
nonderivative instruments) designated as fair value hedging instru
ments, derivative instruments designated as cash flow hedging instru
ments, derivative instruments (and nonderivative instruments) des
ignated as hedging instruments for hedges of the foreign currency
exposure of a net investment in a foreign operation, and all other de
rivatives?
[SFAS 133 par. 44]
Does the description also indicate the entity's risk management policy
for each of those types of hedges, including a description of the items
or transactions for which risks are hedged?
[SFAS 133 par. 44]

For derivative instruments not designated as hedging instruments,
does the description indicate the purpose of the derivative activity?
[SFAS 133 par. 44]
Qualitative disclosures about an entity's objectives and strategies for
using derivative instruments may be more meaningful if such objec
tives and strategies are described in the context of an entity's overall
risk management profile. If appropriate, an entity is encouraged, but
not required, to provide such additional qualitative disclosures. Have
such disclosures been made?
[SFAS 133 par. 44]

No

____

___

____

___

____

___

____

____

____

____

-------

------

N/A

Do the entity's disclosures for every reporting period for which a
complete set of financial statements is presented also include the fol
lowing:
Fair value hedges

a.

For derivative instruments, as well as nonderivative instruments
that may give rise to foreign currency transaction gains or losses
under SFAS 52, Foreign Currency Translation, that have been des
ignated and have qualified as fair value hedging instruments and
for the related hedged items:
(1) The net gain or loss recognized in earnings during the report
ing period representing (a) the amount of the hedges' ineffec
tiveness and (b) the component of the derivative instruments'
gain or loss, if any, excluded from the assessment of hedge
effectiveness, and a description of where the net gain or loss
is reported in the statement of income or other statement of
financial performance?
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(2) The amount of net gain or loss recognized in earnings when
a hedged firm commitment no longer qualifies as a fair value
hedge?
[SFAS 133 par. 45a]

Cash flow hedges
b.

For derivative instruments that have been designated and have
qualified as cash flow hedging instruments and for the related
hedged transactions:
(1) The net gain or loss recognized in earnings during the report
ing period representing (a) the amount of the hedges' ineffec
tiveness and (b) the component of the derivative instruments'
gain or loss, if any, excluded from the assessment of hedge
effectiveness, and a description of where the net gain or loss
is reported in the statement of income or other statement of
financial performance?

(2) A description of the transactions or other events that will re
sult in the reclassification into earnings of gains and losses
that are reported in accumulated OCI, and the estimated net
amount of the existing gains or losses at the reporting date
that is expected to be reclassified into earnings within the next
12 months?
(3) The maximum length of time over which the entity is hedging
its exposure to the variability in future cash flows for fore
casted transactions excluding those forecasted transactions re
lated to the payment of variable interest on existing financial
instruments?

(4) The amount of gains and losses reclassified into earnings as a
result of the discontinuance of cash flow hedges because it is
probable that the original forecasted transactions will not oc
cur by the end of the originally specified time period (as doc
umented at the inception of the hedging relationship) or
within an additional two-month period of time thereafter?
[SFAS 133 par. 45b, as amended by SFAS 138]
Hedges of the net investment in a foreign operation

c.

For derivative instruments, as well as nonderivative instruments
that may give rise to foreign currency transaction gains or losses
under SFAS 52, that have been designated and have qualified as
hedging instruments for hedges of the foreign currency exposure
of a net investment in a foreign operation, the net amount of gains
or losses included in the cumulative translation adjustment dur
ing the reporting period?
[SFAS 133 par. 45c]
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7. The quantitative disclosures about derivative instruments may be
more useful, and less likely to be perceived to be out of context or
otherwise misunderstood, if similar information is disclosed about
other financial instruments or nonfinancial assets and liabilities to
which the derivative instruments are related by activity. Accordingly,
in such situations, has the entity presented a more complete picture
of its activities by disclosing that information? (Encouraged, but not
required.)
[SFAS 133 par. 45]

Yes

No

N/A

____

____

____

Certain Hybrid Financial Instruments

Notes: SFAS 155, Accounting for Certain Hybrid Financial Instruments—an
amendment ofFASB Statements No. 133 and 140, is effective for all financial
instruments acquired, issued, or subject to a remeasurement (new basis)
event occurring after the beginning of an entity's first fiscal year that be
gins after September 15, 2006. The fair value election provided for in par
agraph 4(c) of SFAS 155 may also be applied upon adoption of the state
ment for hybrid financial instruments that had been bifurcated under
paragraph 12 of SFAS 133 prior to the adoption of SFAS 155. At adoption,
any difference between the total carrying amount of the individual com
ponents of the existing bifurcated hybrid financial instrument and the fair
value of the combined hybrid financial instrument shall be recognized as
a cumulative-effect adjustment to beginning retained earnings. An entity
shall separately disclose the gross gains and losses that make up the cu
mulative-effect adjustment, determined on an instrument-by-instrument
basis. Prior periods shall not be restated. SFAS 155 provides a fair value
measurement election for certain hybrid financial instruments with em
bedded derivatives that otherwise would require bifurcation. Hybrid fi
nancial instruments that are elected to be accounted for in their entirety at
fair value cannot be used as a hedge instrument in a SFAS 133 hedge.
In February 2007, FASB issued SFAS 159, which is effective for financial
statements issued for fiscal years beginning after November 15, 2007.
This statement applies to all entities, including not-for-profit organiza
tions. Most of the provisions of this statement apply only to entities that
elect the fair value option. However, the amendment to SFAS 115, applies
to all entities with available-for-sale and trading securities. Some require
ments apply differently to entities that do not report net income.
See part AA, "Fair Value Measurements," for more information. Question
10 applies only if SFAS 159 is applicable to the financial statements.

8. If the entity measures hybrid instruments (financial instruments con
taining embedded derivatives) at fair value in accordance with the
election in SFAS 155 or the practicability exception in SFAS 133, is the
aggregate fair value of those instruments reported separately on the
face of the statement of financial position from the aggregate carrying
amounts of assets and liabilities measured using another measure
ment attribute?
[SFAS 133 par. 44A, as amended by SFAS 155 and SFAS 159]
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9.

Has the entity provided information that will allow users to under
stand the effect of changes in the fair value of hybrid financial instru
ments measured at fair value?
[SFAS 133 par. 44B, as amended by SFAS 155]

10. For those hybrid financial instruments measured at fair value under
the election in SFAS 155 and under the practicability exception in par
agraph 16 of SFAS 155, has the entity disclosed the information in
paragraphs 18-22 of SFAS 159?
[SFAS 133 par. 44A, as amended by SFAS 155]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

Disclosures About Fair Value of Financial Instruments
11. Has the entity disclosed, either in the body of the financial statements
or in the accompanying notes,12 the fair value of financial instruments
(except for those excluded in paragraphs 8 and 13 of SFAS 107) for
which it is practicable to estimate fair value?
[SFAS 107 par. 10, as amended by SFAS 119, SFAS 133, and SFAS 157]

12. Has the fair value disclosed in the notes been presented together with
the related carrying amount in a form that makes it clear whether the
fair value and carrying amount represent assets or liabilities and how
the carrying amounts relate to what is reported in the statement of
financial position?
[SFAS 107 par. 10, as amended by SFAS 119, SFAS 133, and SFAS 157]
13. In disclosing the fair value of a financial instrument, has the entity
taken care not to net that fair value with the fair value of other finan
cial instruments—even if those financial instruments are of the same
class or are otherwise considered to be related, for example, by a risk
management strategy—except to the extent that the offsetting of car
rying amounts in the statement of financial position is permitted un
der the general principle in paragraphs 5-6 of FIN 39 or the excep
tions for master netting arrangements in paragraph 10 of FIN 39 and
for amounts related to certain repurchase and reverse repurchase
agreements in paragraphs 3-4 of FIN 41, Offsetting of Amounts Related
to Certain Repurchase and Reverse Repurchase Agreements—and interpre
tation of APB Opinion No. 10 and a modification of FASB Interpretation
No. 39?
[SFAS 107 par. 13A]

14. If the organization has offset fair value amounts recognized for the
right to reclaim cash collateral (a receivable) or the obligation to re
turn cash collateral (a payable) against fair value amounts recognized
for derivative instruments executed with the same counterparty un
der the same master netting arrangement, have the disclosures in FSP
FIN 39-1, Amendment of FASB Interpretation No. 39, been made?
[FIN 39 par. 10B, as amended by FSP FIN 39-1]

15. If it is not practicable to estimate the fair value of a financial instru
ment or a class of financial instruments, are the following disclosed:

12 If disclosed in more than a single note, one of the notes shall include a summary table. The summary table shall contain the fair value
and related carrying amounts and cross-references to the location(s) of the remaining disclosures required by this statement as amended.
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a.

b.

Information pertinent to estimating the fair value of that financial
instrument or class of financial instruments, such as the carrying
amount, effective interest rate, and maturity?
The reasons why it is not practicable to estimate fair value?
[SFAS 107 par. 14]

Yes

No

N/A

____

____

____

____

____

____

Note: SFAS 126, as amended, makes the disclosures about fair values of
financial instruments prescribed in SFAS 107 optional for reporting enti
ties that

a. are nonpublic entities as defined in paragraph 3 of SFAS 126, as
amended.
b. have total assets of less than $100 million on the date of the financial
statements.
c. have no instrument that, in whole or in part, is accounted for as a
derivative instrument under SFAS 133, other than commitments re
lated to the origination of mortgage loans to be held for sale during
the reporting period.

For purposes of SFAS 126, an entity is a public entity if
1. its debt or equity securities trade in a public market either on a stock
exchange (domestic or foreign) or in the over-the-counter market, in
cluding securities quoted only locally or regionally.

2. it is a conduit bond obligor for conduit debt securities that are traded
in a public market (a domestic or foreign stock exchange or an overthe-counter market, including local or regional markets).
3. it makes a filing with a regulatory agency in preparation for the sale
of any class of debt or equity securities in a public market.

4. it is controlled by an entity covered items 1, 2, or 3.
Disclosure About Concentrations of Credit Risk of All Financial
Instruments
16.

Except as indicated in paragraph 15b13 of SFAS 107, has the entity
disclosed all significant concentrations of credit risk arising from all
financial instruments (including derivative instruments accounted for
under SFAS 133), whether from an individual counterparty or groups
of counterparties? (Group concentrations of credit risk exist if a number
of counterparties are engaged in similar activities and have similar
economic characteristics that would cause their ability to meet con
tractual obligations to be similarly affected by changes in economic or
other conditions.)
[SFAS 107 par. 15a, as amended by SFAS 133]

13 SFAS 107, Disclosures about Fair Value of Financial Instruments, paragraph 15b provides that these disclosure requirements do not
apply to the following financial instruments, whether written or held:
a. Financial instruments of a pension plan, including plan assets, when subject to the accounting and reporting requirements of
SFAS 87, Employers' Accounting for Pensions (financial instruments of a pension plan, other than the obligations for pension
benefits, when subject to the accounting and reporting requirements of SFAS 35, Accounting and Reporting by Defined Benefit
Pension Plans, are subject to the reporting of paragraph 15a).
(continued)
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Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

17. Has the entity made the following disclosures about each significant
concentration:
Information about the (shared) activity, region, or economic char
acteristic that identifies the concentration?
b. The maximum amount of loss due to credit risk that, based on the
gross fair value of the financial instrument, the entity would incur
if parties to the financial instruments that make up the concentra
tion failed completely to perform according to the terms of the
contracts and the collateral or other security, if any, for the
amount due proved to be of no value to the entity?
c. The entity's policy of requiring collateral or other security to sup
port financial instruments subject to credit risk, information about
the entity's access to that collateral or other security, and the na
ture and a brief description of the collateral or other security sup
porting those financial instruments?
d. The entity's policy of entering into master netting arrangements
to mitigate the credit risk of financial instruments, information
about the arrangements for which the entity is a party, and a brief
description of the terms of those arrangements, including the ex
tent to which they would reduce the entity's maximum amount
of loss due to credit risk?
[SFAS 107 par. 15a, as amended by SFAS 133]
18. Has the entity disclosed quantitative information14 about the market
risks of financial instruments that is consistent with the way it man
ages or adjusts those risks? (Encouraged, but not required.)
[SFAS 107 par. 15c, as amended by SFAS 133]
19. Are gains and losses (realized and unrealized) on all derivative instru
ments within the scope of SFAS 133 shown net when recognized in
the income statement, whether or not settled physically, if the deriv
ative instruments are held for trading purposes?
[EITF 02-3 par.16]

a.

Note: SFAS 155 amended SFAS 133 in February 2006. SFAS 155 provides
a fair value measurement election for certain hybrid financial instruments
with embedded derivatives that otherwise would require bifurcation. Hy
brid financial instruments that are elected to be accounted for in their en
tirety at fair value cannot be used as a hedge instrument in a SFAS 133
hedge.
[SFAS 155 app. B]

b. The financial instruments described in paragraphs 8a, 8c, 8e, and 8f of SFAS 107, as amended by SFAS 112, Employers'Accounting
for Postemployment Benefits—an amendment ofFASB Statements No. 5 and 43, SFAS 123, Accounting for Stock-Based Compensation,
and SFAS 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities—a replacement of SFAS
125, except for reinsurance receivables and prepaid reinsurance premiums.
14 Appropriate ways of reporting the quantitative information encouraged will differ for different entities and will likely evolve over
time as management approaches and measurement techniques evolve. Possibilities include disclosing (a) more details about current
positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual income,
of several possible changes in market prices, (c) a gap analysis of interest rate repricing or maturity dates, (d) the duration of the financial
instruments, or (e) the entity's value at risk from derivatives and from other positions at the end of the reporting period and the average
value at risk during the year. This list is not exhaustive, and an entity is encouraged to develop other ways of reporting quantitative
information.
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Yes

No

N/A

The nature of the registration payment arrangement, including
the approximate term of the arrangement, the financial instru
ments) subject to the arrangement, and the events or circum
stances that would require the issuer to transfer consideration un
der the arrangement?

____

____

____

Any settlement alternatives contained in the terms of the registra
tion payment arrangement, including the party that controls the
settlement alternatives?

____

____

____

The maximum potential amount of consideration, undiscounted,
that the issuer could be required to transfer under the registration
payment arrangement (including the maximum number of shares
that may be required to be issued). If the terms of the arrange
ment provide for no limitation to the maximum potential consid
eration (including shares) to be transferred, is that fact disclosed?

____

____

____

____

____

____

____

____

____

20. Does the issuer of a registration payment arrangement disclose the
following information about each registration payment arrangement
or each group of similar arrangements:
a.

b.

c.

d.

The current carrying amount of the liability representing the is
suer's obligations under the registration payment arrangement
and the income statement classification of any gains or losses re
sulting from changes in the carrying amount of that liability?
[FSP EITF 00-19-2 par. 12]

21. If derivative transactions are entered into in connection with the is
suance of contingently convertible securities, do disclosures of the po
tential impact of the contingently convertible securities include the
terms of those derivative transactions (including the terms of settle
ment), how those transactions relate to the contingently convertible
securities, and the number of shares underlying the derivatives?
[FSP 129-1 par. 5]
Disclosures About Certain Financial Instruments With Characteristics of
Both Liabilities and Equity
Notes: Depending upon whether an entity is a nonpublic entity, a public
entity, or an SEC registrant, FSP FAS 150-3, Effective Date, Disclosures, and
Transition for Mandatorily Redeemable Financial Instruments of Certain Non
public Entities and Certain Mandatorily Redeemable Noncontrolling Interests un
der FASB Statement No. 150, defers the effective date for applying the pro
visions of SFAS 150, Accounting for Certain Financial Instruments with
Characteristics of both Liabilities and Equity. Readers should read FSP 150-3
to understand the various effective dates of SFAS 150. FSP 150-3 is avail
able at the FASB Web site at www.fasb.org.

Early adoption of the provisions of SFAS 150 for instruments within the
scope of the indefinite deferrals established by FSP 150-3 is precluded dur
ing the deferral period.

During the deferral period, all public entities as well as nonpublic entities
that are SEC registrants are required to follow the disclosure requirements
in paragraphs 26-27 of SFAS 150 (questions 25-26 that follow) as well as
disclosures required by other applicable guidance.
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22. For items within the scope of SFAS 150, are they presented as liabili
ties (or assets in some circumstances), and are those items not pre
sented between the liabilities section and the equity section of the
statement of financial position?
[SFAS 150 par. 18]
23. If the entity has no equity instruments outstanding but has financial
instruments in the form of shares, all of which are mandatorily re
deemable financial instruments:

a.

Are they classified as liabilities?

b.

Are they described in the statement of financial position as
"shares subject to mandatory redemption"?

c.

Are payments to holders of such instruments and related accruals
presented separately from payments to and interest due to other
creditors in statements of cash flows and income?
[SFAS 150 par. 19 and 28]

24. Do the entities referred to in preceding question 23 above disclose the
components of the liability that would otherwise be related to share
holders' interest and OCI, if any, subject to the redemption feature
(for example, par value and other paid-in amounts of mandatorily re
deemable instruments should be disclosed separately from the
amount of retained earnings or accumulated deficit)?
[SFAS 150 par. 28]

25. For issuers of financial instruments within the scope of SFAS 150:

a.

Are the nature and terms of the financial instruments and the
rights and obligations embodied in those instruments disclosed?

b.

Does that disclosure include information about settlement alter
natives, if any, in the contract and identify the entity that controls
the settlement alternatives?
[SFAS 150 par. 26]

26. For all outstanding financial instruments within the scope of SFAS
150 and for each settlement alternative, do issuers disclose:
a.

The amount that would be paid, or the number of shares that
would be issued and their fair value, determined under the con
ditions specified in the contract if the settlement were to occur at
the reporting date?

b.

How changes in the fair value of the issuer's equity shares would
affect those settlement amounts (for example, "the issuer is obli
gated to issue an additional x shares or pay an additional y dol
lars in cash for each $1 decrease in the fair value of one share")?

c.

The maximum amount that the issuer could be required to pay to
redeem the instrument by physical settlement, if applicable?

d.

The maximum number of shares that could be required to be is
sued, if applicable?

e.

That a contract does not limit the amount that the issuer could be
required to pay or the number of shares that the issuer could be
required to issue, if applicable?
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f.

For a forward contract or an option indexed to the issuer's equity
shares, the forward price or option strike price, the number of is
suer's shares to which the contract is indexed, and the settlement
date or dates of the contract, as applicable?
[SFAS 150 par. 27]

27. Are unconditional mandatorily redeemable financial instruments clas
sified as liabilities if those instruments are mandatorily redeemable on
fixed dates unless the redemption is required to occur only upon the
liquidation or termination of the reporting entity? (Note: A mandato
rily redeemable financial instrument is conditional if the obligation
depends upon the occurrence of an event not certain to occur. Death is
not uncertain of occurrence; thus, death is not a condition.)
[SFAS 150 par. 9-10 and A2]

28. Are financial instruments, other than an outstanding share, that, at
inception, (a) embodies an obligation to repurchase the issuer's equity
shares, or is indexed to such an obligation, and (b) requires or may
require the issuer to settle the obligation by transferring assets, clas
sified as liabilities (or assets in some circumstances)?
[SFAS 150 par. 11]
29. Are financial instruments that embody an unconditional obligation, or
financial instruments other than an outstanding share that embodies
a conditional obligation, that the issuer must or may settle by issuing
a variable number of its equity shares, classified as liabilities (or assets
in some circumstances) if, at inception, the monetary value of the ob
ligation is based solely or predominantly on any one of the items in
dicated in paragraph 12 of SFAS 150?
[SFAS 150 par. 12]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

-------

-------

------

Related to the Adoption of SFAS 150

30. Is the cumulative transition adjustment and any subsequent adjust
ment reported as an excess of liabilities over assets (a deficit) and
changes thereto even though the mandatorily redeemable shares are
reported as a liability?
[FSP FAS 150-2]

31. Is the resulting change in the amount of the mandatorily redeemable
shares, depending on the settlement terms, either measured at the
present value of the amount to be paid at settlement or the amount of
cash that would be paid under the conditions specified in the contract
if settlement occurred at the reporting date recognized as interest cost
(change in redemption amount)?
[FSP FAS 150-2]
32. Although the disclosure requirements of SFAS 150 do not apply for
those mandatorily redeemable instruments of certain nonpublic com
panies while application of the provisions of SFAS 150 to those instru
ments is deferred, are the disclosure requirements in paragraph 4 of
SFAS 129, Disclosure of Information about Capital Structure, in particular,
information about the pertinent rights and privileges of the various
securities outstanding, including mandatory redemption require
ments, still disclosed?
[FSP FAS 150-3]
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33. Although the disclosure requirements of SFAS 150 do not apply for
those mandatorily redeemable instruments of certain nonpublic com
panies while application of the provisions of SFAS 150 to those instru
ments is deferred, are the disclosure requirements in paragraph 8 of
SFAS 129, which requires disclosure of the amount of redemption re
quirements for all issues of stock that are redeemable at fixed or de
terminable prices on fixed or determinable dates in each of the next
five years, still disclosed?
[FSP FAS150-3]
34. During the deferral period, if the entity is a public entity or a non
public entity that is an SEC registrant, are the disclosure requirements
in paragraphs 26-27 of SFAS 150 as well as disclosures required by
other applicable guidance complied with?
[FSP FAS 150-3]
35. Are the disclosures required by EITF 00-19, "Accounting for Deriva
tive Financial Instruments Indexed to, and Potentially Settled in, a
Company's Own Stock," made?
[EITF 00-19]
36. Are the disclosures required by EITF 06-7, "Issuer's Accounting for a
Previously Bifurcated Conversion Option in a Convertible Debt In
strument When the Conversion Option No Longer Meets the Bifurca
tion Criteria in FASB Statement No. 133," made?
[EITF 06-7]

Notes: SFAS 155 amended SFAS 133 in February 2006. SFAS 155 provides
a fair value measurement election for certain hybrid financial instruments
with embedded derivatives that otherwise would require bifurcation. Hy
brid financial instruments that are elected to be accounted for in their en
tirety at fair value cannot be used as a hedge instrument in a SFAS 133
hedge.
[SFAS 155 app. B]
In May 2008, FASB issued FSP APB 14-1, which requires an issuer to sep
arately account for the liability and equity components of convertible debt
instruments within its scope. Convertible debt instruments, including in
struments within the scope of this FSP, consist of a liability component
with a below-market interest coupon (the debt instrument) and an equity
component (the conversion option). Convertible debt instruments within
the scope of this FSP are required to be separated into its liability and
equity components, with each component accounted for pursuant to other
U.S. GAAP applicable to that component.

This FSP applies to convertible debt instruments that, by their stated
terms, may be settled in cash (or other assets) upon conversion, including
partial cash settlement, unless the embedded conversion option is required
to be separately accounted for as a derivative under SFAS 133. Other scope
limitations apply. This FSP shall be effective for financial statements is
sued for fiscal years beginning after December 15, 2008, and interim per
iods within those fiscal years. Early adoption is not permitted. As such,
this checklist has not been updated to include the presentation and disclo
sure requirements of FSP APB 14-1. Readers can refer to the full text of the
FSP on the FASB Web site at www.fasb.org.
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37. For instruments that are within the scope of EITF 05-2, "Meaning of
'Conventional Convertible Debt Instrument' in Issue No. 00-19," are
the applicable disclosures required by SFAS 129 included by the en
tity?
[EITF 05-2 par. 10]
38. Weather derivative contracts within the scope of EITF 99-2, "Account
ing for Weather Derivatives," therefore, are the existing GAAP disclo
sures for financial instruments such as those required in SFAS 107
included?
[EITF 99-2]
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N/A

____

____

____

____

____

____

____

____

____

____

____

____

L1. Financial Instruments of Enterprises Subject to SFAS 161
Derivative Instruments and Hedging Activities

1.

2.

3.

4.

5.

Are derivative instruments that are within the scope of SFAS 133, in
cluding certain derivative instruments embedded in other contracts,
accounted for as assets or liabilities in the statement of financial posi
tion and measured at their fair values?
[SFAS 133 par. 17]

Are gains and losses on derivative instruments or nonderivative fi
nancial instruments that are designated and qualifying as hedges of a
foreign currency exposure of a net investment in a foreign operation
accounted for in the same manner as a translation adjustment to the
extent they are effective as a hedge, that is, are they reported sepa
rately in other comprehensive income in accordance with paragraph
13 of SFAS 52?
[SFAS 133 par. 42]

If an entity holds or issues derivative instruments (or nonderivative
instruments that are designated and qualify as hedging instruments
pursuant to paragraphs 37 and 42 of SFAS 133) have the following
disclosures been made for every annual and interim reporting period
for which a statement of financial position and statement of financial
performance are presented:
a.

Its objectives for holding or issuing those instruments?

____

____

____

b.

The context needed to understand those objectives?

____

____

____

c.

Its strategies for achieving those objectives?
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]

-------

-------

------

-------

-------

------

-------

-------

------

Are the disclosures described in question 3 in the context of each in
strument's primary underlying risk exposure (for example, interest
rate, credit, foreign exchange rate, interest rate and foreign exchange
rate, or overall price?
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]
Do the disclosures described in question 3 distinguish between instru
ments used for risk management purposes and those used for other
purposes?
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Yes

6.

7.

8.

9.

For derivative instruments designated as hedging instruments under
SFAS 161, do the disclosures described in question 3 distinguish be
tween instruments designated as (a) fair value hedging instruments,
(b) cash flow hedging instruments, and (c) hedges of foreign currency
exposure of net investments in foreign operations?
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]

For derivative instruments not designated as hedging instruments un
der SFAS 161, do the disclosures described in question 3 describe the
purpose of holding or issuing the derivatives?
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]
Does the entity disclose (for every annual and interim reporting
period for which a statement of financial position and statement of
financial performance are presented) information that enables users
of its financial statements to understand the volume of its derivative
activity?
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]

Qualitative disclosures about an entity's objectives and strategies for
using derivative instruments may be more meaningful if such objec
tives and strategies are described in the context of an entity's overall
risk exposures relating to interest rate risk, foreign currency exchange
rate risk, commodity price risk, credit risk, and equity price risk. If
appropriate, an entity is encouraged, but not required, to provide
such additional qualitative disclosures. Have such disclosures been
made (for every annual and interim reporting period for which a
statement of financial position and statement of financial performance
are presented)?
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]

10. For every annual and interim reporting period for which a statement
of financial position and statement of financial performance are pre
sented, does the entity disclose, in a tabular format, the location and
fair value amounts of derivative instruments (or nonderivative instru
ments it holds or issues that are designated and qualify as hedging
instruments pursuant to paragraphs 37 and 42 of SFAS 133) reported
in the statement of financial position?
[SFAS 133 par. 44, as amended by SFAS 161 par. 3]

____

____

____

____

____

11. Do the disclosures described in question 10 provide the following:

a.

b.

c.

The fair value on a gross basis (even if the derivative instruments
qualify for net presentation in the statement of financial position
in accordance with FIN 39)?

____

Separate asset and liability values segregated between derivatives
that are designated and qualifying as hedging instruments under
SFAS 161 and those that are not, and within those two broad cat
egories, by type of derivative contract (for example, interest rate
contracts, foreign exchange contracts, equity contracts, commod
ity contracts, credit contracts, and so forth)?

____

The line item(s) in the statement of financial position in which the
fair value amounts for the above categories of derivative instru
ments are included?
[SFAS 133 par. 44Ca, as added by SFAS 161 par. 3]
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Yes

No

N/A

____

____

____

The gains and losses on derivative instruments designated and
qualifying as hedging instruments in fair value hedges and re
lated hedged items designated and qualifying in fair value
hedges?

____

____

____

The effective portion of gains and losses on derivative instru
ments designated and qualifying in cash flow hedges and net in
vestment hedges that was recognized in OCI during the current
period?

____

____

____

The effective portion of gains and losses on derivative instru
ments designated and qualifying in cash flow hedges and net in
vestment hedges recorded in accumulated other comprehensive
income during the term of the hedging relationship and reclassi
fied into earnings during the current period?

____

____

____

The portion of gains and losses on derivative instruments desig
nated and qualifying in cash flow hedges and net investment
hedges representing (a) the amount of the hedges' ineffectiveness
and (b) the amount, if any, excluded from the assessment of hedge
effectiveness?

____

____

____

____

____

____

____

____

____

-------

-------

------

12. For every annual and interim reporting period for which a statement
of financial position and statement of financial performance are pre
sented, does the entity disclose the location and amounts of the gains
and losses for derivative instruments (or nonderivative instruments it
holds or issues that are designated and qualify as hedging instru
ments pursuant to paragraphs 37 and 42 of SFAS 133) reported in the
statement of financial performance (or when applicable, the statement
of financial position; for example, gains and losses initially recognized
in OCI?
[SFAS 133 par. 44Cb, added by SFAS 161 par. 3]
13. Do the disclosures described in question 12 provide separate presen
tation of the following, in tabular format (with the exception of ques
tion 13a for which a tabular or nontabular format is appropriate):

a.

b.

c.

d.

e.

The gains and losses for derivative instruments not designated or
qualifying as hedging instruments under SFAS 161?
[SFAS 133 par. 44Cb, added by SFAS 161 par. 3]

14. Do the disclosures described in question 12 present information sep
arately by type of derivative contract (for example, interest rate con
tracts, foreign exchange contracts, equity contracts, commodity con
tracts, credit contracts, and so forth)?
[SFAS 133 par. 44Cb, as added by SFAS 161 par. 3]

15. Do the disclosures described in question 12 identify the line item(s) in
the statement of financial performance in which the gains and losses
for the categories of derivative instruments are included?
[SFAS 133 par. 44Cb and SFAS 133 par. 205F, as added by SFAS 161
par. 3]
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16. If an entity's policy is to include derivative instruments that are not
designated or qualifying as hedging instruments under SFAS 161 in
its trading activities, and the entity elects to exclude those derivative
instruments from the disclosures described in question 12, has the en
tity disclosed the following information:

a.

The gains and losses on its trading activities (including both de
rivative and nonderivative instruments) recognized in the state
ment of financial performance, separately by major types of items
(such as fixed income/interest rates, foreign exchange, equity,
commodity, and credit)?

b.

The line items in the statement of financial performance in which
trading activities gains and losses are included?

c.

A description of the nature of its trading activities and related
risks, and how the entity manages those risks?
[SFAS 133 par. 44Cc, added by SFAS 161 par. 3]

17. For every annual and interim reporting period for which a statement
of financial position and statement of financial performance are pre
sented, does the entity disclose the following information about deriv
ative instruments it holds or issues (or nonderivative instruments it
holds or issues that are designated and qualify as hedging instru
ments pursuant to paragraphs 37 and 42 of SFAS 133) that have
credit-risk-related contingent features and that are in a net liability
position at the end of the reporting period:

a.

The existence and nature of credit-risk-related contingent features
and the circumstances in which the features could be triggered in
derivative instruments that are in a net liability position at the
end of the reporting period?

b.

The aggregate fair value amounts of derivative instruments that
contain credit-risk-related contingent features that are in a net li
ability position at the end of the reporting period?

c.

The aggregate fair value of assets that are already posted as col
lateral at the end of the reporting period and (1) the aggregate fair
value of additional assets that would be required to be posted as
collateral or (2) the aggregate fair value of assets needed to settle
the instrument immediately, if the credit-risk-related contingent
features were triggered at the end of the reporting period?
[SFAS 133 par. 44D, added by SFAS 161 par. 3]

Fair Value Hedges

18. For every annual and interim reporting period for which a statement
of financial position and statement of financial performance are pre
sented, does the entity disclose the following for derivative instru
ments, as well as nonderivative instruments that may give rise to for
eign currency transaction gains or losses under SFAS 52, that have
been designated and have qualified as fair value hedging instruments
and for the related hedged items:
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a.

b.

Yes

No

N/A

____

____

____

____

____

____

A description of the transactions or other events that will result
in the reclassification into earnings of gains and losses that are
reported in accumulated other comprehensive income, and the es
timated net amount of the existing gains or losses at the reporting
date that is expected to be reclassified into earnings within the
next 12 months?

____

____

____

The maximum length of time over which the entity is hedging its
exposure to the variability in future cash flows for forecasted
transactions excluding those forecasted transactions related to the
payment of variable interest on existing financial instruments?

____

____

____

____

____

____

-------

-------

------

-------

-------

------

The net gain or loss recognized in earnings during the reporting
period representing (a) the amount of the hedges' ineffectiveness
and (b) the component of the derivative instruments' gain or loss,
if any, excluded from the assessment of hedge effectiveness?

The amount of net gain or loss recognized in earnings when a
hedged firm commitment no longer qualifies as a fair value
hedge?
[SFAS 133 par. 45a, as amended by SFAS 161 par. 3]

Cash Flow Hedges

19. For every annual and interim reporting period for which a statement
of financial position and statement of financial performance are pre
sented, does the entity disclose the following for derivative instru
ments that have been designated and have qualified as cash flow
hedging instruments and for the related hedged transactions:
a.

b.

c.

The amount of gains and losses reclassified into earnings as a re
sult of the discontinuance of cash flow hedges because it is prob
able that the original forecasted transactions will not occur by the
end of the originally specified time period or within the addi
tional period of time discussed in paragraph 33?
[SFAS 133 par. 45b, as amended by SFAS 161 par. 3]

20. If the disclosures related to derivative instruments (or nonderivative
instruments that are designated and qualify as hedging instruments
pursuant to paragraphs 37 and 42) are presented in more than a single
footnote, does each derivative note cross-reference the other notes in
which derivative-related information is disclosed?
[SFAS 133 par. 44E, added by SFAS 161 par. 3]
21. The quantitative disclosures about derivative instruments may be
more useful, and less likely to be perceived to be out of context or
otherwise misunderstood, if similar information is disclosed about
other financial instruments or nonfinancial assets and liabilities to
which the derivative instruments are related by activity. Accordingly,
in such situations, an entity is encouraged, but not required, to pres
ent a more complete picture of its activities by disclosing that infor
mation? Have such disclosures been made (for every annual and in
terim reporting period for which a statement of financial position and
statement of financial performance are presented)?
[SFAS 133 par. 45]
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No

N/A

____

____

____

Beginning and ending amounts of cumulative translation adjust
ments?

____

____

____

The aggregate adjustment for the period resulting from transla
tion adjustments and gains and losses from certain hedges and
intercompany balances? (Note: Paragraph 45c of SFAS 133 speci
fies additional disclosures for instruments designated as hedges
of the foreign currency exposure of a net investment in a foreign
operation. See part L, "Financial Instruments.")

____

____

____

The amount of income taxes for the period allocated to translation
adjustments?

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

M. Foreign Currency
1.

2.

Is the aggregate transaction gain or loss included in net income for
the period disclosed? (Note: For this disclosure and only for reporting
periods prior to the effective date of SFAS 161 derivative instruments
are subject to the requirements of paragraph 45 of SFAS 133.)
[SFAS 52 par. 30, as amended by SFAS 133]
Is an analysis of changes during the period in the accumulated
amount of translation adjustments reported in equity, included, and
does it disclose:
a.

b.

c.
d.

3.

4.

5.

6.

The amounts transferred from cumulative translation adjustments
and included in the determination of net income for the period as
a result of the sale or complete or substantially complete liquida
tion of an investment in a foreign entity?
[SFAS 52 par. 31, as amended by SFAS 133 and SFAS 135]

Are rate changes occurring after the date of the financial statements
and the effects on unsettled balances related to foreign currency trans
lations disclosed, if significant?
[SFAS 52 par. 32]
Are any foreign earnings reported in addition to amounts received in
the U.S. disclosed, if significant?
[ARB 43 ch. 12 par. 5]
If the reporting entity entered into a foreign currency swap contract
to replace foreign currency debt with reporting currency debt, and the
contract is not executed with the same counterparty under a master
netting arrangement, is the contract accounted for separately and not
netted against the foreign currency debt (because they are two sepa
rate legal transactions and do not have the legal right of setoff)?
[EITF 86-25; FIN 39; FSP FIN 39-1 par. 4]

Is the entire change in the fair value of foreign-currency-denominated
available-for-sale debt securities reported in shareholders' equity?
[EITF 96-15]
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7.

Yes

No

N/A

____

____

____

____

____

____

A description of the impaired long-lived asset (asset group) and
the facts and circumstances leading to the impairment?

____

____

____

If not separately presented on the face of the statement, the
amount of the impairment loss and the caption in the income
statement that includes the loss?

____

____

____

The method or methods for determining fair value (whether
based on a quoted market price, prices for similar assets, or an
other valuation technique)?

____

____

____

____

____

____

-------

-------

------

Are foreign currency transaction gains and losses on a forward
exchange contract that is designated as, and is effective as, a hedge of
the foreign-currency-denominated available-for-sale debt security also
reported in the SFAS 115 component of shareholders' equity (to offset
the portion of the market value change of a foreign-currency-denom
inated available-for-sale debt security attributable to foreign exchange
rates)?
[EITF 96-15]

N. Impairment of Long-Lived Assets to Be Held and Used

1.

2.

Is an impairment loss recognized for a long-lived asset (asset group)
to be held and used included in income from continuing operations
before income taxes in the income statement of a business enterprise?
[SFAS 144 par. 25]
Is the following information disclosed in the notes to the financial
statements that include the period in which an impairment loss is rec
ognized:
a.

b.

c.

d.

3.

4.

If applicable, the segment in which the impaired long-lived asset
(asset group) is reported under SFAS 131, Disclosures about Seg
ments of an Enterprise and Related Information?
[SFAS 144 par. 26]

If the occurrence of a significant event or circumstance at any time
during the assessment period results in an expectation that the criteria
in paragraph 42 of EITF 03-13, "Applying the Conditions in Para
graph 42 of FASB Statement No. 144 in Determining Whether to Re
port Discontinued Operations," will be met by the end of the assess
ment period, is the component's operations presented as discontinued
operations?
[EITF 03-13 par. 13]

Is the following information disclosed in the notes to the financial
statements for each discontinued operation that generates continuing
cash flows:

a.

The nature of the activities that give rise to continuing cash flows?

-------

-------

------

b.

The period of time continuing cash flows are expected to be gen
erated?

-------

-------

------

-------

-------

------

c.

The principal factors used to conclude that the expected continu
ing cash flows are not direct cash flows of the disposed compo
nent?
[EITF 03-13 par. 17]
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5.

6.

Additionally, for each discontinued operation in which the ongoing
entity will engage in a "continuation of activities" with the disposed
component after its disposal and for which the amounts presented in
continuing operations after the disposal transaction include a contin
uation of revenues and expenses that were intercompany transactions
(eliminated in consolidated financial statements) before the disposal
transaction, are the intercompany amounts before the disposal trans
action disclosed for all periods presented?
[EITF 03-13 par. 17]
Are the types of continuing involvement, if any, that the entity will
have after the disposal transaction disclosed? Also, is that information
disclosed in the period in which operations are initially classified as
discontinued?
[EITF 03-13 par. 17]

-------

-------

O. Long-Lived Assets and Disposal Groups to Be Disposed Of
Reporting Discontinued Operations

1.

Are the results of operations of a component of an entity (as that phrase
is defined in SFAS 144) that either has been disposed of or is classified
as held for sale reported in discontinued operations in accordance
with paragraph 43 of SFAS 144 (questions 2-5 that follow) if both of
the following conditions are met:

a.

b.

2.

3.

4.

5.

The operations and cash flows of the component have been (or
will be) eliminated from the ongoing operations of the entity as a
result of the disposal transaction? and
The entity will not have any significant continuing involvement
in the operations of the component after the disposal transaction?
[SFAS 144 par. 42]

In a period in which a component of an entity either has been dis
posed of or is classified as held for sale, does the income statement
for current and prior periods report the results of operations of the
component, including any gain or loss recognized in accordance with
paragraph 37 of SFAS 144, in discontinued operations?
[SFAS 144 par. 43, as amended by SFAS 154]
Are the results of operations of a component classified as held for sale
reported in discontinued operations in the period(s) in which they oc
cur?
[SFAS 144 par. 43, as amended by SFAS 154]
Are the results of discontinued operations, less applicable income
taxes (benefit), reported as a separate component of income before ex
traordinary items and the cumulative effect of accounting changes (if
applicable)?
[SFAS 144 par. 43, as amended by SFAS 154]
Is the gain or loss recognized on the disposal disclosed either on the
face of the income statement or in the notes to the financial state
ments?
[SFAS 144 par. 43, as amended by SFAS 154]
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6.

7.

Are adjustments to amounts previously reported in discontinued op
erations that are directly related to the disposal of a component of an
entity in a prior period classified separately in the current period in
discontinued operations?
[SFAS 144 par. 44]
Are the nature and amount of such adjustments (as discussed in ques
tion 6) disclosed?
[SFAS 144 par. 44]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

-------

-------

------

Reporting Disposal Gains or Losses in Continuing Operations

8.

9.

Is a gain or loss, that is recognized on the sale of a long-lived asset
(disposal group) that is not a component of an entity, included in in
come from continuing operations before income taxes in the income
statement?
[SFAS 144 par. 45, as amended by SFAS 145]

If a subtotal such as "income from operations" is presented, does it
include the amounts of those gains or losses considered in question 8?
[SFAS 144 par. 45, as amended by SFAS 145]

Reporting a Long-Lived Asset or Disposal Group Sold or Classified as
Held for Sale

10. If the criteria of paragraph 30 of SFAS 144 are met (and thus a longlived asset is classified as held for sale) after the balance sheet date
but before issuance of the financial statements, does the long-lived
asset continue to be classified as held and used in those financial state
ments when issued and is the information required by paragraph
47(a) of SFAS 144 (question 15a) disclosed in the notes to the financial
statements?
[SFAS 144 par. 33]
11. Is a long-lived asset that is classified as held for sale presented sepa
rately in the statement of financial position?
[SFAS 144 par. 46]

12. Are the assets and liabilities of a disposal group that is classified as
held for sale presented separately in the asset and liability sections,
respectively, of the statement of financial position?
[SFAS 144 par. 46]

13. Are those assets and liabilities considered in question 12, not offset
and presented as a single amount?
[SFAS 144 par. 46]
14. Are the major classes of assets and liabilities that are classified as held
for sale separately disclosed either on the face of the statement of fi
nancial position or in the notes to financial statements?
[SFAS 144 par. 46]
15. Is the following information disclosed in the notes to the financial
statements that cover the period in which a long-lived asset (disposal
group) either has been sold or is classified as held for sale:
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Yes

a.

b.

c.
d.

A description of the facts and circumstances leading to the ex
pected disposal, the expected manner and timing of that disposal,
and, if not separately presented on the face of the statement, the
carrying amount(s) of the major classes of assets and liabilities in
cluded as part of a disposal group?

------

The gain or loss recognized in accordance with paragraph 37 of
SFAS 144 and if not separately presented on the face of the in
come statement, the caption in the income statement that includes
that gain or loss?

------

If applicable, amounts of revenue and pretax profit or loss re
ported in discontinued operations?

-----

If applicable, the segment in which the long-lived asset (disposal
group) is reported under SFAS 131?
[SFAS 144 par. 47]

16. If either paragraph 38 or 40 of SFAS 144 applies, is a description of
the facts and circumstances leading to the decision to change the plan
to sell the long-lived asset (disposal group) and its effect on the results
of operations for the period and any prior periods presented disclosed
in the notes to the financial statements that include the period of that
decision?
[SFAS 144 par. 48]

17. If a long-lived asset is to be disposed of other than by sale, does it
continue to be classified as held and used until it is disposed of?
[SFAS 144 par. 27, as amended by SFAS 153]

------

-----

___

P. Accounting for Servicing Financial Assets

Collateral
1.

2.

3.

4.

Is the policy for requiring collateral or other security disclosed if the
reporting entity has entered into repurchase agreements or securities
lending transactions?
[SFAS 140 par. 17a(1)]
If the entity has pledged any of its assets as collateral that are not
reclassified and separately reported in the statement of financial po
sition pursuant to paragraph 15a of SFAS 140, is the carrying amount
and classification of those assets as of the date of the latest statement
of financial position presented?
[SFAS 140 par. 17a(2)]
If the entity has accepted collateral that it is permitted by contract or
custom to sell or repledge, is the fair value, as of the date of each
statement of financial position presented, of that collateral and of the
portion of that collateral that it has sold or repledged disclosed?
[SFAS 140 par. 17a(3)]
If debt was considered to be extinguished by in-substance defeasance
under the provisions of SFAS 76 prior to the effective date of SFAS
125, do the disclosures include a general description of the transaction
and the amount of debt that is considered extinguished at the end of
the period so long as that debt remains outstanding?
[SFAS 140 par. 17b]
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5.

6.

Yes

No

N/A

____

____

____

____

____

____

Management's basis for determining its classes of servicing assets
and servicing liabilities per SFAS 140 paragraph 13A, as
amended?

____

____

____

A description of the risks inherent in servicing assets and servic
ing liabilities and, if applicable, the instruments used to mitigate
the income statement effect of changes in fair value of the servic
ing assets and servicing liabilities? (Disclosure of quantitative in
formation about the instruments used to manage the risks inher
ent in servicing assets and servicing liabilities, including the fair
value of those instruments at the beginning and end of the period,
is encouraged but not required.)

____

____

____

____

____

____

(1) The beginning and ending balances?

____

____

____

(2) Additions (through purchases of servicing assets, assump
tions of servicing obligations, and servicing obligations that
result from transfers of financial assets)?

-------

-------

------

(3) Disposals?

-------

-------

------

(4) Changes in the fair value during the period resulting from
changes in valuation inputs or assumptions used in the valu
ation model?

-------

-------

------

If assets are set aside after the effective date of SFAS 125 solely for
satisfying scheduled payments of a specific obligation, do the disclo
sures include a description of the nature of restrictions placed on
those assets?
[SFAS 140 par. 17c]
If it is not practicable to estimate the fair value of certain assets ob
tained or liabilities incurred in transfers of financial assets during the
period, are those items and the reasons why it is not practicable to
estimate fair value described in the notes to the financial statements?
[SFAS 140 par. 17d, as amended by SFAS 156]

Servicing Assets and Servicing Liabilities

7.

For all servicing assets and servicing liabilities, are the following dis
closures made:

a.

b.

c.

8.

The amount of contractually specified servicing fees (as defined
in the glossary of SFAS 156), late fees, and ancillary fees earned
for each period for which results of operations are presented, in
cluding a description of where each amount is reported in the
statement of income?
[SFAS 140 par. 17e, as amended by SFAS 156]

For servicing assets and servicing liabilities measured at fair value,
are the following disclosures made:

a.

For each class of servicing assets and servicing liabilities, the ac
tivity in the balance of servicing assets and the activity in the bal
ance of servicing liabilities (including a description of where
changes in fair value are reported in the statement of income for
each period for which results of operations are presented), includ
ing, but not limited to, the following:
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(5) Changes in the fair value during the period resulting from
other changes in fair value and a description of those
changes?
(6) Other changes that affect the balance and a description of
those changes?

b.

A description of the valuation techniques or other methods used
to estimate the fair value of servicing assets and servicing liabili
ties? If a valuation model is used, the description shall include the
methodology and model validation procedures, as well as quan
titative and qualitative information about the assumptions used
in the valuation model (for example, discount rates and prepay
ment speeds)? (An entity that provides quantitative information
about the instruments used to manage the risks inherent in the
servicing assets and servicing liabilities, as encouraged by para
graph 17(e)(2), is also encouraged, but not required, to disclose a
description of the valuation techniques, as well as quantitative
and qualitative information about the assumptions used to esti
mate the fair value of those instruments.)
[SFAS 140 par. 17f, as amended by SFAS 156]

9. For servicing assets and servicing liabilities subsequently amortized
in proportion to and over the period of estimated net servicing in
come or loss and assessed for impairment or increased obligation:

a.

For each class of servicing assets and servicing liabilities, the ac
tivity in the balance of servicing assets and the activity in the bal
ance of servicing liabilities (including a description of where
changes in the carrying amount are reported in the statement of
income for each period for which results of operations are pre
sented), including, but not limited to, the following:
(1) The beginning and ending balances?
(2) Additions (through purchases of servicing assets, assumption
of servicing obligations, and servicing obligations that result
from transfers of financial assets)?

(3) Disposals?
(4) Amortization?
(5) Application of valuation allowance to adjust carrying value of
servicing assets?
(6) Other-than-temporary impairments?

(7) Other changes that affect the balance and a description of
those changes?
b.

For each class of servicing assets and servicing liabilities, the fair
value of recognized servicing assets and servicing liabilities at the
beginning and end of the period if it is practicable to estimate the
value?
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Yes

c.

d.

e.

No

A description of the valuation techniques or other methods used
to estimate fair value of the servicing assets and servicing liabili
ties? If a valuation model is used, the description shall include the
methodology and model validation procedures, as well as quan
titative and qualitative information about the assumptions used
in the valuation model (for example, discount rates and prepay
ment speeds)? (An entity that provides quantitative information
about the instrument used to manage the risks inherent in the
servicing assets and servicing liabilities, as encouraged by para
graph 17(e)(2), is also encouraged, but not required, to disclose a
description of the valuation techniques as well as quantitative and
qualitative information about the assumptions used to estimate
the fair value of those instruments.)

____

___

The risk characteristics of the underlying financial assets used to
stratify recognized servicing assets for purposes of measuring im
pairment in accordance with paragraph 63 of SFAS 140, as
amended?

____

___

____

___

Its accounting policies for initially measuring the interests that
continue to be held by the transferor, if any, and servicing assets
or servicing liabilities, if any, including the methodology
(whether quoted market price, prices based on sales of similar as
sets and liabilities, or prices based on valuation techniques) used
in determining their fair value (per paragraphs 68-70 of SFAS 140,
as amended by SFAS 156)?

____

____

The characteristics of securitizations (a description of the trans
feror's continuing involvement with the transferred assets, includ
ing, but not limited to, servicing, recourse, and restrictions on in
terests that continue to be held by the transferor) and the gain or
loss from sale of financial assets in securitizations?

-------

------

The activity by class in any valuation allowance for impairment
of recognized servicing assets—including beginning and ending
balances, aggregate additions charged and recoveries credited to
operations, and aggregate write-downs charged against the al
lowance—for each period for which results of operations are pre
sented?
[SFAS 140 par. 17g, as amended by SFAS 156]

N/A

Securitized Financial Assets Accounted for as a Sale
10. If the entity has securitized financial assets during any period pre
sented and accounts for that transfer as a sale, are the following items
disclosed for each major asset type (for example, mortgage loans,
credit card receivables, and automobile loans):

a.

b.
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d.

Yes

No

N/A

-------

-------

-------

-------

-------

-------

Its accounting policies for subsequently measuring those interests,
including the methodology (whether quoted market price, prices
based on sales of similar assets and liabilities, or prices based on
valuation techniques) used in determining their fair value?

-------

-------

-------

The key assumptions used in subsequently measuring the fair
value of those interests (including, at a minimum, quantitative in
formation about discount rates, expected prepayments including
the expected weighted-average life of prepayable financial assets,
and anticipated credit losses, including expected static pool
losses, if applicable)?

____

____

____

A sensitivity analysis or stress test showing the hypothetical effect
on the fair value of those interests (including any servicing assets
or servicing liabilities) of two or more unfavorable variations
from the expected levels for each key assumption that is reported
under b. above independently from any change in another key
assumption, and a description of the objectives, methodology,
and limitations of the sensitivity analysis or stress test?

____

____

____

____

____

____

The key assumptions15 used in measuring the fair value of interest
that continue to be held by the transferor and servicing assets or
servicing liabilities, if any, at the time of securitization (including,
at a minimum, quantitative information about discount rates, ex
pected prepayments including the expected weighted-average life
of prepayable financial assets, and anticipated credit losses, if ap
plicable)?

Cash flows between the securitization special purpose entity and
the transferor, unless reported separately elsewhere in the finan
cial statements or notes (including proceeds from new securitiza
tions, proceeds from collections reinvested in revolving-period se
curitizations, purchases of delinquent or foreclosed loans,
servicing fees, and cash flows received on interests that continue
to be held by the transferor)?
[SFAS 140 par. 17h, as amended by SFAS 156 and SFAS 157]

Interests in Financial Assets That Continue to be Held by the Transferor

11. If the entity has interests that continue to be held by the transferor in
financial assets that it has securitized or servicing assets or servicing
liabilities relating to assets that it has securitized, at the date of the
latest statement of financial position presented, are the following
items disclosed for each major asset type (for example, mortgage
loans, credit card receivables, and automobile loans):
a.

b.

c.

d.

For the securitized assets and any other financial assets that it
manages together with them:16
(1) The total principal amount outstanding, the portion that has
been derecognized, and the portion that continues to be rec
ognized in each category reported in the statement of finan
cial position, at the end of the period?

15 If an entity has made multiple securitizations of the same major asset type during a period, it may disclose the range of assumptions.
16 Excluding securitized assets than an entity continues to service but with which it has no other continuing involvement.
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(2) Delinquencies at the end of the period?

____

___

(3) Credit losses, net of recoveries, during the period?
[SFAS 140 par. 17h, as amended by SFAS 157]

____

___

N/A

Note: Disclosure of average balances during the period is encouraged, but
not required.
Q. Nonmonetary Transactions
1.

2.

Do disclosures for nonmonetary transactions during the period in
clude:

a.

Nature of the transactions?

b.

Basis of accounting for the assets transferred?

c.

Gains or losses recognized on the transfers?
[APB 29 par. 28]

Is the amount of gross operating revenue recognized as a result of
nonmonetary transactions addressed by EITF 00-8, "Accounting by a
Grantee for an Equity Instrument to Be Received in Conjunction with
Providing Goods or Services," disclosed in each period's financial
statements?
[EITF 00-8]

R. Subsequent Events

1.

Are subsequent events that provide evidence about conditions that
did not exist at the balance sheet date, but arose subsequent to that
date, adequately disclosed to keep the financial statements from being
misleading?
[SFAS 5 par. 11; AU 560.05-.07, .09, and 561.01-.09]

Note: Consider the appropriateness of dual-dating the auditor's report if a
subsequent event is disclosed in the financial statements.
[AU 530.05]
S. Costs Associated With Exit or Disposal Activities

1.

Is the following information disclosed in notes to the financial state
ments that include the period in which an exit or disposal activity is
initiated and any subsequent period until the activity is completed:

a.

A description of the exit or disposal activity, including the facts
and circumstances leading to the expected activity and the ex
pected completion date?

b.

For each major type of cost associated with the activity (for ex
ample, one-time termination benefits, contract termination costs,
and other associated costs):
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(1) The total amount expected to be incurred in connection with
the activity, the amount incurred in the period, and the cu
mulative amount incurred to date?
(2) A reconciliation of the beginning and ending liability balances
showing separately the changes during the period attributa
ble to costs incurred and charged to expense, costs paid or
otherwise settled, and any adjustment to the liability with an
explanation of the reason(s) therefore?

c.

The line item(s) in the income statement in which the costs in b
above are aggregated?

d.

For each reportable segment:
(1) The total amount of costs expected to be incurred in connec
tion with the activity?
(2) The amount incurred in the period?
(3) The cumulative amount incurred to date, net of any adjust
ments to the liability with an explanation of the reason(s)
therefore?

e.

If a liability for a cost associated with the activity is not recog
nized because fair value cannot be reasonably estimated, that fact
and the reasons therefore?
[SFAS 146 par. 20]

2.

Are costs associated with an exit or disposal activity that does not
involve a discontinued operation included in income from continuing
operations before income taxes, for example, in a subtotal such as
"income from operations"?
[SFAS 146 par. 18]

3.

Are costs associated with an exit or disposal activity that involves a
discontinued operation included in the results of discontinued opera
tion?
[SFAS 146 par. 18]

4.

If an event or circumstance occurs that discharges or removes an en
tity's responsibility to settle a liability for a cost associated with an
exit or disposal activity recognized in a prior period, is the liability
reversed?
[SFAS 146 par. 19]

5.

Are the related costs reversed through the same line item(s) in the
income statement used when those costs were recognized initially?
[SFAS 146 par. 19]
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T. Business Combinations
*

Notes: In December 2007, FASB issued SFAS 141(R) to improve the rele
vance, representational faithfulness, and comparability of the information
that a reporting entity provides in its financial reports about a business
combination and its effects. SFAS 141(R) supersedes SFAS 141, Business
Combinations, but retains the fundamental requirements in SFAS 141 that
the acquisition method of accounting (formerly called the purchase
method in SFAS 141) be used for all business combinations and that an
acquirer be identified for each business combination.
Among many other significant amendments to existing pronouncements
precipitated by SFAS 141(R), this statement redefines goodwill in SFAS
142 to mean an asset representing the future economic benefits arising
from other assets acquired in a business combination that are not individ
ually identified and separately recognized.
SFAS 141(R) applies to all transactions or other events in which an entity
(the acquirer) obtains control of one or more businesses (the acquiree), in
cluding those sometimes referred to as true mergers or mergers of equals and
combinations achieved without the transfer of consideration, for example,
by contract alone or through the lapse of minority veto rights. This state
ment applies to all business entities, including mutual entities that previ
ously used the pooling-of-interests method of accounting for some busi
ness combinations. It does not apply to

a. the formation of a joint venture.
b. the acquisition of an asset or a group of assets that does not consti
tute a business.
c. a combination between entities or businesses under common con
trol.
d. a combination between not-for-profit organizations or the acquisi
tion of a for-profit business by a not-for-profit organization.
This statement applies prospectively to business combinations for which
the acquisition date is on or after the beginning of the first annual report
ing period beginning on or after December 15, 2008. An entity may not
apply it before that date. As such, this checklist has not been updated to
include the requirements of SFAS 141(R).
In March 2008, FASB issued SFAS 160 to establish accounting and report
ing standards for the noncontrolling interests in a subsidiary and for the
deconsolidation of a subsidiary, areas for which limited guidance previ
ously existed.
(continued)

* See note in part F, "Contingencies and Commitments," for an important notice regarding a proposed SFAS titled Disclosure of Certain
Loss Contingencies—an amendment of FASB Statements No. 5 and 141(R) that would replace the disclosure requirements in SFAS 5. If
finalized and issued as currently drafted, this statement would change the requirements of this question and would be effective for
annual financial statements issued for fiscal years ending after December 15, 2008, and interim and annual periods in subsequent fiscal
years. This checklist has not been updated to include the presentation and disclosure requirements of this proposed statement. Readers
may continue to check the status of this proposed statement on the FASB Web site at www.fasb.org.

FSP §20,300.03

126

Life and Health Insurance Entities
Yes

In addition to the overview of this statement provided in a note appearing
earlier in this checklist, readers should be aware that SFAS 160 requires
acquisitions of noncontrolling interests to be accounted for as equity trans
actions. Thus, no goodwill or other intangible assets would be recognized
on acquisitions of noncontrolling interests after the effective date of that
statement.
SFAS 160 is effective for fiscal years, and interim periods within those fis
cal years, beginning on or after December 15, 2008 (that is, January 1,2009,
for entities with calendar year-ends). Earlier adoption is prohibited. As
such, this checklist has not been updated to include the presentation and
disclosure requirements of SFAS 160. The effective date of this statement
is the same as that of SFAS 141(R).

Readers can refer to the full text of both of the aforementioned SFASs at
www.fasb.org.
1. Do the notes to the financial statements of a combined entity disclose
the following information in the period in which a material business
combination is completed:

a.
b.

c.

d.

e.

f.

g.

h.

i.

The name and a brief description of the acquired entity and the
percentage of voting equity interests acquired?

____

The primary reasons for the acquisition, including a description
of the factors that contributed to a purchase price that results in
recognition of goodwill?

____

The period for which the results of operations of the acquired en
tity are included in the income statement of the combined entity?

____

The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred
shares, or partnership interests) issued or issuable, the value as
signed to those interests, and the basis for determining that value?

____

A condensed balance sheet disclosing the amount assigned to
each major asset and liability caption of the acquired entity at the
acquisition date?

____

Contingent payments, options, or commitments specified in the
acquisition agreement and the accounting treatment that will be
followed should any such contingency occur?

____

The amount of purchased research and development assets ac
quired and written off in the period (refer to paragraph 42 of
SFAS 141) and the line item in the income statement in which the
amounts written off are aggregated?

____

For any purchase price allocation that has not been finalized, that
fact and the reasons therefore?

____

In subsequent periods, the nature and amount of any material ad
justment made to the initial allocation of the purchase price?
[SFAS 141 par. 51]
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2.

Yes

No

N/A

(1) The total amount assigned and the amount assigned to a ma
jor intangible asset class?

____

____

____

(2) The amount of any significant residual value, in total and by
major intangible asset class?

____

____

____

(3) The weighted-average amortization period, in total and by
major intangible asset class?

____

____

____

For intangible assets not subject to amortization in accordance
with SFAS 142, the total amount assigned and the amount as
signed to any major intangible asset class?

____

____

____

____

____

____

____

____

____

The number of entities acquired and a brief description of those
entities?

____

____

____

The aggregate cost of the acquired entities, the number of equity
interests, (such as common shares, preferred shares, or partner
ship interests) issued or issuable, and the value assigned to those
interests?

____

____

____

The aggregate amount of any contingent payments, options, or
commitments and the accounting treatment that will be followed
should any contingency occur (if potentially significant in relation
to the aggregate cost of the acquired entities)?

-------

-------

------

-------

-------

------

Is the following information disclosed in the notes to the financial
statements in the period in which a material business combination is
completed if the amounts assigned to goodwill or to other intangible
assets acquired are significant in relation to the total cost of the ac
quired entity:

a.

b.

c.

For intangible assets subject to amortization in accordance with
SFAS 142:

For goodwill:
(1) The total amount of goodwill and the amount that is expected
to be deductible for tax purposes?
(2) The amount of goodwill by reportable segment (if the com
bined entity is required to disclose segment information in ac
cordance with SFAS 131), unless not practicable.
[SFAS 141 par. 52]

3.

If a series of individually immaterial business combinations com
pleted during the period are material in the aggregate, is the follow
ing disclosed:

a.
b.

c.

d.

4.

The information described in question 2, if the aggregate amount
assigned to goodwill or to other intangible assets acquired is sig
nificant in relation to the aggregate cost of the acquired entities?
[SFAS 141 par. 53]

If the combined entity is a public business enterprises, is the following
supplemental information on a pro forma basis for the period in
which a material business combinations occurs (or for the period in
which a series of individually immaterial business combinations occur
that are material in the aggregate) disclosed:
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a.

b.

Results of operations for the current period as though the busi
ness combination or combinations had been completed at the be
ginning of the period unless the acquisition was at or near the
beginning of the period?
Results of operations for the comparable period as though the
business combination or combinations had been completed at the
beginning of that period if comparative financial statements are
presented?
[SFAS 141 par. 54]

5. Does the supplemental pro forma information display revenue, in
come before extraordinary items and the cumulative effect of account
ing changes, net income, and earnings per share at a minimum?
[SFAS 141 par. 55, as amended by SFAS 154]

------

------

------

Note: In determining the pro forma amounts, income taxes, interest ex
pense, preferred share dividends, and depreciation and amortization of
assets shall be adjusted to the accounting base recognized for each in re
cording the combination. Pro forma information related to results of op
erations of periods prior to the combination shall be limited to the results
of operations for the immediately preceding period.
[SFAS 141 par. 55, as amended by SFAS 154]

6.

7.

8.

Does the supplemental pro forma information disclose the nature and
amount of material, nonrecurring items included in the reported pro
forma results of operations, if any?
[SFAS 141 par. 55, as amended by SFAS 154]
In the period in which an extraordinary gain is recognized related to
a business combination, do the notes to the financial statements dis
close the information required by paragraph 11 of APB 30?
[SFAS 141 par. 56]
If a material business combination is completed after the balance sheet
date but before the financial statements are issued, is the information
required by the preceding questions 1-2 disclosed if practicable?
[SFAS 141 par. 57]

-------

____

____

Interim Financial Information

9.

For summarized interim financial information of a public business en
terprise is the following information disclosed if a material business
combination is completed during the current year up to the date of
the most recent interim statement of financial position presented:

a.
b.

c.

The name and a brief description of the acquired entity and the
percentage of voting equity interests acquired?

____

The primary reasons for the acquisition, including a brief descrip
tion of the factors that contributed to a purchase price that results
in recognition of goodwill?

____

The period for which the results of operations of the acquired en
tity are included in the income statement of the combined entity?

____
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Yes

d.

e.

f.

g.

No

The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred
shares, or partnership interests) issued or issuable, the value as
signed to those interests, and the basis for determining that value?

____

___

Supplemental pro forma information that discloses the results of
operations for the current interim period and the current year up
to the date of the most recent interim statement of financial posi
tion presented (and for the corresponding periods in the preced
ing year) as though the business combination had been completed
as of the beginning of the period reported on?

____

___

The nature and amount of any material, nonrecurring items in
cluded in the reported pro forma results of operations?

____

___

____

___

____

___

____

___

Do the pro forma information disclosures in e above display at a
minimum, revenue, income before extraordinary items and the
cumulative effect of accounting changes (including those on an
interim basis), net income and earnings per share?
[SFAS 141 par. 58, as amended by SFAS 154]

N/A

Other Disclosures and Presentation Items
10. Is any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to re
duce goodwill and other noncurrent intangible assets of an acquired
entity or directly to contributed capital (paragraphs 30 and 36 of SFAS
109) disclosed?
[SFAS 109 par. 48]
11. If a material liability is recognized by the combined institution for
costs incurred to (1) exit and activity, (2) involuntarily terminate em
ployees of an acquired institution, or (3) relocate employees of an ac
quired entity, are disclosures made in accordance with EITF 95-3,
"Recognition of Liabilities In Connection with a Purchase Business
Combination?"
[EITF 95-3]

12. Are the following disclosures made for business combinations be
tween parties with a preexisting relationship:
a.

The nature of the preexisting relationship?

-------

-----

b.

The measurement of the settlement amount of the preexisting re
lationship, if any, and the valuation method used to determine
the settlement amount?

-------

-----

-------

-----

c.

The amount of any settlement gain or loss recognized and its clas
sification in the statement of operations?
[EITF 04-1 par. 8]
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13. Amounts previously recognized as goodwill should not be reclassi
fied as an identifiable intangible asset, however, previously recog
nized goodwill should be tested for impairment by applying the con
sensuses in step 2 of a goodwill impairment test. As a result of the
application of EITF 04-1, "Accounting for Preexisting Relationships
between the Parties to a Business Combination," is any effect on a
goodwill impairment charge reported in operating income?
[EITF 04-1 par. 9]

U. Segment Information
Note: Public business enterprises are required to provide the disclosures
described in SFAS 131 and nonpublic business enterprises are encouraged
to do so.

1.

Are the factors used to identify the reporting entity's reportable seg
ments, including the basis of organization (for example, whether man
agement has chosen to organize the reporting entity around differ
ences in products and services, geographic areas, regulatory
environments, or a combination of factors and whether operating seg
ments have been aggregated) disclosed?
[SFAS 131 par. 26]

2.

Are the types of products and services from which each reportable
segment derives its revenues disclosed?
[SFAS 131 par. 26]

3.

Has a measure of profit or loss and total assets been reported for each
reportable segment?
[SFAS 131 par. 27, as amended by SFAS 135]

4.

If the following specified amounts (a) are included in the measure of
segment profit or loss reviewed by the chief operating decision maker
or (b) are otherwise regularly provided to the chief operating decision
maker, even if not included in that measure of segment profit or loss,
are they disclosed for each reportable segment:

a.

Revenues from external customers?

b.

Revenues from transactions with other operating segments of the
same enterprise?

c.

Interest revenue?

d.

Interest expense?

e.

Depreciation, depletion, and amortization expense?

f.

Unusual items as described in paragraph 26 of APB 30?

g.

Equity in the net income of investees accounted for by the equity
method?

h.

Income tax expense or benefit?

i.

Extraordinary items?
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j.

5.

6.

N/A

____

____

____

____

____

____

____

____

____

The basis of accounting for any transactions between reportable
segments?

____

____

____

The nature of any differences between the reporting entities' con
solidated income before taxes, extraordinary items, and discontin
ued operations (if not apparent from the reconciliations required
by SFAS 131 par. 32)?

____

____

____

The nature of any differences between the measurements of the
reportable segments' assets and the reporting entity's consoli
dated assets (if not apparent from the reconciliations required by
SFAS 131 par. 32)?

____

____

____

The nature of any changes from prior periods in the measurement
methods used to determine reported segment profit or loss and
the effect, if any, of those changes on the measure of segment
profit or loss?

____

____

____

____

____

____

____

____

____

-------

-------

------

Significant noncash items other than depreciation, depletion, and
amortization expense?
[SFAS 131 par. 27, as amended by SFAS 135]

a.

The amount of investment in equity method investees?

b.

Total expenditures for additions to long-lived assets other than
financial instruments, deferred policy acquisition costs, and de
ferred tax assets?
[SFAS 131 par. 28, as amended by SFAS 135]

Is an explanation of the measurements of segment profit or loss and
segment assets that discloses the following for each reportable seg
ment provided:

b.

c.

d.

e.

8.

No

If the following specified amounts are (a) included in the determina
tion of segment assets reviewed by the chief operating decision maker
or (b) are otherwise regularly provided to the chief operating decision
maker, even if not included in that measure of segment assets, are
they disclosed for each reportable segment:

a.

7.

Yes

The nature and effect of any asymmetrical allocations to seg
ments?
[SFAS 131 par. 31, as amended by SFAS 154]

Are reconciliations of the totals of the reportable segments' revenues,
measures of profit or loss, assets, and every other significant item of
information disclosed to corresponding consolidated amounts pre
sented with all significant reconciling items separately identified and
described?
[SFAS 131 par. 32, as amended by SFAS 154]
If the reporting entity changes the structure of its internal organiza
tion in a manner that changes the composition of its reportable seg
ments, is the corresponding information for prior periods restated
and is the fact that the corresponding items of segment information
for earlier periods have been restated disclosed?
[SFAS 131 par. 34]
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9.

Yes

No

N/A

____

____

____

____

____

____

(1) Revenues from external customers (a) attributed to the report
ing entity's country of domicile and (b) attributed to all for
eign countries in total from which the reporting entity derives
revenue?

____

____

____

(2) Revenues from external customers attributed to an individual
foreign country, if material?

____

____

____

(3) The basis for attributing revenues from external customers to
individual countries?

____

____

____

(4) Long-lived assets other than financial instruments, deferred
policy acquisition costs, and deferred tax assets (a) located in
the reporting entity's country of domicile and (b) located in
all foreign countries in total in which the reporting entity
holds assets?

____

____

____

____

____

____

____

____

____

____

____

____

If the reporting entity changes the structure of its internal organiza
tion in a manner that changes the composition of its reportable seg
ments and the corresponding information for prior periods is not re
stated, does disclosure in the year in which the change occurs include
segment information for the current period under both the old basis
and the new basis?
[SFAS 131 par. 35]

10. For all reporting entities subject to SFAS 131, including those that
have a single reportable segment, are the following enterprise-wide
items disclosed:

a.

b.

Revenues from external customers for each product and service
or each group of similar products and services unless it is imprac
ticable to do so?
[SFAS 131 par. 37]
The following geographic information unless it is impracticable to
do so:

(5) Long-lived assets as described above in an individual foreign
country, if material?
[SFAS 131 par. 38]

c.

Information about the extent of the reporting entity's reliance on
its major customers, including the following:
(1) If revenues from transactions with any single customer
amount to 10 percent or more of the reporting entity's reve
nues, that fact, the total amount of revenues from each such
customer, and the identity of the segment or segments report
ing the revenue?
[SFAS 131 par. 39]

11. If the information described in questions 10a-b has not been disclosed
because it is impracticable, is that fact disclosed?
[SFAS 131 par. 37-38]
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____

____

____

The nature and terms of such arrangements that existed during
the period and the potential effects of those arrangements on
shareholders?

____

____

____

The effect of compensation cost arising from share-based payment
arrangements on the income statement?

____

____

____

The method of estimating the fair value of the goods or services
received, or the fair value of the equity instruments granted (or
offered to grant), during the period?

____

____

____

____

____

____

V. Postemployment Benefits
1.

If an obligation for postemployment benefits (for example, salary con
tinuation, supplemental unemployment benefits, severance benefits,
disability related benefits, job training and counseling, and continua
tion of health and insurance coverage) has not been accrued because
the amount cannot be reasonably estimated, is that fact disclosed in
the financial statements?
[SFAS 112 par. 7]

W. Stock Compensation Plans

1.

If the entity has one or more share-based payment arrangements, does
it disclose information that enables users of the financial statements
to understand:

a.

b.

c.

d.

The cash flow effects resulting from share-based payment ar
rangements?
[SFAS 123(R) par. 64]

Notes: Paragraphs A240-A241 of SFAS 123(R) indicate the minimum in
formation needed to achieve those objectives and illustrate how the disclo
sure requirements might be satisfied. In some circumstances, an entity
may need to disclose information beyond that listed in paragraph A240 to
achieve the disclosure objectives.
On October 20, 2006, FSP FAS 123 (R)-6, Technical Corrections ofFASB State
ment No. 123(R), which addresses certain technical corrections of SFAS
123(R). Specifically, it amends paragraph A240(d)(1) to exempt nonpublic
entities from disclosing the aggregate intrinsic value of outstanding fully
vested share options (or share units), among other matters.

The provisions in FSP FAS 123(R)-6 are effective in the first reporting pe
riod beginning after October 20, 2006. If in applying SFAS 123(R) an entity
did so in a manner consistent with the provisions of this FSP, then that
entity should continue to apply the provisions in this FSP to prior periods.
However, if an entity did not apply SFAS 123(R) in a manner consistent
with the provisions of this FSP, then that entity should retrospectively ap
ply the provisions in this FSP to prior periods when those periods' finan
cial statements are included for comparative purposes with current-period
financial statements.
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2.

3.

If the entity acquires goods or services other than employee services
in share-based payment transactions, does it provide disclosures sim
ilar to those in question 1 required by paragraph 64 of SFAS 123(R) to
the extent that those disclosures are important to an understanding of
the effects of those transactions on the financial statements?
[SFAS 123(R) par. 65]
If the entity has multiple share-based payment arrangements with
employees, does it disclose information separately for different types
of awards under those arrangements to the extent that differences in
the characteristics of the awards make separate disclosure important
to an understanding of the entity's use of share-based compensation?
(See paragraph A240 of SFAS 123(R).)
[SFAS 123(R) par. 65]

Notes: EITF 06-11 is effective for income tax benefits that result from div
idends on equity-classified employee share-based payment awards that
are declared in fiscal years beginning after December 15, 2007, and interim
periods within those fiscal years. Early application is permitted as of the
beginning of a fiscal year for which interim or annual financial statements
have not yet been issued. Retrospective application to previously issued
financial statements is prohibited.
This issue clarifies that a realized income tax benefit from dividends or
dividend equivalents charged to retained earnings and that are paid to
employees for equity classified nonvested equity shares, nonvested equity
share units, and outstanding equity share options should be recognized as
an increase to additional paid-in capital. The amount recognized in addi
tional paid-in capital for the realized income tax benefit from dividends
on those awards should be included in the pool of excess tax benefits
available to absorb tax deficiencies on share-based payment awards (as
described in paragraphs 62-63 of SFAS 123(R)).

4. If an entity awards its employees, as part of a share-based payment
arrangement, with (a) dividends on equity-classified nonvested
shares, (b) dividend equivalents on equity-classified nonvested share
units, or (c) payments equal to the dividends paid on the underlying
shares while an equity-classified share option is outstanding, and
those dividends or dividend equivalents are charged to retained earn
ings under SFAS 123(R) resulting in an income tax deduction for the
employer, is the realized income tax benefit:

a.

Recognized as an increase to additional paid-in capital?

b.

Included in the pool of excess tax benefits available to absorb tax
deficiencies on share-based payment awards (as described in par
agraphs 62-63 of SFAS 123(R))?

c.

That is reclassified from additional paid-in capital to the income
statement when an entity's estimate of forfeitures increases (or ac
tual forfeitures exceed the entity's estimates), limited to the en
tity's pool of excess tax benefits available to absorb tax deficien
cies on the date of the reclassification?
[EITF 06-11 par. 6; SFAS 123(R), fn. 61]
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A general description of the asset retirement obligations and the
associated long-lived assets?

____

____

____

The fair value of assets that are legally restricted for purposes of
settling asset retirement obligations?

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

-------

-------

------

X. Asset Retirement Obligations
1.

Is the following information about its asset retirement obligations dis
closed:

a.

b.
c.

2.

3.

A reconciliation of the beginning and ending aggregate carrying
amount of asset retirement obligations showing separately the
changes attributable to (1) liabilities incurred in the current pe
riod, (2) liabilities settled in the current period, (3) accretion ex
pense, and (4) revisions in estimated cash flows, whenever there
is a significant change in one or more of those four components
during the reporting period?
[SFAS 143 par. 22]

If the fair value of an asset retirement obligation cannot be reasonably
estimated is that fact and the reasons therefore disclosed?
[SFAS 143 par. 22]
In addition to the disclosures required by paragraphs 19 (c)-(d), and
21 of APB 20, is the liability for the asset retirement obligation com
puted on a pro forma basis disclosed in the footnotes for the begin
ning of the earliest year presented and at the end of all years pre
sented as if SFAS 143 and FIN 47, Accounting for Conditional Asset
Retirement Obligations—an interpretation ofFASB Statement No. 143, had
been applied during all periods affected?
[SFAS 143 par. 27; FIN 47 par. 11]

Y. Demutualizations and Formations of Mutual Insurance Holding
Companies

1.

2.

3.

Are the nature and terms of a demutualization or formation of and
MIHC and the basis of presentation and terms of operation of the
closed block disclosed?
[SOP 00-3 par. 24 (ACC 10,810.24)]

Is a general description of the method of emergence of earnings from
the closed block, presentation of assets and liabilities of the closed
block, and policyholder dividend obligation provided?
[SOP 00-3 par. 24 (ACC 10,810.24)]
If a closed block has formed, is the following disclosed (Note: Refer to
appendix A, "Illustrative Guidance—Footnote Disclosure for the
Closed Block," of SOP 00-3, Accounting by Insurance Enterprises for De
mutualizations and Formations of Mutual Insurance Holding Companies
and for Certain Long-Duration Participating Contracts (AICPA, Technical
Practice Aids, ACC sec. 10,810) for an illustrative example):
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a.

b.

A general description of the closed block, including the purpose
of the closed block, the types of insurance policies included, and
the nature of the cash flows that increase and decrease the
amount of closed block liabilities?
[SOP 00-3 par. 25a (ACC 10,810.25a)]

An indication the continuing responsibility of the insurance enter
prise to support the payment of contractual benefits and the na
ture of expenses charged to the closed block operations?
[SOP 00-3 par. 25a (ACC 10,810.25a)]

____

____

4. Is summarized financial data of the closed block as of, or for periods
ending on the date of, the financial statements presented, including at
a minimum:

The carrying amounts for the major types of invested assets of the
closed block?

____

b.

Future policy benefits and policyholders' account balances?

____

c.

Policyholder dividend obligation?

____

d.

Premiums?

____

e.

Net investment income?

____

f.

Realized investment gains and losses?

____

g.

Policyholder benefits?

____

h.

Policyholder dividends?

____

i.

The amount of maximum future earnings remaining to inure to
the benefit of stockholders from the assets and liabilities of the
closed block as well as an analysis of the changes in the policy
holder dividend obligation?
[SOP 00-3 par. 25b (ACC 10,810.25b)]

a.

Note: GAAP disclosures that typically would be required for the various
specific elements included in the closed block need not be made separately
for the closed block if the nature of the information for the closed block
would not differ significantly from that already included for the reporting
entity as a whole. For example, it is not necessary to show a separate
schedule of contractual maturities of closed block fixed maturity securities
if the relative composition of contractual maturities is similar to those of
the reporting entity taken as a whole. However, if the relative maturities
of the closed block fixed maturities securities differ from those of the re
porting entity taken as a whole, separate disclosures should be made.
[SOP 00-3 par. 25c (ACC 10,810.25c)]
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The nature of the guarantee, including the approximate term,
how the guarantee arose, and the events or circumstances that
would require the guarantor to perform under the guarantee?

____

____

____

The maximum potential amount of future payments (undis
counted) the guarantor could be required to make under the guar
antee?

____

____

____

If the terms of the guarantee provide for no limitation to the max
imum potential future payments under the guarantee, is that fact
disclosed?

____

____

____

If the guarantor is unable to develop an estimate of the maximum
potential amount of future payments under its guarantee, are the
reasons why the maximum potential amount cannot be estimated
disclosed (see paragraph 14 of FIN 45 for an exception to this re
quirement)?

____

____

____

The current carrying amount of the liability, if any, for the guar
antor's obligations under the guarantee, including the amount, if
any, recognized under SFAS 5 paragraph 8, regardless of whether
the guarantee is freestanding or embedded in another contract?

____

____

____

(1) any recourse provisions that would enable the guarantor to
recover from third parties any of the amounts paid under the
guarantee? and

____

____

____

(2) any assets held either as collateral or by third parties that,
upon the occurrence of any triggering event or condition un
der the guarantee, the guarantor can obtain and liquidate to
recover all or a portion of the amounts paid under the guar
antee?

-------

-------

------

-------

-------

------

Z. Guarantees

1.

Is the following information disclosed by a guarantor about each
guarantee, or each group of similar guarantees, even if the likelihood
of the guarantor's having to make any payments under the guarantee
is remote (except as provided in paragraph 14 of FIN 45, Guarantor's
Accounting and Disclosure Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others—an interpretation of FASB State
ments No. 5, 57, and 107 and rescission of FASB Interpretation No. 34,
with respect to the disclosure specified in par.13(b)):

a.

b.

c.

d.

e.

f.

g.

2.

The nature of

If estimable, the approximate extent to which the proceeds from
liquidation of those assets would be expected to cover the maxi
mum potential amount of future payments under the guarantee?
[FIN 45 par. 13]

For product warranties and other guarantee contracts that are ex
cluded from the initial recognition and initial measurement require
ments of FIN 45 pursuant to paragraph 7(b) of FIN 45 (collectively
referred to as product warranties), is the following information dis
closed:
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a.

The guarantor's accounting policy and methodology used in de
termining its liability for product warranties (including any liabil
ity associated with extended warranties)?

b.

A tabular reconciliation of the changes in the guarantor's aggre
gate product warranty liability for the reporting period?

c.

Does the tabular reconciliation present

(1) the beginning balance of the aggregate product warranty lia
bility?

(2) the aggregate reductions in that liability for payments made
(in cash or in kind) under the warranty?
(3) the aggregate changes in the liability for accruals to product
warranties issued during the reporting period, and the aggre
gate changes in the liability for accruals related to preexisting
warranties, including adjustments related to changes in esti
mates?

(4) the ending balance of the aggregate product warranty liabil
ity?
[FIN 45 par. 14]
3.

Are the disclosure requirements in paragraphs 13-14 of FIN 45 com
plied with for intellectual property infringement indemnifications as
described in FSP FIN 45-1?
[FSP FIN 45-1]

4.

Are the disclosure requirements in paragraphs 13-16 of FIN 45 ap
plied to all minimum revenue guarantees in financial statements of
interim or annual periods ending after the beginning of the first fiscal
quarter following November 10, 2005, the date that the final FSP was
posted to the FASB Web site? Thus, the disclosure requirements in
paragraphs 13-16 should be applied to any minimum revenue guar
antees issued prior to the initial application of the FSP, regardless of
whether those guarantees were recognized and measured under FIN
45?
[FSP FIN 45-3, par. 7]

AA. Fair Value Measurements
Notes: In February 2007, FASB issued SFAS 159, which is effective for fi
nancial statements issued for fiscal years beginning after November 15,
2007. Early adoption is permitted as of the beginning of a fiscal year that
begins on or before November 15, 2007, provided the organization also
elects to apply the provisions of SFAS 157. The choice to adopt early
should be made after issuance of this statement but within 120 days of the
beginning of the fiscal year of adoption, provided the entity has not yet
issued financial statements, including required notes to those financial
statements, for any interim period of the fiscal year of adoption.

This statement applies to all entities. Most of the provisions of this state
ment apply only to entities that elect the fair value option. However, the
amendment to SFAS 115 applies to all entities with available-for-sale and
(continued)
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trading securities. Some requirements apply differently to entities that do
not report net income.
The statement permits an organization to irrevocably elect fair value as the
initial and subsequent measurement attribute for certain financial assets
and financial liabilities on a contract-by-contract basis, with changes in fair
value recognized in earnings (or another performance indicator if the busi
ness entity does not report earnings) at each subsequent reporting date.
The provisions of this statement need not be applied to immaterial items.
If SFAS 159 is applicable to the financial statements (and related notes) of
the entity, questions 9-15 should be answered.

In September 2006, FASB issued SFAS 157, Fair Value Measurements, which
defines fair value, establishes a framework for measuring fair value in
GAAP, and expands disclosures about fair value measurements. The state
ment is effective for financial statements issued for fiscal years beginning
after November 15, 2007, and interim periods within those fiscal years.

In February 2008, FASB issued FSP FAS 157-1, Application of FASB State
ment No, 157 to FASB Statement No. 13 and Other Accounting Pronouncements
That Address Fair Value Measurements for Purposes of Lease Classification or
Measurement under Statement 13, which establishes that SFAS 157 does not
apply under SFAS 13 and other accounting pronouncements that address
fair value measurements for purposes of lease classification or measure
ment under SFAS 13. This scope exception does not apply to assets ac
quired and liabilities assumed in a business combination that are required
to be measured at fair value under SFAS 141 or SFAS 141(R), regardless of
whether those assets and liabilities are related to leases.
Also note, with the issuance of FSP FAS 157-2, Effective Date of FASB State
ment No. 157, in February 2008, FASB has deferred the effective date of
SFAS 157 to November 15, 2008, for nonfinancial assets and liabilities, ex
cept for items that are recognized or disclosed at fair value in an entity's
financial statements on a recurring basis (at least annually).

Additionally, on September 30, 2008, the SEC issued a press release titled
"SEC Office of the Chief Accountant and FASB Staff Clarifications on Fair
Value Accounting," which assisted preparers and auditors by providing
immediate clarification on fair value accounting until FASB provided ad
ditional interpretative guidance (see next paragraph on FSP FAS 157-3).
This press release can be found on the SEC's Web site and users are en
couraged to read the full release.
In October 2008, FASB issued FSP FAS 157-3, Determining the Fair Value of
a Financial Asset When the Market for That Asset Is Not Active. This FSP clar
ifies the application of SFAS 157 in a market that is not active and provides
an example to illustrate key considerations in determining the fair value
of a financial asset when the market for that financial asset is not active.
This FSP was effective upon issuance. Users are encouraged to read the
full FSP on the FASB Web site. Also note that the guidance in FSP FAS
157-3 is consistent with and amplifies the guidance in the above referenced
press release.
(continued)
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If SFAS 157 is applicable to the financial statements (and related notes) of
the entity, and the entity is either not eligible for or has not elected to
apply the deferral provisions of FSP FAS 157-2, questions 1-7 should be
answered. For those entities that are eligible to apply the provisions of FSP
FAS 157-2 (and have elected to do so), questions 1-7 should be answered
only in the context of assets and liabilities outside the scope of the FSP,
and question 8 should be answered also.
1.

For assets and liabilities that are measured at fair value on a recurring
basis in periods subsequent to initial recognition (for example, trading
securities), the reporting entity shall disclose information that enables
users of its financial statements to assess the inputs used to develop
those measurements and for recurring fair value measurements using
significant unobservable inputs (level 3), the effect of the measure
ments on earnings (or changes in net assets) for the period. To meet
that objective, the reporting entity shall disclose the following infor
mation for each interim and annual period (except as otherwise spec
ified) separately for each major category of assets and liabilities:

a.

The fair value measurements at the reporting date.

b.

The level within the fair value hierarchy in which the fair value
measurements in their entirety fall, segregating fair value meas
urements using quoted prices in active markets for identical as
sets or liabilities (level 1), significant other observable inputs
(level 2), and significant unobservable inputs (level 3).

c.

For fair value measurements using significant unobservable in
puts (level 3), a reconciliation of the beginning and ending bal
ances, separately presenting changes during the period attributa
ble to the following:17

(1) Total gains or losses for the period (realized and unrealized),
segregating those gains or losses included in earnings (or
changes in net assets), and a description of where those gains
or losses included in earnings (or changes in net assets) are
reported in the statement of income (or activities).
(2) Purchases, sales, issuances, and settlements (net).
(3) Transfers in and/or out of level 3 (for example, transfers due
to changes in the observability of significant inputs).
d.

The amount of the total gains or losses for the period in subpara
graph (c)(1) above included in earnings (or changes in net assets)
that are attributable to the change in unrealized gains or losses
relating to those assets and liabilities still held at the reporting
date and a description of where those unrealized gains or losses
are reported in the statement of income (or activities).

e.

In annual periods only, the valuation technique(s) used to meas
ure fair value and a discussion of changes in valuation tech
niques, if any, during the period.
[SFAS 157 par. 32]

17 For derivative assets and liabilities, the reconciliation disclosure required by paragraph 32(c) may be presented net.
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2.

b.

c.

d.

4.

5.

No

N/A

The fair value measurements recorded during the period and the
reasons for the measurements?

____

____

____

The level within the fair value hierarchy in which the fair value
measurements in their entirety fall, segregating fair value meas
urements using quoted prices in active markets for identical as
sets or liabilities (level 1), significant other observable inputs
(level 2), and significant unobservable inputs (level 3)?

____

____

____

For fair value measurements using significant unobservable in
puts (level 3), a description of the inputs and the information used
to develop the inputs?

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

For assets and liabilities that are measured at fair value on a nonre
curring basis in periods subsequent to initial recognition (for example,
impaired assets), the reporting entity shall disclose information that
enables users of its financial statements to assess the inputs used to
develop those measurements. To meet that objective, the reporting en
tity shall disclose the following information for each interim and an
nual period (except as otherwise specified) separately for each major
category of assets and liabilities:
a.

3.

Yes

In annual periods only, the valuation technique(s) used to meas
ure fair value and a discussion of changes, if any, in the valuation
technique(s) used to measure similar assets and/or liabilities in
prior periods?
[SFAS 157 par. 33]

Are the quantitative disclosures required in questions 1-2 above pre
sented using a tabular format? (See appendix A of SFAS 157 for im
plementation guidance and examples.)
[SFAS 157 par. 34]
Is the fair value information disclosed under SFAS 157 and the fair
value information disclosed under other accounting pronouncements
(for example, SFAS 107) combined in the periods in which those dis
closures are required, if practicable? (Encouraged, but not required.)
[SFAS 157 par. 35]

Is information about other similar measurements (for example, inven
tories measured at market value under ARB 43 chapter 4) disclosed,
if practicable? (Encouraged, but not required.)
[SFAS 157 par. 35]

Transition Guidance
6.

At the date that SFAS 157 is initially applied to the financial instru
ments, is the difference between the carrying amounts and the fair
values of those instruments recognized as a cumulative-effect adjust
ment to the opening balance of retained earnings (or other appropri
ate components of equity or net assets in the statement of financial
position) for that fiscal year, presented separately?
[SFAS 157 par. 38]

Note: The disclosure requirements of SFAS 154 for a change in accounting
principle do not apply.
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7.

Are the disclosure requirements of SFAS 157 (paragraphs 32-35), in
cluding those disclosures that are required in annual periods only,
applied in the first interim period of the fiscal year in which this state
ment is initially applied?
[SFAS 157 par. 39]

8.

For those entities that are eligible to apply the deferral provisions of
FSP FAS 157-2 (and have elected to do so), has the entity disclosed the
following:

a.

The fact that the entity has only partially applied SFAS 157?

b.

Each major category of assets and liabilities that are recognized or
disclosed at fair value for which, in accordance with FSP FAS 1572, the entity has not applied the provisions of SFAS 157?
[FSP FAS 157-2 par. 12]

Note: The disclosure requirements of SFAS 157, including those disclo
sures that are required in annual periods only, shall be applied in the first
interim period of the fiscal year in which this statement is initially applied.
The disclosure requirements of this statement need not be applied for fi
nancial statements for periods presented prior to initial application of this
statement.

9. If the organization reports assets and liabilities at fair value pursuant
to the fair value option in SFAS 159, has it either (a) presented the
aggregate of fair value and non-fair-value amounts in the same line
item in the statement of financial position and parenthetically dis
closed the amount measured at fair value included in the aggregate
amount or (b) presented two separate line items to display the fair
value and non-fair-value carrying amounts of similar assets and lia
bilities?
[SFAS 159 par. 15]

Note: The disclosures described in paragraphs 18-22 of SFAS 159 are re
quired for items measured at fair value under the option in SFAS 159 and
the option in paragraph 16 of SFAS 133 (as amended by SFAS 155). Those
disclosures are not required for securities classified as trading securities
under SFAS 115, life settlement contracts measured at fair value pursuant
to FSP TB 85-4-1, Accounting for Life Settlement Contracts by Third-Party In
vestors, or servicing rights measured at fair value pursuant to SFAS 156.
Entities shall provide the disclosures required by paragraphs 18-22 of
SFAS 159 in both interim and annual financial statements. Entities are en
couraged but are not required to present the disclosures required by SFAS
159 in combination with related fair value information required to be dis
closed by other statements (for example, SFAS 107 and SFAS 157). Appen
dix B of SFAS 159 provides illustrative fair value disclosures.
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10. As of each date for which a statement of financial position is pre
sented, do the entities disclose the following information about items
measured at fair value under the option in SFAS 159 or the option in
paragraph 16 of SFAS 133:

a.
b.

c.

d.

e.

Management's reasons for electing a fair value option for each el
igible item or group of similar eligible items?

____

___

(1) A description of those similar items and the reasons for par
tial election?

____

___

(2) Information to enable users to understand how the group of
similar items relates to individual line items on the statement
of financial position?

____

___

(1) Information to enable users to understand how each line item
in the statement of financial position relates to major catego
ries of assets and liabilities presented in accordance with
SFAS 157's fair value disclosure requirements?

____

___

(2) The aggregate carrying amount of items included in each line
item in the statement of financial position that are not eligible
for the fair value option, if any?

____

___

(1) Loans and long-term receivables (other than securities subject
to SFAS 115) that have contractual principal amounts and for
which the fair value option has been elected?

-------

-----

(2) Long-term debt instruments that have contractual principal
amounts and for which the fair value option has been elected?

____

___

(1) The aggregate fair value of loans that are 90 days or more
past due?

-------

-----

(2) If the entity's policy is to recognize interest income separately
from other changes in fair value, the aggregate fair value of
loans in nonaccrual status?

-------

------

(3) The difference between the aggregate fair value and the ag
gregate unpaid principal balance for loans that are 90 days or
more past due, in nonaccrual status, or both?

-------

------

The following information if the fair value option is elected for
some but not all eligible items within a group of similar eligible
items:

The following information for each line item in the statement of
financial position that includes an item or items for which the fair
value option has been elected:

The difference between the aggregate fair value and the aggregate
unpaid principal balance of:

For loans held as assets for which the fair value option has been
elected:

FSP §20,300.03

144

Life and Health Insurance Entities

Yes

f.

For investments that would have been accounted for under the
equity method if the entity had not chosen to apply the fair value
option, the information required by paragraph 20 of APB 18 (ex
cluding the disclosures in paragraphs 20(a)(3), 20(b), and 20(e) of
that opinion)?
[SFAS 159 par. 18]

No

____

___

For each line item in the statement of financial position, the
amounts of gains and losses from fair value changes during the
period included in earnings and in which line in the income state
ment those gains and losses are reported? (An organization may
meet this requirement by disclosing amounts of gains and losses
that include amounts of gains and losses for other items measured
at fair value, such as items required to be measured at fair value.)

____

___

A description of how interest and dividends are measured and
where they are reported in the income statement?

____

___

(1) the estimated amount of gains or losses included in earnings
during the period attributable to changes in instrument-spe
cific credit risk?

____

___

(2) How the gains or losses attributable to changes in instrumentspecific credit risk were determined?

____

____

(1) The estimated amount of gains and losses from fair value
changes included in earnings that are attributable to changes
in the instrument-specific credit risk?

____

____

(2) Qualitative information about the reasons for those changes?

____

____

(3) How the gains and losses attributable to changes in instru
ment-specific credit risk were determined?
[SFAS 159 par. 19]

____

____

____

____

____

____

____

____

11. As of each period for which an income statement is presented, has the
organization disclosed the following information about items meas
ured at fair value under the option in SFAS 159 or the option in par
agraph 16 of SFAS 133:

a.

b.

c.

d.

For loans and other receivables held as assets:

For liabilities with fair values that have been significantly affected
during the reporting period by changes in the instrument-specific
credit risk:

12. Has the organization disclosed the methods and significant assump
tions used to estimate the fair value of items for which the fair value
option has been elected?
[SFAS 159 par. 21]
13. If an organization elects the fair value option at a remeasurement
event, has it disclosed the following for the period of the election:
a.

Qualitative information about the nature of the event?

b.

Quantitative information by line item in the statement of financial
position indicating which line items in the statement of activities
include the effect of initially electing the fair value option for an
item?
[SFAS 159 par. 22]
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Yes

No

N/A

Transition Guidance

Note: Retrospective application of SFAS 159 to fiscal years preceding the
effective date, which would involve restatement of previously issued fi
nancial statements, is not permitted because of the elective nature of the
statement and the benefit of hindsight. Readers should refer to paragraph
30 of SFAS 159 for specific requirements applicable to the early adoption
of this statement.
14. At the date that SFAS 159 is initially applied to the financial state
ments, is the effect of the adoption attributable to the election of the
fair value option for selected financial assets and financial liabilities
accounted for as a cumulative-effect adjustment to the opening bal
ance of retained earnings (or other appropriate components of equity
or net assets in the statement of financial position) as of the effective
date, and not the beginning of the earliest year presented?
[SFAS 159 par. 25]

15. Has the organization electing the fair value option for items existing
at the effective date provided the following in its annual and firstinterim-period financial statements for the fiscal year that includes the
effective date (or early adoption date):
a.

A schedule that presents the following by line item in the state
ment of financial position:
(1) The pretax portion of the cumulative-effect adjustment to re
tained earnings (or appropriate class or classes of net assets)
for items on that line?
(2) The fair value at the effective date (or early adoption date) of
eligible items for which the fair value option is elected and
the carrying amount of those same items immediately before
electing the fair value option?

b.

The net effect on the entity's deferred tax assets and liabilities of
electing the fair value option?

c.

Management's reasons for electing the fair value option for each
existing eligible item or group of similar eligible items?

d.

If the fair value option is elected for some but not all eligible items
within a group of similar eligible items:

(1) A description of those similar items and the reasons for par
tial election?
(2) Information to enable users to understand how the group of
similar items relates to individual line items on the statement
of financial position?
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Yes

e.

The amount of valuation allowances that were removed from the
statement of financial position because they related to items for
which the fair value option was elected?
[SFAS 159 par. 27]
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Auditor’s Reports Checklist
This section of the checklist has been developed primarily to address the requirements most
likely to be encountered when reporting on financial statements of commercial corporations in
accordance with generally accepted auditing standards (GAAS) as issued by the Auditing Stan
dards Board (ASB), a senior technical committee of the AICPA. Certain key differences in re
porting requirements between audits conducted in accordance with GAAS and audits conducted
in accordance with the rules and standards of the Public Company Accounting Oversight Board
(PCAOB) are identified in bold text throughout this section of the checklist. However, the differ
ences identified are not intended to be all inclusive, and readers should seek appropriate guidance
for a comprehensive source of reporting requirements associated with audits conducted in
accordance with the rules and standards of the PCAOB.

.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of
the AICPA as a nonauthoritative practice aid.

.02

.03

Explanation of References:

AR =

Reference to section number in AICPA Professional Standards (vol. 2)

ASB =

Auditing Standards Board

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

FASB =

Financial Accounting Standards Board

PCAOB =

Public Company Accounting Oversight Board

SAS =

AICPA Statement on Auditing Standards

SSARS =

AICPA Statement on Standards for Accounting and Review Services

Checklist Questionnaire:

1.

2.

3.

Is every financial statement audited specifically identified in the intro
ductory paragraph of the auditor's report?
[AU 508.06]

Do the titles of the financial statements referred to in the introductory
paragraph of the auditor's report match the titles of the financial state
ments presented?
[Generally Accepted]
Do the dates of the financial statements referred to in the introductory
paragraph of the auditor's report match the dates of the financial
statements presented?
[Generally Accepted]

Yes

No

N/A

-------

-------

------

-------

-------

------

-------

-------

------
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4. Is the report appropriately addressed?
[AU 508.09]

Yes

No

N/A

____

____

____

Practice Tip

Auditing Interpretation No. 17, "Clarification in the Audit Report of the Extent of Testing of Internal Control
Over Financial Reporting in Accordance With Generally Accepted Auditing Standards," of AU section 508,
Reports on Audited Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 9508, par. .85-.88), pro
vides language that may be added to the auditor's standard report on the financial statements of a nonissuer
to clarify differences between a GAAS audit and an audit conducted in accordance with the standards of
the PCAOB. Auditing Interpretation No. 18, "Reference to PCAOB Standards in an Audit Report on a Non
issuer," of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508, par. .89-.92), explains how
the auditor should report if engaged to also follow PCAOB Auditing Standards in the audit of a nonissuer.
5. Does the independent auditor's report include the following elements:

a.

A title that includes the word independent?
[AU 508.08a]

b.

A statement that the financial statements identified in the report
were audited?
[AU 508.08b]

c.

A statement that the financial statements are the responsibility of
management and that the auditor's responsibility is to express an
opinion on the financial statements based on his or her audit?
[AU 508.08c]

d.

(Audits of Nonissuers Only) For audits conducted in accordance
with GAAS in the United States, a statement that the audit was
conducted in accordance with GAAS and an identification of the
country of origin of those standards (for example, auditing stan
dards generally accepted in the United States of America or U.S.
GAAS)?
[AU 508.08d]

e.

(Audits of Issuers Only) A statement that the audit was con
ducted in accordance with the standards of the PCAOB (United
States)?
[AS 1.03]

f.

A statement that these standards require that the auditor plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement?
[AU 508.08c]

g.

A statement that an audit includes examining, on a test basis, ev
idence supporting the amounts and disclosures in the financial
statements; assessing the accounting principles used and signifi
cant estimates made by management; and evaluating the overall
financial statement presentation?
[AU 508.08f]

h.

A statement that the auditor believes that his or her audit pro
vides a reasonable basis for his or her opinion?
[AU 508.08g]

FSP §20,400.03

149

Auditor's Reports Checklist

i.

When the auditor reports on financial statements presented in
conformity with U.S. generally accepted accounting principles
(GAAP), an opinion as to whether the financial statements pres
ent fairly, in all material aspects, the financial position of the com
pany as of the balance sheet date and the results of operations and
its cash flows for the period then ended in conformity with GAAP
and an identification of the country of origin of those accounting
principles (for example, accounting principles generally accepted
in the United States of America or U.S. GAAP?
[AU 508.08h]

Yes

No

N/A

____

____

____

Notes: In May 2008, the ASB issued Auditing Interpretation No. 19, "Fi
nancial Statements Prepared in Conformity With International Financial
Reporting Standards as Issued by the International Accounting Standards
Board" of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec.
9508 par. .93-.97) which provides that, when the auditor of a nonissuer
reports on financial statements prepared in conformity with International
Financial Reporting Standards (IFRS), the auditor would refer, in the au
ditor's report, to IFRS rather than U.S. GAAP.
When an auditor of a nonissuer reports on financial statements presented
in conformity with both IFRS as issued by the International Accounting
Standards Board and a jurisdictional variation of IFRS, the auditor would
refer, in the auditor's report, to both IFRS and IFRS as endorsed by [insert
name of endorsing country or economic union].
When an auditor of a nonissuer reports on financial statements presented
in conformity with a jurisdictional variation of IFRS such that the entity's
financial statements do not contain an explicit and unreserved statement
of compliance with IFRS as issued by the International Accounting Stan
dards Board, paragraphs .14-.15 of AU section 534, Reporting on Financial
Statements Prepared for Use in Other Countries (AICPA, Professional Stan
dards, vol. 1), and paragraphs .35-.60 of AU section 508 apply to financial
statements prepared for more than limited distribution in the United
States.
j.

When the auditor reports on financial statements presented in
conformity with IFRS, an opinion as to whether the financial
statements present fairly, in all material respects, the financial po
sition of the reporting entity as of the balance sheet date and the
results of its operations and its cash flows for the period then
ended in conformity with IFRS as issued by the International Ac
counting Standards Board?
[AU 9508.93-.97]
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k.

l.

When the auditor reports on financial statements presented both
in conformity with IFRS and a jurisdictional variant of IFRS, an
opinion as to whether the financial statements present fairly, in
all material respects, the financial position of the reporting entity
as of the balance sheet date and the results of its operations and
its cash flows for the period then ended in conformity with IFRS
as issued by the International Accounting Standards Board and
with IFRS as endorsed by [insert name of endorsing country or eco
nomic union]?
[AU 9508.93-.97]
When the auditor reports on financial statements presented in
conformity with a jurisdictional variation of IFRS such that the
entity's financial statements do not contain an explicit and unre
served statement of compliance with IFRS as issued by the Inter
national Accounting Standards Board, a variation of the standard
report that reflects the guidance in paragraphs .14-.15 of AU sec
tion 534 and paragraphs .35-60 of AU section 508 for financial
statements prepared for more than limited distribution in the
United States?
[AU 9508.93-.97]

m. The manual or printed signature of the auditor's firm?
[AU 508.08l]

n.

The date of the audit report?
[AU 508.08j]

Yes

No

N/A

-------

-------

------

-------

-------

------

____

____

____

____

____

____

Practice Tip
Paragraph .08 of AU section 508 illustrates the form of the auditor's standard report on financial statements
covering a single year and on comparative financial statements.

Notes: In May 2008, the ASB issued Auditing Interpretation No. 14 (re
vised 2008), "Reporting on Audits Conducted in Accordance With Audit
ing Standards Generally Accepted in the United States of America and in
Accordance With International Standards on Auditing" of AU section 508
(AICPA, Professional Standards, vol. 1, AU sec. 9508 par. .56—.59) which pro
vides that, when the audit of a nonissuer is conducted both in accordance
with standards generally accepted in the United States of America and in
accordance with the International Standards on Auditing (ISA), the audi
tor may so indicate in the auditor's report.

To determine whether an audit was conducted in accordance with ISA, it
is necessary to consider the text of ISA in their entirety, including the basic
principles and essential procedures together with the related guidance in
cluded in ISA.
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6. If the audit of financial statements to be used in the United States was
conducted in accordance with ISA as issued by the International Au
diting and Assurance Standards Board, in their entirety, has the au
ditor considered indicating in the auditor's report that the audit was
also conducted in accordance with ISA as allowed? (Note: Not re
quired: Interpretation No. 14 of AU 508 provides an example report.)
[AU 9508.57-.59]

Yes

No

N/A

____

____

____

Notes: On May 24, 2007, the PCAOB adopted Auditing Standard No. 5,
An Audit of Internal Control Over Financial Reporting That Is Integrated with
An Audit of Financial Statements (AICPA, PCAOB Standards and Related
Rules, Rules of the Board, "Standards"), that supersedes Auditing Stan
dard No. 2. The PCAOB adopted Auditing Standard No. 5 with the pri
mary objective of focusing the auditor on matters most important to inter
nal control. Goals of this new standard are to eliminate unnecessary
procedures, to simplify and shorten the standard by reducing detail and
specificity, and to make the audit more scalable for smaller and less com
plex companies.

Auditing Standard No. 5 is effective for audits of internal control over fi
nancial reporting required by Section 404(b) of the Sarbanes-Oxley Act of
2002 for fiscal years ending on or after November 15, 2007.
Among other significant guidance, Auditing Standard No. 5 states that an
audit of internal control over financial reporting should be integrated with
the audit of the financial statements. The auditor may choose to issue a
combined report (that is, one report containing both an opinion on the
financial statements and an opinion on internal control over financial re
porting) or separate reports on the company's financial statements and on
internal control over financial reporting. Paragraph 85 of Auditing Stan
dard No. 5 lists the basic elements that an auditor's report on the audit of
internal control over financial reporting must include. Readers can refer to
the full text of the Auditing Standard at www.pcaob.org.

7.

8.

If a subsequent event disclosed in the financial statements occurs after
the original date of the independent auditor's report but before the
issuance of the related financial statements, has the auditor followed
one of the following two methods available for dating the report:

a.

Dual dating, in which the independent auditor's responsibility for
events occurring subsequent to the original report date is limited
to the specific event referred to in an explanatory note in the re
port (or otherwise disclosed)?

b.

Dating the report as of the later date, in which the independent
auditor's responsibility for subsequent events extends to the date
of the report?
[AU 530.03-.05]

(Audits of Issuers Only) If the auditor obtains knowledge about a
subsequent event that:
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a.

b.

9.

Materially and adversely affects the effectiveness of the com
pany's internal control over financial reporting as of the date
specified in the assessment, has the auditor either:
(1.) Issued an adverse opinion on internal control over financial
reporting (and followed the direction in paragraph C2 of
PCAOB Auditing Standard No. 5 if management's assessment
states that internal control over financial reporting is effec
tive)?

____

(2.) Disclaimed an opinion if the auditor is unable to determine
the effect of the subsequent event on the effectiveness of the
company's internal control over financial reporting?

____

Relates to conditions that did not exist at the date specified in the
assessment but arose subsequent to that date and before issuance
of the auditor's report, and the subsequent event has a material
effect on the company's internal control over financial reporting,
has the auditor included in his or her report an explanatory par
agraph describing the event and its effects or directed the reader's
attention to the event and its effects as disclosed in management's
report?
[AS 5.96-.97]

____

If the accountant is not independent, has he or she followed one of
the two reporting alternatives available:
a.

b.

Disclaiming the opinion with respect to the financial statements
and specifically stating that he or she is not independent?
Issuing a compilation report in accordance with SSARS indicating
the lack of independence (nonpublic companies only)?
[AU 504.05 and .09-.10; AR 100A.21 and .48-.53]

____
____

10. If the opinion is based in part on the report of another auditor:
a.

b.

Does the introductory paragraph of the standard report disclose
the fact that the opinion is based, in part, on the report of other
auditors?
Does the opinion paragraph include a reference to the report of
the other auditor?
[AU 508.11a and .12-.13]

11. If, to prevent the financial statements from being misleading because
of unusual circumstances, the financial statements contain a departure
from an accounting principle promulgated by a body designated by
the AICPA Council to establish such principles, does the report in
clude, in a separate paragraph or paragraphs, the information re
quired by the rule?
[AU 508.111b and .15]

____
____

____

12. If there is substantial doubt about the entity's ability to continue as a
going concern for a reasonable period of time, not to exceed one year
beyond the date of the financial statements being audited:

a.

Does the report include an explanatory paragraph, following the
opinion paragraph, to reflect that conclusion?
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b.

Is that conclusion expressed through the use of the phrase "sub
stantial doubt about its (the entity's) ability to continue as a going
concern" or similar wording that includes the terms substantial
doubt and going concern?
[AU 508.11c; AU 341.12]

Yes

No

N/A

____

____

____

Practice Tip

In evaluating whether there is substantial doubt about the entity's ability to continue as a going concern, the
auditor's evaluation is based on his or her knowledge of relevant conditions that exist at or have occurred
prior to the date of the auditor's report. If, after considering identified conditions and events and manage
ment's plans, the auditor concludes that substantial doubt about the entity's ability to continue as a going
concern for a reasonable period of time remains, the audit report should include an explanatory paragraph
to reflect that conclusion.

In a going concern paragraph, the auditor should not use conditional language in expressing a conclusion
concerning the existence of substantial doubt about the entity's ability to continue as a going concern. See
AU section 341 paragraph .13 for an example.
13. (Audits of Nonissuers Only) Is the report dated no earlier than the
date on which the auditor has obtained sufficient appropriate audit
evidence to support the auditor's opinion on the financial statements?
[AU 530.01]
14. (Audits of Issuers Only) Is the report dated no earlier than the date
on which the auditor has obtained sufficient competent evidence to
support the auditor's opinion on the financial statements?
[AS 5.89]

15. (Audits of Issuers Only) When performing an integrated audit of fi
nancial statements and internal control over financial reporting, are
the auditor's reports on the company's financial statements and on
internal control over financial reporting dated the same?
[AS 5.89]
16. (Audits of Issuers Only) Prior to the report release date, among other
matters, has the auditor obtained sufficient evidence to support the
representations in the auditor's reports?
[AS 3.15]

____

____

____

____

____

____

____

____

____

____

____

____

Notes: For audits of issuers, certain circumstances, though not affecting
the auditor's unqualified opinion, may require that the auditor add ex
planatory language to the standard report as described in paragraphs
.11-.19 of AU section 508 (AICPA, PCAOB Standards and Related Rules,
PCAOB Standards, As Amended).
Other circumstances may require a departure from an unqualified opin
ion, either in the form of a qualified opinion, an adverse opinion, or a
disclaimed opinion as described in paragraphs .20-63 of AU section 508
(AICPA, PCAOB Standards and Related Rules, PCAOB Standards, As
Amended).

For special reporting situations relating to the auditor's report on internal
control over financial reporting, refer to appendix C, "Special Reporting
Situations," of Auditing Standard No. 5.
(continued)
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******
In January, 2008, the PCAOB adopted Auditing Standard No. 6, Evaluating
Consistency of Financial Statements, and an accompanying set of amend
ments to the PCAOB's interim Auditing Standards. Among other signifi
cant provisions, the new standard and related amendments update the au
ditor's responsibilities to evaluate and report on the consistency of a
company's financial statements and align the auditor's responsibilities
with FASB Statement No. (SFAS) 154, Accounting Changes and Error Correc
tions—a replacement of APB Opinion No. 20 and FASB Statement No. 3.
One significant difference in terminology between SFAS 154 and Auditing
Standard No. 6 is the use of the term error in the SFAS compared with the
use of the term misstatement in the PCAOB standard, which specifically
states that the meaning is the same for purposes of the PCAOB Auditing
Standards. Auditing Standard No. 6 also establishes that the auditor's re
port should indicate whether an adjustment to previously issued financial
statements results from a change in accounting principle or the correction
of a misstatement.

Auditing Standard No. 6 contains numerous amendments to PCAOB AU
section 508 and other interim PCAOB Auditing Standards. The Securities
and Exchange Commission (SEC) approved Auditing Standard No. 6 in its
Release No. 34-58555 dated September 16, 2008. The new standard and
related amendments are effective November 15, 2008. If Auditing Stan
dard No. 6 is applicable to issuers' financial statements, answer questions
18-19; otherwise, skip questions 18-19. For more information and for the
full text of the Auditing Standard, refer to the PCAOB Web site at
www.pcaob.org. Also refer to the SEC Web site at www.sec.gov.
17. (Audits of Nonissuers Only) If there has been a material change be
tween periods in accounting principles or in the method of their ap
plication, including a change from an accounting principle that is not
generally accepted to one that is generally accepted and a change in
accounting principle that is inseparable from the effect of a change in
estimate, that has a material effect on the comparability of the report
ing entity's financial statements:
a.

Does the report include an explanatory paragraph, following the
opinion paragraph that refers to the change?

h.

Does the explanatory paragraph identify the nature of the change
and refer the reader to the note to the financial statements that
discusses the change in detail?
[AU 508.05-.06 and .12-.13]

c.

If the change in the accounting principle is a change in reporting
entity that did not result from a transaction or an event, is an ex
planatory paragraph included in the auditor's report? (Note: A
change in the reporting entity resulting from a transaction or
event, such as the creation, cessation, or complete or partial pur
chase or disposition of a subsidiary or other business unit does
not require that an explanatory paragraph about consistency be
included in the auditor's report.)
[AU 420.08]
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Yes

No

N/A

18. (Audits of Nonissuers Only) If there has been a change in accounting
principle that has a material effect on the financial statements, includ
ing a change in the method of applying an accounting principle, a
change in estimate effected by a change in accounting principle, and
a change in classification that represents a change in accounting prin
ciple, and meets the four criteria established in paragraph 7 of PCAOB
Auditing Standard No. 6:

a.

b.

c.

Does the report include an explanatory paragraph, following the
opinion paragraph, in the year of the change and in subsequent
years until the new accounting principle is applied in all periods
presented?

____

____ _ ____

Does the explanatory paragraph identify the nature of the change
and include a reference to the note disclosure describing the
change?

____

____ _ ____

____

____ _ ____

____

____ _ ____

____

____ _ ___

-------

------ - -----

(1) The date of the auditor's previous report?

-------

------ - -----

(2) The type of opinion previously expressed?

-------

------ -

(3) The circumstances or events that caused the auditor to ex
press a different opinion?

-------

-------- -----

If the change in the accounting principle is a change in reporting
entity that did not result from a transaction or an event, is an ex
planatory paragraph included in the auditor's report? (Note: A
change in the reporting entity resulting from a transaction or
event, such the creation, cessation, or complete or partial pur
chase or disposition of a subsidiary or other business unit, does
not require recognition in the auditor's report.)
[AS 6.04-.08 and .11]

19. (Audits of Issuers Only) If there has been a correction of a material
misstatement in previously issued financial statements, including a
change from an accounting principle that is not generally accepted to
one that is generally accepted and a change in classification that rep
resents the correction of a material misstatement, does the auditor's
report contain an explanatory paragraph, following the opinion par
agraph, that includes:

a.

b.

A statement that the previously issued financial statements have
been restated for the correction of a misstatement in the respective
period?
A reference to the company's disclosure of the correction of the
misstatement?
[AS 6.04-.08 and .11]

20. If in an updated report on the individual financial statements of one
or more prior periods presented on a comparative basis with those of
the current period the opinion is different from the opinion previ
ously expressed on the financial statements of a prior period:

a.

b.

Does the report include an explanatory paragraph, preceding the
opinion paragraph that discloses all of the substantive reasons for
the different opinion?

Does the explanatory paragraph disclose:

-----
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(4) That the auditor's updated opinion on the financial state
ments of the prior period is different from his or her previous
opinion on those statements?
[AU 508.11e and .69]

21. If financial statements of a prior period (presented for comparative
purposes) have been audited by a predecessor auditor whose report
is not presented:
a.

Does the introductory paragraph of the successor's auditor report
indicate:

(1) That the financial statements of the prior period were audited
by another auditor?
(2) The date of the predecessor auditor's report?
(3) The type of report issued by the predecessor auditor?
(4) If the report was other than a standard report, the substantive
reasons therefore including a description of the nature of and
reasons for the explanatory paragraph added to the predeces
sor's report or his or her opinion qualification?
b.

If the financial statements have been restated, does the introduc
tory paragraph indicate that the predecessor auditor reported on
the financial statements of the prior period before restatement?
[AU 508.11e and .74]

22. Is an explanatory paragraph (or other explanatory language) added
to the standard auditor's report if:

a.

The auditor wishes to clarify that an audit performed in accor
dance with GAAS does not require the same level of testing and
reporting on internal control over financial reporting as an audit
of an issuer when Section 404(b) of the Sarbanes-Oxley Act is ap
plicable? (Note: Not required: Interpretation No. 17 of AU section
508 provides an example report.)
[AU 9508.85-.88]

b.

The audit is conducted in accordance with both GAAS and the
PCAOB's Auditing Standards? (Note: Not required: Interpreta
tion No. 18 of AU 508 provides an example report.)
[AU 9508.89-.92]

23. Is an explanatory paragraph (or other explanatory language) added
to the standard auditor's report if the prior period's financial state
ments are audited by a predecessor auditor who had ceased opera
tions?
[AU 9508.60-.75]

24. If selected quarterly financial data required by SEC Regulation S-K
has been omitted or has not been reviewed, does the report include
an additional paragraph stating that fact?
[AU 508.11/ AU 722.50]
25. If other information in a document containing audited financial state
ments is materially inconsistent with information appearing in the fi
nancial statements, has it been determined whether the financial state
ments, the auditor's report, or both require revision?
[AU 508.11h; AU 550.04]
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Yes

No

N/A

____

____

____

____

____

____

____

____

____

Are all of the substantive reasons for the qualification disclosed in
one or more explanatory paragraphs preceding the opinion para
graph?

____

____

____

Does the qualified opinion include the word except or exception in
a phrase such as except for or with the exception of?

____

____

____

Is the situation described and referred to in both the scope and
opinion paragraphs?

____

____

____

____

____

____

26. If supplementary information required by GAAP has been omitted,
the presentation of such information departs materially from pre
scribed guidelines, the auditor is unable to complete prescribed pro
cedures with respect to such information, or the auditor is unable to
remove substantial doubt about whether the supplementary informa
tion conforms to prescribed guidelines, does the report include an ad
ditional paragraph stating that fact?
[AU 508.11g; AU 558.08]
27. If the auditor decides to emphasize a matter regarding the financial
statements in the report, is the matter being emphasized disclosed in
the financial statements and is the explanatory information presented
in a separate paragraph that avoids use of phrases such as “with the
foregoing (following) explanation?"
[AU 508.11 and .19; AU 9410.18; AU 9342.03]
28. If it has not been possible to conduct the audit in accordance with
GAAS or to apply all of the procedures considered necessary in the
circumstances, has consideration been given to the need to issue a
qualified opinion or to disclaim an opinion?
[AU 508.22]

29. If a qualified opinion is to be expressed because of a scope limitation:

a.

b.

c.

d.

Does the wording in the opinion paragraph indicate that the qual
ification pertains to the possible effects on the financial statements
and not the scope limitation itself?
[AU 508.21-.32; AU 318.76]
Practice Tip

Scope limitations can be imposed by the client or by circumstances such as the timing of the auditor's work,
the inability to obtain sufficient appropriate audit evidence, or an inadequacy in the accounting records.
Sufficient appropriate audit evidence includes, among other things, management having asserted responsi
bility for the final financial statements. As provided in Technical Practice Aid (TPA) Technical Questions
and Answers (TIS) section 9100.06, "Signing and Dating Reports" (AICPA, Technical Practice Aids), the au
ditor will need to have the signed management representation letter in hand prior to releasing the auditor's
report because management's refusal to furnish written representations constitutes a limitation on the scope
of the audit sufficient to preclude an unqualified opinion.
In circumstances in which the auditor is unable to obtain sufficient appropriate audit evidence to support
management's assertions about the nature of a matter involving an uncertainty and its presentation or dis
closure in the financial statements, the auditor should consider the need to express a qualified opinion or to
disclaim an opinion because of a scope limitation.
[AU 508.22 and .31]
(continued)
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In circumstances in which the auditor is unable to audit the existence or measurement of interests in invest
ments in securities and interests in trusts, the auditor should consider whether that scope limitation requires
the auditor to either qualify his or her opinion or to disclaim an opinion, as discussed in paragraphs .22-.26
of AU section 508; Interpretation No. 1, "Auditing Interests in Trusts Held by a Third-Party Trustee and
Reported at Fair Value" of AU section 328, Auditing Fair Value Measurements and Disclosures (AICPA, Profes
sional Standards, vol. 1, AU sec. 9238, paragraphs .01-.04); and Auditing Interpretation No. 1, "Auditing
Investments in Securities Where a Readily Determinable Fair Value Does Not Exist" of AU section 332,
Auditing Derivative Instruments, Hedging Activities, and Investments in Securities (AICPA, Professional Standards,
vol. 1, AU sec. 9332, paragraphs .01-.04).
In circumstances in which the auditor is unable to audit the existence or measurement of interests in invest
ments in securities and interests in trusts, the auditor should consider whether that scope limitation requires
the auditor to either qualify his or her opinion or to disclaim an opinion, as discussed in paragraphs .22-26
of AU section 508 (AICPA, Professional Standards, vol. 1), AU section 9328 paragraphs .01-.04, and AU section
9332 paragraphs .01-.04

30. Is a qualified opinion or disclaimer of opinion expressed if the audi
tor's understanding of internal control raises doubts about the auditability of an entity's financial statements, such as:

a.

Concerns about the integrity of an entity's management cause the
auditor to conclude that the risk of management misrepresenta
tion in the financial statements is such that an audit cannot be
conducted?

b.

Concerns about the condition and reliability of an entity's records
cause the auditor to conclude that it is unlikely that sufficient ap
propriate audit evidence will be available to support an unquali
fied opinion on the financial statements?
[AU 314.109]

31. If, in the auditor's judgment, the two-way communication between
the auditor and those charged with governance as described in AU
section 380 is not adequate and the situation cannot be resolved,
thereby prohibiting the auditor from obtaining all the audit evidence
required to form an opinion on the financial statements, has the au
ditor considered the following:

a.

Modifying the audit opinion on the basis of a scope limitation?

b.

Obtaining legal advice about the consequences of different
courses of action?

c.

Communicating with an appropriate third party (for example, a
regulator)?

d.

Withdrawing from the engagement?
[AU 380.62-.63]

32. If, in the auditor's judgment, significant difficulties in dealing with
management such as those described in AU section 380 have been
encountered, has the auditor considered modifying the audit opinion
on the basis of a scope limitation?
[AU 380.39]
33. If an opinion is disclaimed because of a scope limitation:

a.

Are all of the substantive reasons for the disclaimer stated in a
separate paragraph or paragraphs?
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Does the report state that the scope of the audit was not sufficient
to warrant the expression of an opinion?

____

____

____

Does the report avoid identifying procedures that were per
formed?

____

____

____

d.

Is the scope paragraph omitted?

____

____

____

e.

If there are reservations about fair presentation of the financial
statements in conformity with GAAP, are they described in the
report?
[AU 508.62-.63]

____

____

____

b.

c.

Note: Consult the Topical Index to the AICPA Professional Standards under
"Scope of Audit—Limitations" for additional references to specific types
of scope limitations that could result in either a qualified or disclaimer of
opinion.

34. If the financial statements are materially affected by a departure from
GAAP (including, for example, inadequate disclosure, inappropriate
accounting principles, and unreasonable accounting estimates), has
the auditor issued a qualified opinion or an adverse opinion?
[AU 508.35]
35. If a qualified opinion is to be expressed because of a GAAP departure:

a.

Are all of the substantive reasons that have led to the conclusion
that there is a departure from GAAP disclosed in one or more
separate explanatory paragraphs preceding the opinion para
graph?

b.

Does the qualified opinion include the word except or exception in
a phrase such as except for or with the exception of and a reference
to the explanatory paragraph?

c.

Does the explanatory paragraph disclose the principle effects of
the departure on financial position, results of operations, and cash
flows, if practicable, or state that the effects are not reasonably
determinable?
[AU 508. 21 and AU 508.37-.39]

36. If an adverse opinion is to be expressed because of a GAAP departure:

a.

Are all of the substantive reasons for the adverse opinion dis
closed in one or more separate explanatory paragraphs preceding
the opinion paragraph?

b.

Does the explanatory paragraph disclose the principle effects of
the departure on financial position, results of operations, and cash
flows, if practicable, or state that the effects are not reasonably
determinable?

c.

State that the financial statements do not present fairly the finan
cial position, or results of operations or cash flows in conformity
with GAAP?
[AU 508.58-.59]
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Notes: Consult the Topical Index to the AICPA Professional Standards un
der "Departures From Standard Report" for additional information.
Readers may also wish to refer to TIS section 1400.31, "GAAP Departure
for FIN No. 46(R)" (AICPA, Technical Practice Aids), for assistance in deter
mining the implications on the auditor's report if the reporting entity does
not consolidate a variable interest entity.

Practice Tip

Reporting on financial statements prepared in conformity with an other comprehensive basis of accounting
(OCBOA) is addressed in AU section 623, Special Reports (AICPA, Professional Standards, vol. 1). For purposes
of that section, a comprehensive basis of accounting other than GAAP is one of the following:

a. A basis of accounting that the reporting entity uses to comply with the requirements or financial
reporting provisions of a governmental regulatory agency to whose jurisdiction the entity is subject.
An example is a basis of accounting insurance companies use pursuant to the rules of a state insur
ance commission.
b. A basis of accounting that the reporting entity uses or expects to use to file its income tax return for
the period covered by the financial statements.

c. The cash receipts and disbursements basis of accounting, and modifications of the cash basis having
substantial support, such as recording depreciation on fixed assets or accruing income taxes.

d. A definite set of criteria having substantial support that is applied to all material items appearing in
financial statements, such as the price-level basis of accounting.
In considering whether the financial statements (including the accompanying notes) include all informative
disclosures that are appropriate for the basis of accounting used, paragraph .09 of AU section 623 states that
the auditor should apply essentially the same criteria to financial statements prepared on an OCBOA as he
or she does to financial statements prepared in conformity with GAAP.

37. When reporting on financial statements prepared in conformity with
a comprehensive basis of accounting other than GAAP, as defined in
paragraph .04 of AU section 623, does the independent auditor's re
port include the following elements (for audits prepared in conform
ity with GAAS):

a.

A title that includes the word independent?
[AU 623.05a]

b.

A paragraph that states that:

(1) The financial statements identified in the report were au
dited?
(2) The financial statements are the responsibility of the com
pany's management and that the auditor is responsible for ex
pressing an opinion on the financial statements based on the
audit?
[AU 623.05b]

c.

A paragraph that states that:
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(1) The audit was conducted in accordance with GAAS with spe
cific identification of the United States of America as the
country of origin of those standards?

____

____

____

(2) Those standards require that the auditor plan and perform
the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement?

____

____

____

(3) An audit includes examining, on a test basis, evidence sup
porting the amounts and disclosures in the financial state
ments; assessing the accounting principles used and signifi
cant estimates made by management; and evaluating the
overall financial statement presentation?

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

(4) The auditor believes that his or her audit provides a reasona
ble basis for the opinion?
[AU 623.05c]

d.

A paragraph that states:
(1) The basis of presentation and refers to the note to the financial
statements that describes the basis?

(2) That the basis of presentation is a comprehensive basis of ac
counting other than GAAP?
[AU 623.05d]

e.

f.

A paragraph that expresses the auditor's opinion (or disclaims an
opinion) on whether the financial statements are presented fairly,
in all material respects, in conformity with the basis of accounting
described?
[AU 623.05c]
If the financial statements are prepared in conformity with the re
quirements or financial reporting provisions of a governmental
regulatory agency, a separate paragraph at the end of the report
stating that the report is intended solely for the information and
use of those within the entity and the regulatory agencies to
whose jurisdiction the entity is subject, and is not intended to be
and should not be used by anyone other than these specified par
ties?
[AU 623.05f]

g.

The manual or printed signature of the auditor's firm?
[AU 623.05g]

____

____

____

h.

The date of the audit report?
[AU 623.05h]

____

____

____

38. When the financial statements are prepared in conformity with the
requirements or financial reporting provisions of a governmental reg
ulatory agency and the financial statements and reports will be used
by parties or distributed by the entity to parties other than the regu
latory agencies to whose jurisdiction the entity is subject, has the stan
dard form of report been modified as appropriate because of the de
partures from GAAP and has an additional paragraph been added to
express an opinion on whether the financial statements are presented
in conformity with the regulatory basis of accounting? (Note: Audit
ing Interpretation No. 15, "Auditor Reports on Regulatory Account
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ing or Presentation When the Regulated Entity Distributes the Finan
cial Statements to Parties Other Than the Regulatory Agency Either
Voluntarily or Upon Specific Request" of AU section 623 [AICPA, Pro
fessional Standards, vol. 1, AU sec. 9623 par. .96-.98], provides an ex
ample report.)
[AU 544.04; AU 9623.96-.98]

39. If certain other information, including supplementary information re
quired by GAAP, contained in annual reports and other client-pre
pared documents described in AU section 550 paragraph .02 that con
tain audited financial statements has been subjected to auditing
procedures applied in the audit of the basic financial statements, does
the auditor express an opinion on whether the information is fairly
stated in all material respects in relation to those financial statements
taken as a whole in the auditor's report and does the report describe
clearly the character of the auditor's work and the degree of respon
sibility the auditor is taking?
[AU 550.07; AU 558.09]

40. If other information contained in annual reports and other client-pre
pared documents described in AU section 550 paragraph .02 that in a
document containing audited financial statements is materially incon
sistent with information appearing in the financial statements, has it
been determined whether the financial statements, the auditor's re
port, or both require revision?
[AU 508.11h; AU 550.04]
41. If other information contained in annual reports and other client-pre
pared documents described in AU section 550 paragraph .02 that con
tain audited financial statements is materially inconsistent with infor
mation appearing in the financial statements, and the auditor has
determined that neither the financial statements nor the auditor's re
port require revision, has the auditor either:
a.

Requested that the client revise the other information to eliminate
the material inconsistency?

b.

Considered other actions such as revising the audit report to in
clude an explanatory paragraph describing the material inconsis
tency, withholding the use of the audit report in the document,
and withdrawing from the engagement?
[AU 550.04]

42. If information accompanies the basic financial statements and audi
tor's report in an auditor-submitted document, is it accompanied by a
report that:
a.

States that the audit was performed for the purpose of forming an
opinion on the basic financial statements taken as a whole?

b.

Specifically identifies the accompanying information?

c.

States that the accompanying information is presented for pur
poses of additional analysis and is not a required part of the basic
financial statements?
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d.

Includes either an opinion on whether the accompanying infor
mation is fairly stated in all material respects in relation to the
basic financial statements taken as a whole or a disclaimer of
opinion (depending on whether the information was subjected to
the auditing procedures applied in the audit of the basic financial
statements)?
[AU 551.05-.06]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

-------

-------

------

43. If information accompanying the basic financial statements and audi
tor's report in an auditor-submitted document is materially misstated
in relation to the basic financial statements taken as a whole, has the
auditor either:

a.
b.

Requested that the client revise the accompanying information to
eliminate the material misstatement?
Considered other actions such as modifying the audit report to
describe the misstatement or refusing to include the accompany
ing information in the auditor-submitted document?
[AU 551.09]

44. When the basic financial statements are accompanied by supplemen
tary information required by GAAP and such supplementary infor
mation has not been audited as part of the basic financial statements,
does the auditor's report exclude any language that refers to the sup
plementary information or the limited procedures applied (except in
the circumstances described in AU section 558 paragraph .08)?
[AU 558.08]
45. When the basic financial statements are accompanied by supplemen
tary information required by GAAP and such supplementary infor
mation has been audited as part of the basic financial statements, has
the audit report been expanded in accordance with AU section 550
paragraph .07?
[AU 558.09]

46. If supplementary information required by GAAP has been omitted,
the presentation of such information departs materially from pre
scribed guidelines, the auditor is unable to complete prescribed pro
cedures with respect to such information, or the auditor is unable to
remove substantial doubt about whether the supplementary informa
tion conforms to prescribed guidelines, does the report include an ad
ditional paragraph stating that fact?
[AU 508.11g; AU 558.08]
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Supplemental Information for Life
Insurance Companies That are
Securities and Exchange
Commission Registrants
.01 Footnote 3 to AU section 411, The Meaning of Present Fairly in Conformity With Generally Accepted
Accounting Principles (AICPA, Professional Standards, vol. 1), states, in part, that for Securities and Exchange
Commission (SEC) registrants, rules and releases of the SEC have an authority similar to other officially
established accounting principles.
Regulation S-X is the primary source of requirements for financial statements and related footnotes required
to be included in documents filed with the SEC. In addition to Regulation S-X, preparers and auditors of
financial statements should be familiar with the SEC's Financial Reporting Releases (FRR) and Staff Account
ing Bulletins (SAB). FRRs communicate the SEC's position on accounting and auditing principles and prac
tices. SABs represent interpretations and practices followed by the Division of Corporation Finance and the
Office of the Chief Accountant of the SEC. Insurance companies are subject to the requirements of Articles
1-4, 7, 10, and 12 of Regulation S-X.
When determining compliance with SEC requirements, preparers and auditors should refer to the appropri
ate SEC pronouncements to ensure compliance with SEC disclosure rules. In particular, the following doc
uments should be consulted:

•

Regulation S-X, Article 1, Application of Regulation S-X

•

Regulation S-X, Article 2, Qualifications and Reports of Accountants

•

Regulation S-X, Article 3, General Instructions as to Financial Statements

•

Regulation S-X, Article 3A, Consolidated and Combined Financial Statements

•

Regulation S-X, Article 4, Rules of General Application

•

Regulation S-X, Article 7, Insurance Companies

•

Regulation S-X, Article 10, Interim Financial Statements

•

Regulation S-X, Article 12, Form and Content of Schedules

•

SABs reflect the SEC staff's views regarding accounting-related disclosure practices. They represent
interpretations and policies followed by the Division of Corporation Finance and the Office of the
Chief Accountant in administering the disclosure requirements of the federal securities laws.

•

FRRs adopt, change, or interpret requirements relating to accounting, auditing, and disclosure
issues.

•

The Sarbanes-Oxley Act of 2002

•

Rules and standards of the Public Company Accounting Oversight Board
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Illustrative Financial Statements
.01 This section contains illustrative financial statements prepared in conformity with generally accepted
accounting principles (GAAP). The financial statements are for illustrative purposes only, are not intended
to be comprehensive and are not intended to establish preference among alternative principles acceptable
under GAAP. Decisions about the application of the GAAP discussed in the accounting and financial re
porting sections of the AICPA Audit and Accounting Guide Life and Health Insurance Entities (2008) should
not be made by reference to the illustrative financial statements but by a careful reading to the specified
authoritative literature. The illustrative financial statements reflect many of the minimum disclosure require
ments for a life and health insurance entity but do not include all of the amounts or transactions discussed
in other chapters of the guide or that might be found in practice. For example, the illustrative notes indicate
the subject matter generally required to be disclosed, but they should be expanded, reduced, or otherwise
modified to suit individual circumstances based on a careful reading of the specified authoritative literature.

.02 The illustrative financial statements do not include other transactions not unique to life and health
insurance entities, such as disclosures about segments, employee benefit plans, certain risks and uncertain
ties, or postemployment benefits other than pensions. Preparers and auditors should consult authoritative
pronouncements for guidance on presenting such other information.
.03 The illustrative financial statements do not reflect rules and releases of the Securities and Exchange
Commission (SEC) that, for SEC registrants, have an authority similar to other officially established account
ing principles. SEC Regulation S-X, Article 7, Insurance Companies, should be referred to.

.04 Auditors of SEC-registrant financial statements are reminded that, in May 2007, the Public Company
Accounting Oversight Board (PCAOB) adopted Auditing Standard No. 5, An Audit of Internal Control Over
Financial Reporting That Is Integrated with An Audit of Financial Statements (AICPA, PCAOB Standards and
Related Rules, Rules of the Board, "Standards"), which was later approved by the SEC on July 25, 2007. This
standard replaces Auditing Standard No. 2, An Audit of Internal Control Over Financial Reporting Performed in
Conjunction With an Audit of Financial Statements. Auditing Standard No. 5 is principles-based and presents
a risk-based, top-down approach designed to increase the likelihood that material weaknesses will be found
before resulting in a material misstatement of a company's financial statements, while eliminating unneces
sary procedures. The standard was also designed to make audits more scaleable for smaller or less complex
companies. This new standard is required for all audits of internal control for fiscal years ending on or after
November 15, 2007. However, early adoption is permitted and encouraged. For more information, readers
may refer to the AICPA Audit Risk Alert titled SEC and PCAOB Developments—2008 (product no. 022498kk).
.05 The illustrative financial statements also do not reflect the impact of laws and regulations of the
insurance entity's state of domicile. The impact on the financial statements of such laws and regulations
vary by state. Many states require conformity with the codification of statutory accounting practices in the
National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures Manual to the
extent it does not conflict with its own state laws and regulations. Refer to the NAIC Accounting Practices
and Procedures Manual, NAIC Annual Statement Instructions, and specific state laws and regulations to deter
mine the impact of codification and individual state laws and regulations.
.06 These illustrative financial statements are not intended to include items that should be accounted for
under the requirements of Financial Accounting Standards Board (FASB) Statement of Financial Accounting
Standards No. (SFAS) 133, Accounting for Derivative Instruments and Hedging Activities, and, therefore, do not
reflect the requirements of SFAS 133 or its amendments. Practitioners should refer to SFAS 133 and related
amendments for guidance on reporting derivative instruments and hedging activities.
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Life and health insurance entities generally present unclassified balance sheets.

.08 Also, preparers and auditors of SEC-registrant financial statements are reminded that as discussed
in Staff Accounting Bulletin No. 74, Topic 11M, Disclosure of the Impact that Recently Issued Accounting Stan
dards will have on the Financial Statements of the Registrant when Adopted in a Future Period, and Interpretation
No. 3, "The Impact on an Auditor's Report of an FASB Statement Prior to the Statement's Effective Date" of
AU section 410, Adherence to Generally Accepted Accounting Principles (AICPA, Professional Standards, vol. 1,
AU sec. 9410, paragraphs .13-18), filings with the SEC that include financial statements for a period ending
after the issuance of an accounting standard but before the required date of adoption of that accounting
standard should include disclosure of the impact that the recently issued accounting standard will have on
the financial position and results of operations of the registrant when such standard is adopted in a future
period. The following disclosures should be considered by registrants:
•

A brief description of the new standard, the date that adoption is required and the date that the
registrant plans to adopt, if earlier.

•

A discussion of the methods of adoption allowed by the standard and the method expected to be
utilized by the registrant, if determined.

•

A discussion of the impact that adoption of the standard is expected to have on the financial state
ments of the registrant, unless unknown or not reasonably estimable. In that case, a statement to
that effect may be made.

•

Disclosure of the potential impact of other significant matters that the registrant believes might re
sult from the adoption of the new standard (such as technical violations of debt covenant agree
ments and planned or intended changes in business practices).
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ABC LIFE INSURANCE COMPANY
Balance Sheet

December 31, 20X2 and 20X1
(Amounts in Thousands)
Assets
Investments:
Debt and equity securities:
Fixed maturities, held to maturity, at amortized cost
(estimated fair value: $47,830 in 20X2 and $45,255 in 20X1)
Fixed maturities, available for sale, at estimated fair value
(amortized cost: $247,525 in 20X2 and $219,565 in 20X1)
Trading account securities, at estimated fair value
(cost: $4,220 in 20X2 and $4,419 in 20X1)
Mortgage loans
Real estate
Policy loans
Short-term investments
Total investments
Cash and cash equivalents
Accrued investment income
Premiums due and other receivables,1 net of allowance
of $4,500 and $2,100 for doubtful accounts
Reinsurance receivable on paid and unpaid losses
Reinsurance receivable related to contract holder liabilities
Deferred policy acquisition costs
Property and equipment, net of accumulated depreciation
Other assets
Separate account assets
Total assets

Liabilities
Future policy benefits
Guaranteed interest contracts
Policyholders funds on deposit
Unpaid claims
Policyholders dividends
Amounts held in escrow and accrued expenses
Deferred federal income taxes
Other liabilities
Separate account liabilities
Total liabilities
Commitments and contingencies (Note 12)

20X2

20X1

$ 44,864

$ 46,310

255,893

214,563

3,950
79,258
6,410
43,549
7,515
441,439
5,285
6,660

4,190
106,692
6,147
51,013
6,321
435,236
3,343
8,026

1,647
596
5,714
38,936
501
152
732
$501,662

1,092
407
3,048
36,429
420
158
525
$488,684

$345,887
21,342
49,408
5,418
2,335
4,977
1,412
253
732
431,764

$341,207
23,555
46,202
4,737
3,450
4,562
1,027
4,465
525
429,730
(continued)

1 Statement of Position (SOP) 01-6, Accounting by Certain Entities (Including Entities With Trade Receivables) That Lend to or Finance the
Activities of Others (AICPA, Technical Practice Aids, ACC sec. 10,850), requires, among other things, that the summary of significant
accounting policies include the basis for accounting for trade receivables, and the classification and method of accounting for other
receivables. SOP 01-6 requires that a description of the accounting policies and methodology the entity used to estimate its allowance for
doubtful accounts be included in the notes to the financial statements. Such a description should identify the factors that influenced
management's judgment and may also include discussion of risk elements relevant to particular categories of financial instruments. In
addition, SOP 01-6 requires that the summary of significant accounting policies include the policy for charging off uncollectible trade
receivables.
SOP 01-6 contains other presentation and disclosure requirements that may apply to the financial statements of insurance entities.
Readers should refer to the full text of SOP 01-6.
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Shareholders' Equity
Capital stock: authorized—5,000,000 shares of $2 par value;
3,341,624 shares issued and outstanding
Retained earnings
Accumulated other comprehensive income
Total shareholders' equity
Total liabilities and shareholders' equity
See accompanying notes to financial statements.
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20X1

6,683
57,776
5,439
69,898
$501,662

6,683
55,522
(3,251)
58,954
$488,684
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ABC LIFE INSURANCE COMPANY

Statements of Income
Years Ended December 31, 20X2 and 20X1

(Amounts in Thousands)
20X2

20X1

$24,833
10,141
20
1,961
32,998

$24,783
9,153
43
1,844
35,141

Premiums and Other Revenues
Premiums:
Life and annuity premiums
Accident and health premiums
Other premiums
Contract holder fees
Net investment income
Net realized gains (losses) on investments and
other
Total premiums and other revenues

Benefits and Other Expenses
Policyholder benefits
Interest credited to policyholder accounts
General expenses
Amortization of deferred policy acquisition costs
Underwriting, acquisition, and insurance expenses
Policyholders' dividends
Total benefits and expenses
Income before income taxes

Income taxes:
Current
Deferred
Total income taxes
Net income
Net income per common share
Dividends per common share

4,222
74,175

(2,670)
68,294

39,158
4,363
4,288
1,276
18,029
4,665
71,779
2,396

30,815
4,156
4,984
1,305
17,266
6,898
65,424
2,870

1,547
(1,405)
142
2,254

601
540
1,141
1,729

.67
—

.52
.98

See accompanying notes to financial statements.
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ABC LIFE INSURANCE COMPANY

Statements of Comprehensive Income (Loss)
Years Ended December 31, 20X2 and 20X1

(Amounts in Thousands)

Net income
Other comprehensive income (loss)
Total comprehensive income (loss)

20X2

20X1

$ 2,254
8,690
$10,944

$ 1,729
(1,730)
$
(1)

See Note 5 to the financial statements for information about other comprehensive income (loss).
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ABC LIFE INSURANCE COMPANY
Statement of Changes in Shareholders' Equity
Years Ended December 31, 20X2 and 20X1
(Amounts in Thousands)

Balance at January 1, 20X1
Net income for 20X1
Shareholders' dividends
Other comprehensive income (loss)
Balance at December 31, 20X1
Net income for 20X2
Other comprehensive income
Balance at December 31, 20X2

Capital
Stock
$6,683
—
—
—
6,683
—
—
$6,683

Retained
Earnings
$57,068
1,729
(3,275)
—
55,522
2,254
—
$57,776

Accumulated
Other
Comprehensive
Income (Loss)
$(1,521)
—
—
(1,730)
(3,251)
—
8,690
$ 5,439

Total
Shareholders'
Equity
$62,230
1,729
(3,275)
(1,730)
58,954
2,254
8,690
$69,898

See accompanying notes to financial statements.
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.13
ABC LIFE INSURANCE COMPANY

Statements of Cash Flows
Years Ended December 31, 20X2 and 20X1
(Amounts in Thousands)

20X1

20X2
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net
cash provided by operating activities:
Interest credited to universal life policies
Accrual of discount on investments, net
Net realized (gains) losses on investments
Depreciation and amortization
Amortization of deferred policy acquisition costs
Deferred federal income taxes
Change in operating assets and liabilities:
Accrued investment income
Capitalization of deferred policy acquisition costs
Policy liabilities
Other items, net
Net cash provided by operating activities

2,254

$

$

1,729

7,927
(976)
(4,222)
3,041
1,276
(2,538)

10,445
(1,328)
2,670
3,534
1,305
540

1,366
(3,783)
(3,440)
(644)

880
(6,645)
(16,234)
3,269
165

261

Cash flows from investing activities:

Cost of investments purchased:
Fixed maturities and equity securities
Mortgage loans and real estate
Proceeds from investments sold, redeemed, or matured:
Fixed maturities and equity securities
Mortgage loans and real estate
Policy loans, net
Short-term investments, net
Net cash provided by investing activities
Cash flows from financing activities:
Dividends to shareholders
Receipts from universal life policies credited to contract
holder account balances
Return of contract holder account balances on universal
life policies
Withdrawals from interest-sensitive contracts
Cash used in financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental cash flow information:
Income taxes paid

See accompanying notes to financial statements.
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(228,053)
(921)

(122,495)
—

206,051
27,970
2,320
409
7,776

95,177
18,621
6,468
15,446
13,217

—

(3,275)

7,918

8,365

(4,165)
(9,848)
(6,095)
1,942
3,343
$ 5,285

(3,718)
(13,046)
(11,674)
1,708
1,635
$ 3,343

$

1,205

$

785
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.14

ABC LIFE INSURANCE COMPANY
Notes to Financial Statements

Years Ended December 31, 20X2 and 20X1

Note 1: Organization and Significant Accounting Policies
Organization. ABC Life Insurance Company (ABC or the company) is a stock life insurance com
pany incorporated in the state of ABC that offers individual life, disability income, long-term care,
annuity, and investment products. ABC does business in the continental United States, with a
concentration in New York, New Jersey, and Connecticut.
Basis of presentation. The significant accounting policies followed by ABC that materially affect
financial reporting are summarized as follows. The accompanying financial statements have been
prepared in accordance with generally accepted accounting principles (GAAP) that differ from
statutory accounting practices (SAP) used for regulatory authorities. The preparation of the finan
cial statements in conformity with GAAP requires management to make estimates and assump
tions that affect the reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates.

Investments. Fixed maturity securities available for sale consist of bonds, notes, and redeemable
and nonredeemable preferred stock not classified as either trading or held to maturity, and are
reported at estimated fair value. Unrealized holding gains and losses, net of tax, on available-forsale securities are reported as a net amount in other comprehensive income. Deferred policy ac
quisition cost offsets for universal life type contracts and amounts attributable to certain partici
pating contracts are recorded as a separate component of accumulated other comprehensive
income. Fixed maturity securities held to maturity consist of bonds, notes, redeemable and non
redeemable preferred stock which the insurance company has the intent and ability to hold to
maturity, and are reported at amortized cost and adjusted for amortization of premium or dis
count. Declines in fair value of individual held-to-maturity and available-for-sale securities below
their cost that are other then temporary have resulted in write-downs of the individual securities
to their fair value. The related write-downs have been included in earnings as realized losses.
Trading account securities consist of bonds, notes, and redeemable and nonredeemable preferred
stock, and common stock held principally for resale in the near term, and are recorded at their
estimated fair values. Realized and unrealized gains and losses on trading account securities are
included in other income.

Mortgage loans on real estate are carried at unpaid balances and are adjusted for amortization of
premium or discount, less allowance for losses. Real estate held for sale is carried at the lower of
depreciated cost or fair value less estimated selling costs. Real estate classified as held-for-sale is
no longer depreciated. Real estate, including real estate acquired in satisfaction of debt, is carried
at depreciated cost. Impaired real estate is written down to fair value with the impairment loss
being included in net realized gains (losses) on investments and other. Upon foreclosure (includ
ing in-substance foreclosure), the carrying value of the property is recorded at the lower of cost
or fair value (less selling costs if to be sold), which becomes its new cost basis. The estimated fair
value for real estate is determined based upon independent appraisals and other available infor
mation about the property, which may take into consideration a number of factors, including (i)
discounted cash flows, (ii) sales of comparable properties, (iii) geographic location of property
and related market conditions, and (iv) disposition costs.
Foreclosed properties are actively managed by the company in order to maximize their value.
Subsequent to foreclosure, the carrying value of the property is periodically evaluated and a val
uation allowance is established, if necessary, to reflect any additional amounts considered unre
coverable upon sale. At the time of the sale, the difference between the sales price and the carry
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ing value is recorded as a realized gain or loss. Policy loans are carried at unpaid balances.
Short-term investments are stated at amortized cost, which approximates fair value.
•
Provisions for impairments of securities classified as held to maturity are included in net realized
gains (losses) on investments and other. Realized gains and losses are determined by specific
identification.

Cash and cash equivalents. Cash equivalents are carried at cost, which approximates fair value.
Cash equivalents are highly liquid financial instruments with an original maturity of three
months or less.
Deferred policy acquisition costs. Commissions and other costs of acquiring traditional life insur
ance, universal life insurance and investment products, and accident and health insurance, that
vary with and are primarily related to the production of new and renewal business, have been
deferred. Traditional life insurance and accident and health insurance acquisition costs are being
amortized over the premium-paying period of the related policies using assumptions consistent
with those used in computing future policy benefit liabilities. For universal life-type contracts and
investment contracts that include significant surrender charges or that yield significant revenues
from sources other than the investment of contract holders' funds, the deferred contract acquisi
tion cost amortization is matched to the recognition of gross profit.
Otherwise, deferred policy acquisition costs on investment contracts are amortized using an ac
counting method that recognizes acquisition costs as expenses at a constant rate applied to net
policy liabilities. The effect on the deferred acquisition costs (DAC) asset that would result from
realization of unrealized gains (losses) is recognized with an offset to accumulated other compre
hensive income in consolidated shareholders' equity as of the balance sheet date.
Effective January 1, 2007, the company adopted Statement of Position (SOP) 05-1, Accounting by
Insurance Enterprises for Deferred Acquisition Costs in Connection With Modifications or Exchanges of
Insurance Contracts (AICPA, Technical Practice Aids, ACC sec. 10,920), which provides guidance on
accounting by insurance enterprises for DAC on internal replacements of insurance and invest
ment contracts other than those specifically described in Financial Accounting Standards Board
(FASB) Statement of Financial Accounting Standards No. (SFAS) 97, Accounting and Reporting by
Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and Losses from the
Sale of Investments. SOP 05-1 defines an internal replacement and is effective for internal replace
ments occurring in fiscal years beginning after December 15, 2006. In addition, in February 2007,
the AICPA issued related Technical Practice Aids (TPAs) to provide further clarification of SOP
05-1. The TPAs became effective concurrently with the adoption of SOP 05-1. As a result of the
adoption of SOP 05-1 and the related TPAs, if an internal replacement modification substantially
changes a contract, then the DAC is written off immediately through income and any new defer
rable costs associated with the new replacement are deferred. If a contract modification does not
substantially change the contract, the DAC amortization on the original contract will continue
and any acquisition costs associated with the related modification are immediately expensed.
The adoption of SOP 05-1 and the related TPAs resulted in a reduction to DAC and value of
business acquired on January 1, 2007, and an acceleration of the amortization period relating
primarily to the company's group life and health insurance contracts that contain certain rate
reset provisions. Prior to the adoption of SOP 05-1, DAC on such contracts was amortized over
the expected renewable life of the contract. Upon adoption of SOP 05-1, DAC on such contracts
is to be amortized over the rate reset period. The impact as of January 1, 2007, was a cumulative
effect adjustment of $XXX, net of income tax of $XXX, which was recorded as a reduction to
retained earnings.

Deferred sales inducements. Costs related to sales inducements offered on sales to new customers,
principally on investment contracts and primarily in the form of additional credits to the cus
tomer's account value or enhancements to interest credited for a specified period, which are be
yond amounts currently being credited to existing contracts, are deferred and recorded as other
assets. All other sales inducements are expensed as incurred and included in interest credited to
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contract holders' funds. Deferred sales inducements are amortized to income using the same
methodology and assumptions as DAC, and are included in interest credited to contract holders'
funds. Deferred sales inducements are periodically reviewed for recoverability and written down
when necessary.

Property and equipment. Property and equipment are reported at cost, net of accumulated depre
ciation of $1,915,000 and $1,721,000 in 20X2 and 20X1, respectively. Property and equipment are
depreciated using the straight-line method over their estimated useful lives.
Future policy benefits and expenses. The liabilities for traditional life insurance and accident and
health insurance contract benefits and expenses are computed using a net level premium method
including assumptions about investment yields, mortality, withdrawals, and other assumptions
based on ABC's experience modified as necessary to reflect anticipated trends and to include
provisions for possible unfavorable deviations. Liability interest assumptions are graded and
range from 3 percent to 10 percent. Benefit liabilities for traditional life insurance contracts in
clude certain deferred profits on limited-payment policies that are being recognized in income
over the contract term. Contract benefit claims are charged to expense in the period that the
claims are incurred.

The accrued account balance for nontraditional life insurance and investment contracts is com
puted as deposits net of withdrawals made by the contract holder, plus amounts credited based
on contract specifications, less contract fees and charges assessed, plus any additional interest.
Interest crediting rates for universal life and investment products range from 5.50 percent to 9.25
percent.

Included in contract holders' account balances is a provision for contract holder dividends. Ben
efit liabilities for contract holders' account balances are computed under a retrospective deposit
method and represent contract account balances before applicable surrender charges. Contract
benefits and claims that are charged to expense include benefit claims incurred in the period in
excess of related contract account balances. Interest crediting rates for universal life and invest
ment products range from 5.50 percent to 9.25 percent. Benefits and expenses are charged against
the account balance to recognize costs as incurred over the estimated lives of the contracts. Ex
penses include interest credited to contract account balances and benefits paid in excess of con
tract account balances.
Minimum guarantees. The company issues variable annuity contracts through separate accounts
where the company contractually guarantees to the contract holder total deposits made to the
contract less any partial withdrawals plus a minimum return. This guarantee includes benefits
that are payable in the event of death, annuitization, or at specified dates during the accumulation
period.

Accounting policy for health liabilities. Unpaid claims on accident and health policies represent the
estimated liability for benefit expenses both reported but not paid and incurred but not reported
to ABC through December 31. ABC does not discount its liabilities for unpaid claims. Liabilities
for unpaid claims are estimated using individual case-basis valuations and statistical analyses.
Those estimates are subject to the effects of trends in claim severity and frequency. Although
considerable variability is inherent in such estimates, management believes that the liabilities for
unpaid claims are adequate. The estimates are continually reviewed and adjusted as necessary as
experience develops or new information becomes known; such adjustments are included in cur
rent operations.
Income taxes. Federal income taxes are charged or credited to operations based upon amounts
estimated to be payable or recoverable as a result of taxable operations for the current year. De
ferred income taxes have been provided for temporary differences between the tax basis of assets
and liabilities calculated using the criteria of SFAS 109, Accounting for Income Taxes, as amended
by FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes—an interpretation of
FASB Statement No. 109, and their reported amounts in the financial statements using enacted
income tax rates and laws. The company recognizes interest and penalties accrued on any unre-
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cognized tax benefits as a component of income tax expense. The company did not have any
accrued and recognized interest or penalties associated with unrecognized tax benefits for the
years ending December 31, 20X2 and 20X1.1
Reinsurance. In the normal course of business, the company seeks to limit its exposure to loss on
any single insured and to recover a portion of benefits paid by ceding reinsurance to other insur
ance entities or reinsurers under excess coverage and coinsurance contracts. The company retains
a maximum of $400,000 of coverage per individual life. Amounts paid or deemed to have been
paid for reinsurance contracts are recorded as reinsurance receivable.

Insurance premium revenues. Traditional life premiums, which include those products with fixed
and guaranteed premiums and benefits and consist principally of whole life insurance contracts,
limited-payment life insurance contracts, and certain annuities with life contingencies, are gener
ally recognized as revenue when due. Revenues on universal life and investment-type contracts
consist of contract charges against contract holders' funds for the cost of insurance, administra
tion, surrender charges, actuarial margin, and other fees. Accident and health insurance premi
ums are recognized as revenue pro rata over the terms of the contracts.
Separate accounts. Separate account assets and liabilities generally represent funds maintained in
accounts to meet specific investment objectives of contract holders who bear the investment risk.
Investment income and investment gains and losses accrue directly to such contract holders. The
assets supporting the variable portion of both traditional variable annuities and variable contracts
with guarantees are carried at fair value and reported as summary total separate account assets
with an equivalent summary total reported for liabilities. Amounts assessed against the contract
holders for mortality, administrative, and other services are included in revenue and changes in
liabilities for minimum guarantees are included in policyholder benefits in the statement of op
erations. Separate account net investment income, net investment gains and losses, and the re
lated liability changes are offset within the same line item in the statement of operations.
Business risks and uncertainties. The development of liabilities for future policy benefits for the
company's products requires management to make estimates and assumptions regarding mortal
ity, morbidity, lapse, expense, and investment experience. Such estimates are primarily based on
historical experience and future expectations of mortality, morbidity, expense, persistency, and
investment assumptions. Actual results could differ materially from those estimates. Management
monitors actual experience and, if circumstances warrant, revises its assumptions and the related
future policy benefit estimates.
The company's investments are primarily comprised of fixed maturity securities, equity securi
ties, real estate, and mortgage loans. Significant changes in prevailing interest rates and geo
graphic conditions may adversely affect the timing and amount of cash flows on such invest
ments and their related values. In addition, the value of these investments is often derived from
an appraisal, an estimate or opinion of value. A significant decline in the fair value of these in
vestments could have an adverse effect on the company's balance sheet.

The company regularly invests in mortgaged backed securities (MBS) and other securities subject
to prepayment and call risk. Significant changes in prevailing interest rates may adversely affect
the timing and amount of cash flows on such securities. In addition, the amortization of market
premium and accretion of market discount for MBS is based on historical experience and esti
mates of future payment speeds on the underlying mortgage loans. Actual prepayment speeds
will differ from original estimates and may result in material adjustments to amortization or ac
cretion recorded in future periods.
Codification. The National Association of Insurance Commissioners (NAIC) revised the Accounting
Practices and Procedures Manual in a process referred to as codification. Codification became effec
tive on January 1, 2001. The company's state of domicile has adopted the provisions of the revised
1 Because these standards are not insurance industry specific, transition and adoption specifics are excluded.
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manual effective January 1, 2001. The revised manual has changed to some extent, prescribed
SAP, and has resulted in changes to the company's statutory-basis financial statements. The cu
mulative effect of changes in accounting principles adopted to conform to the revised Accounting
Practices and Procedures Manual of $______has been reported as an adjustment to increase (de
crease) surplus in the company's statutory-basis financial statements as of January 1, 2001.

Guaranty funds. Guaranty fund (and other) assessments are accrued at the time the events occur
on which assessments are expected to be based.

Note 2: Earnings Per Common Share
Basic and diluted earnings per common share are as follows.

(Thousands, except per
common share data)

Income
(Numerator)

Shares
(Denominator)

Per Common
Share Amount

20X2
Net income
Income applicable to common ownership

2,254
2,254

3,342

.67

20X1
Net income
Income applicable to common ownership

1,729
1,729

3,342

.52

Note 3: Investments
In reporting disclosures about investments in securities, entities should comply primarily with
the requirements of paragraphs 6,17, and 19-22 of SFAS 115, Accounting for Certain Investments in
Debt and Equity Securities (as amended); paragraphs 17-18 of FSP FAS 115-1 and 124-1, The Mean
ing of Other-Than-Temporary Impairment and Its Application to Certain Investments; paragraphs
47-48 of SFAS 60, Accounting and Reporting by Insurance Enterprises (as amended); paragraphs
22-23 and 28 of SFAS 91, Accounting for Nonrefundable Fees and Costs Associated with Originating or
Acquiring Loans and Initial Direct Costs of Leases—an amendment ofFASB Statements No. 13, 60, and
65 and a rescission of FASB Statement No. 17 (as amended); and appendix C of the Audit and
Accounting Guide Life and Health Insurance Entities. Other disclosure requirements may also be
applicable.
Note 4: Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of
financial instruments for which it is practicable to estimate that value in conformity with SFAS
157, Fair Value Measurements, and SFAS 159, The Fair Value Option for Financial Assets and Financial
Liabilities—Including an amendment ofFASB Statement No. 115.
Short-term investments. For those short-term instruments amortized cost is a reasonable estimate
of fair value.
Investment securities and trading account assets. For securities held for trading purposes and mar
ketable equity securities held for investment purposes, fair values are based on quoted market
prices or dealer quotes. For other securities held as investments, fair value equals quoted market
price, if available. If a quoted market price is not available, fair value is estimated using quoted
market prices for similar securities.

Mortgage loans on real estate and policy loans. The fair value of mortgage loans on real estate is
estimated using discounted cash flows. The fair value of policy loans is estimated by discounting
the future cash flows using reasonable assumptions for mortality and repayments and using the
current rates at which similar loans would be made to contract holders with similar credit ratings
and the same remaining maturities.
The estimated fair values of ABC's mortgage loans on real estate and policy loans are as follows.

FSP §20,600.14

180

Life and Health Insurance Entities

20X1

20X2

(Amounts in thousands)

Fair
Value
$83,506
60,000

Carrying
Amount

Mortgage loans on real estate
Policy loans

$79,258
43,549

Carrying
Amount
$106,692
51,013

Fair
Value
$112,027
59,000

Note 5: Accumulated Other Comprehensive Income
Accumulated other comprehensive income (loss) represents cumulative gains and losses on items
that are not reflected in earnings. The balances and activity for the years 20X2 and 20X1 are as
follows.
20X2

20X1

(Amounts in thousands)

Changes in net unrealized gains (losses) on investment securities:
Net unrealized gains (losses) arising during the period
Reclassification adjustment for gains (losses) included
in net earnings
Changes in net unrealized gains (losses) on investment securities
Adjustments for:
Policyholder liabilities, deferred acquisition costs and deferred
federal income taxes
Changes in net unrealized gains (losses) net of adjustments
Total other comprehensive income (loss)

$13,324

$(1,873)

46
13,370

(300)
(2,173)

(4,680)
8,690
$ 8,690

443
(1,730)
$(1,730)

Note 6: Income Taxes

Significant components for income tax expense attributable to continuing operations are as follows.
20X2

20X1

(Amounts in thousands)
Current income tax expense
Deferred income tax (benefit) expense
Total income tax expense

$ 1,547
(1,405)
$ 142

$ 601
540
$1,141

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts
of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.
Significant components of the company's deferred tax liabilities and assets are as follows.
December 31,
December 31,
20X2
20X1
(Amounts in thousands)

Deferred tax liabilities:
Deferred policy acquisition costs
Future policy benefits
Accrual of discount on bonds
Other
Total deferred tax liabilities
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—
924
3,641
17,696

$12,297
512
1,982
1,024
15,815
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December 31,
December 31,
20X2
20X1
(Amounts in thousands)

Deferred tax assets:
Policyholder dividends
Future policy benefits
Deferred policy acquisition costs
Investment valuation allowance
Retirement plan accruals
Tax credits and loss carryforwards
Investment income differences
Other
Total deferred tax assets
Valuation allowance for deferred tax assets
Net deferred tax assets
Net deferred tax liabilities

8,067
851
2,078
1,087
1,917
1,820
574
406
16,800

(516)
16,284
$ 1,412

8,224
—
1,561
1,651
497
1,945
556
354
14,788
—
14,788
$ 1,027

A valuation allowance has been established due to the uncertainty of realized certain tax credits
and loss carryforwards, and a portion of other deferred tax assets.

A reconciliation of federal income tax expense as presented in the financial statements and in
come taxes calculated using the statutory corporate tax rate follows.

20X1
20X2
(Amounts in thousands)
Income from operations
Application of income tax rate
Small company deduction for life insurance companies
Policyholders' share of income (loss) in excess of (less than)
dividends paid
Dividend received deduction
Other
Total tax expense

$2,396
838
(556)

$2,870
1,005
(496)

(264)
(3)
127
$ 142

752
(50)
(70)
$1,141

Reconciliation of Unrecognized Tax Benefits

20X1
20X2
(Amounts in thousands)
Beginning Balance
Prior period position increases
Prior period position decreases
Current period position increases
Current period position decreases
Decreases relating to settlements with taxing authorities
Reductions due to a lapse of applicable statue of limitations
Ending balance

$XXX
XXX
(XXX)
XXX
(XXX)
(XXX)
(XXX)
XXX

$XXX
XXX
(XXX)
XXX
(XXX)
(XXX)
(XXX)
XXX

None of the aforementioned unrecognized tax benefits, if recognized, would affect the effective
tax rate. Additionally, no tax positions exist for which it is reasonably possible that the total
amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of
December 31, 20X2. No interest or penalties were recognized in the statement of operations or the
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statement of financial position for the years ending December 31, 20X2 and 20X1. Tax years that
remain subject to examination by major tax jurisdictions include the years ending December 31,
19X9-20X2.

Note 7: Financial Instruments With Off-Balance Sheet Risk and Concentration of Credit Risk
At December 31, 20X2, ABC held unrated or less-than-investment grade corporate debt securities
of $8,000,000, net of allowance for losses, with an aggregate market value of $7,500,000. Those
holdings amounted to 4 percent of ABC's corporate debt securities investments and less than 2
percent of total assets. The holdings of less-than-investment grade securities are widely diversi
fied and of satisfactory quality based on ABC's investment policies and credit standards. ABC
also invests in mortgage loans principally involving commercial real estate. At December 31,
20X2, 3 percent of such mortgages ($2,000,000) involved properties located in California and Ar
izona. Such investments consist of first mortgage liens on completed income-producing proper
ties, and mortgages on individual properties do not exceed $300,000.

Note 8: Liability for Unpaid Claims
The liability for unpaid claims and claim adjustment expenses is based on the estimated amount
payable on claims reported prior to the balance sheet date that have not yet been settled, claims
reported subsequent to the balance sheet date that have been incurred during the period then
ended, and an estimate (based on prior experience) of incurred but unreported claims relating to
such period.

Activity in the liability for unpaid claims and claim adjustment expenses for the company's health
and disability coverages is summarized as follows.
20X2

20X1

(Amounts in thousands)

Balance, beginning of year
Less: reinsurance recoverables
Net balance, beginning of year
Amount incurred, related to
prior years
Current year
Total
Amount paid, related to
prior years
Current year
Total
Net balance, end of year
Plus: reinsurance recoverables
Balance, end of year

$ 4,737
296
4,441
$

(297)
26,197
25,900

6,923
18,303
25,226
5,115
303
$ 5,418

$ 7,669
1,018
6,651

313
25,671
25,984

$

8,937
19,257
28,194
4,441
296
$ 4,737

As a result of changes in estimates of insured events in prior years, the provision of claims and
claim adjustment expenses (net of reinsurance recoveries of $(7,000) and $722,000 in 20X2 and
20X1, respectively) decreased by $297,000 in 20X2 reflecting lower-than-anticipated losses on
___________ , and increased by $313,000 in 20X1 reflecting higher-than-anticipated losses and
related expenses for claims for____________
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Note 9: Minimum Guarantees
The following summarizes the liabilities for guarantees on variable contracts reflected in the general
account.

Balance at January 1
Incurred guarantee
benefits1
Paid guarantee
benefits
Balance at
December 31, 20XX1
2

Guaranteed
Minimum
Accumulation
Benefit (GMAB)

Guaranteed
Minimum Income
Benefit (GMIB)

Totals

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

Minimum
guaranteed Death
Benefit (MGDB)
$X,XXX,XXX

The minimum guaranteed death benefit (MGDB) liability is established equal to a benefit ratio
multiplied by the cumulative contract charges earned, plus accrued interest less contract benefit
payments. The benefit ratio is calculated as the estimated present value of all expected contract
benefits divided by the present value of all expected contract charges. The company regularly
evaluates estimates used and adjusts the additional liability balance, with a related charge or
credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions
should be revised.
The following assumptions and methodology were used to determine the MGDB liability at De
cember 31, 20XX:
•

Data used was 1,000 stochastically generated investment performance scenarios.

•

Mean investment performance assumption was XX.

•

Volatility assumption was XX.

•

Mortality was assumed to be 90 percent of the Annuity 2000 table.

•

Lapse rates vary by contract type and duration and range from 1 percent to 20 percent,
with an average of 3 percent.

•

Discount rate was XX percent.

Guaranteed minimum accumulation benefits are considered to be derivatives under SFAS 133,
Accounting for Derivative Instruments and Hedging Activities, as amended, and are recognized at fair
value through earnings.
The guaranteed minimum income benefit (GMIB) liability is established equal to a benefit ratio
multiplied by the cumulative contract charges earned, plus accrued interest less contract benefit
payments. The benefit ratio is calculated as the estimated present value of all expected contract
benefits divided by the present value of all expected contract charges. The company regularly
evaluates estimates used and adjusts the additional liability balance, with a related charge or
credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions
should be revised. The assumptions used for calculating the GMIB liability at December 31,20XX,
are consistent with those used for calculating the MGDB liability. Underlying assumptions for the
liability related to income benefits include assumed future annuitization elections based on fac
tors such as the extent of benefit to the potential annuitant, eligibility conditions and the annui
1 For guaranteed minimum accumulation benefits, incurred guarantee benefits incorporates all changes in fair value other than
amounts resulting from paid guarantee benefits.
2 Included in the total reserve balance are reserves for variable annuity death benefits of $--------- , variable annuity income benefits of
$_____ and other guarantees of $______
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tant's attained age. In addition, the calculation of the GMIB liability assumes X percent of the
potential annuitizations that would be beneficial to the contract holder will be elected.

Note 10: Reinsurance
The company utilizes indemnity reinsurance agreements to reduce its exposure to large losses in
all aspects of its insurance business. Such reinsurance permits recovery of a portion of losses from
reinsurers, although it does not discharge the primary liability of the company as direct insurer
of the risks reinsured. The company evaluates the financial strength of potential reinsurers and
continually monitors the financial condition of reinsurers. The following tables include premium
amounts ceded or assumed to or from other companies.

Direct
Amount

20X2
Premiums:
Life insurance
Accident and health
Annuities
Total earned premiums

$2,090
1,440
3,130
$6,660

20X1
Premiums:
Life insurance
Accident and health
Annuities
Total earned premiums

$2,080
1,510
1,840
$5,430

Ceded to
Assumed from
Other Companies
Other Companies
(Amounts in thousands)

$ 560
1,290
—

$1,850

$ 520
1,370
—

$1,890

Net
Amount

$3,330
—
70
$3,400

$4,860
150
3,200
$8,210

$3,680
—
30
$3,710

$5,240
140
1,870
$7,250

Note 11: Separate Accounts

At December 31, 20X1 and 20X2, the company had the following variable contracts with guaran
tees. The company's variable annuity contracts may offer more than one type of guarantee in
each contract; therefore, the sum of amounts listed exceeds the total account balances of variable
annuity contracts' separate accounts with guarantees.

Return of net deposits plus a minimum return:
In the event of death

Account value

$XXX

$XXX

Net amount at risk1

$XXX

$XXX

Average attained age of contract holders
Range of guaranteed minimum return rates

XX
X-X%

XX

X-X%

At annuitization
Account value

$XXX

$XXX

Net amount at risk1
2

$XXX

$XXX

1 Defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.

2 Defined as the present value of the minimum guaranteed annuity payments determined in accordance with the terms of the contract
in excess of the current account balance.

FSP §20,600.14

185

Illustrative Financial Statements

Weighted average period remaining until expected annuitization
Range of guaranteed minimum return rates

XX

XX

X-X%

X-X%

Accumulation at specified date
Account value

$XXX

$XXX

Net amount at risk3

$XXX

$XXX

X-X%

X-X%

Range of guaranteed minimum return rates

Account balances of contracts with guarantees were invested in variable separate accounts as
follows:

Asset Type
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
Obligations of states of the United States and
political subdivisions of the states

December 31, 20X1

$

December 31, 20X2
$

Corporate debt securities:
—Investment grade
—Noninvestment grade
Foreign debt securities
Mortgage-backed securities
Equity securities (including mutual funds)4
Real estate
Mortgage loans
Derivative financial instruments
Cash and cash equivalents

Total

___________
$X,XXX,XXX

$X,XXX,XXX

Assets transferred from the general account to the separate accounts are recognized at fair value
to the extent of third-party contract holders' proportionate interest in separate accounts when the
arrangement meets applicable criteria (paragraph 11 of SOP 03-1, Accounting and Reporting by
Insurance Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts
[AICPA, Technical Practice Aids, ACC sec. 10,870]). The gains recognized assets transferred to the
separate accounts during 20X2 and 20X1 were XX,XXX and XX,XXX, respectively.

Note 12: Guaranty Fund Assessments
At December 31, 20X2 and 20X1, ABC has recorded $45,000 and $67,000, respectively, in liabilities
related to guaranty fund (and other) assessments which are included in other liabilities in the
balance sheet. At December 31, 20X2 and 20X1, the carried liability was reduced by recoverables
for related premium tax offsets and policy surcharges in the amount of $25,000 and $35,000, re
spectively. The period over which the assessments are expected to be paid and the recorded pre
mium tax offsets and policy surcharges are expected to be realized is up to five and four years,
respectively.

3 Defined as the present value of the guaranteed minimum accumulation balance in excess of the current account balance.
4 The insurance enterprise may want to consider disclosing mutual funds by investment objective or other meaningful groupings that
are useful in understanding the nature of the guarantee risk.
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Note 13: Statutory Financial Information

Under the law of ABC state, the state of incorporation, the maximum dividend that may be paid
(without prior approval of the ABC state insurance department), in any 12 month period is the
greater of (a) net investment income for the preceding calendar year or (b) 10 percent of contract
holders' surplus at the end of the preceding calendar year. In general, net investment income for
dividend purposes is interpreted by the insurance department to be the statutory pretax net in
vestment income including net realized capital losses but excluding net realized capital gains.
The maximum permissible amount of dividends for 20X3, based on statutory net investment in
come for 20X2, is $20,000.
The company, which is domiciled in ABC state, prepares its statutory financial statements in
accordance with accounting principles and practices prescribed or permitted by the ABC state
insurance department, which (state of domicile) recognizes for determining solvency under the
(state of domicile) insurance law. The commissioner of the state of domicile insurance department
has the right to permit other practices that may deviate from prescribed practices. Prescribed SAP
are those practices that are incorporated directly or by reference in state laws, regulations, and
general administrative rules applicable to all insurance enterprises domiciled in (state of domi
cile). Permitted SAP encompass all accounting practices that are not prescribed; such practices
differ from state to state, may differ from company to company within a state, and may change
in the future.
Note: Although the following reconciliation to statutory financial information is not required to
be disclosed in financial statements prepared in conformity with GAAP, insurance entities some
times include such disclosures to facilitate use of those financial statements for purposes of filing
with state regulatory authorities. The second disclosure on variances from NAIC SAP (defined as
follows) and permitted accounting practices is required under SOP 94-5, Disclosures of Certain
Matters in the Financial Statements of Insurance Enterprises (AICPA, Technical Practice Aids, ACC sec.
10,630), as amended by SOP 01-5, Amendments to Specific AICPA Pronouncements for Changes Re
lated to the NAIC Codification (AICPA, Technical Practice Aids, ACC sec. 10,840).

The following reconciles ABC's statutory net income and statutory surplus and capital stock de
termined in accordance with accounting practices prescribed or permitted by the insurance de
partment of Connecticut with net earnings (loss) and equity on a GAAP basis.
20X2

20X1

(Amount in thousands)

$ 3,572

$ 2,719

Statutory net income
Adjustments:
Future policy benefits and policyholders' account balances
Deferred policy acquisition costs
Deferred federal income tax (expense) benefit
Valuation of investments
Postretirement benefits
Other, net
GAAP net income

$ 2,254

894
40
540
270
354
(3,088)
$ 1,729

Statutory surplus and capital stock
Asset valuation reserves
Statutory surplus, capital stock and asset valuation reserves

$65,388
(1,054)
(875)

$54,505
(1,972)
(967)

Adjustments:
Fixed income securities
Future policy benefits and policyholders' account balances

(29,472)
115

(27,905)
270
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20X2
20X1
(Amount in thousands)

Deferred federal income taxes
Valuation of investments
Deferred policy acquisition costs
Postretirement benefits
Other, net
GAAP equity

(1,412)
772
38,936
(2,272)
(228)
$69,898

(1,027)
891
36,429
(2,354)
1,084
$58,954

The company's statutory financial statements are presented on the basis of accounting practices
prescribed or permitted by the [state of domicile] insurance department. [State of domicile] has
adopted the NAIC Accounting Practices and Procedures Manual as the basis of its SAP, except that
it has retained the prescribed practice of writing off goodwill immediately to statutory surplus in
the year of acquisition.
In addition, the commissioner of [state of domicile] insurance department has the right to permit
other specific practices that may deviate from prescribed practices. The commissioner has per
mitted the company to record its home office property at estimated fair value instead of at depre
ciated cost, as required by NAIC SAP. This accounting practice increased statutory capital and
surplus by $X million and $X million at December 31, 20X2 and 20X1, respectively, over what it
would have been had the permitted practice not been allowed. The company's statutory capital
and surplus, including the effects of the permitted practice, was $X million and $X million at
December 31, 20X2 and 20X1, respectively.

Had the company amortized its goodwill over ten years and recorded its home office property at
depreciated cost, in accordance with NAIC SAP, the company's capital and surplus would have
been $X million and $X million at December 31, 20X2 and 20X1, respectively.
Note 14: Commitments and Contingencies

Future minimum rental payments, principally for administrative offices, under noncancellable
operating leases at December 31, 20X2, are as follows: 20X3, $1,113,000; 20X4, $1,064,000; 20X5,
$1,011,000; 20X6, $976,000; 20X7, $976,000; and $3,906,000 thereafter. Rental expense was
$1,164,000 in 20X2 and $1,184,000 in 20X1.
ABC is named as defendant in a number of legal actions arising primarily from claims made
under insurance contracts or in connection with previous reinsurance agreements. These actions
have been considered in establishing its contract benefit liability. Management and its legal coun
sel are of the opinion that the settlement of these actions will not have a material effect on ABC's
financial position or results of operations.
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